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Short summary 
Butylated hydroxytoluene (BHT, E321) is a synthetic antioxidant authorised as food and feed 
additive in the EU. In addition, BHT is used in e.g. cosmetics and food contact materials. To 
our knowledge, risk assessments including exposure estimates for BHT from multiple sources 
and exposure pathways have not been performed.  
BHT is characterised by extensive use and multiple exposure sources and routes. Therefore, 
it is important that these sources and routes are included in the estimations to arrive at the 
most accurate picture of the population's exposure. In addition, the main sources 
contributing to the exposure should be identified.  
Toxicity 
An acceptable daily intake (ADI) of 0.25 mg/kg bodyweight (bw) per day was established by 
EFSA based on effects on the litter size and pup body weight in two 2-generation studies in 
rats (EFSA, 2012). The ADI was based on the no observed adverse effect level (NOAEL) of 
25 mg/kg bw per day in these two studies and an uncertainty factor of 100. The ADI was 
used as reference point for BHT toxicity in this risk assessment.  
Exposure  
The exposure was estimated for «realistic» and «high» scenarios. The consumption data 
used for the exposure estimation were from Norkost 3 (foods), EuroMix (foods and personal 
care products) and the Environmental Protection Agency (US; indoor dust). The 
concentration data used were from scientific literature, and identified through literature 
searches. The concentration data for the exposure estimation from foods and PCPs were 
limited and therefore considered to be the largest source of uncertainty in the exposure 
estimates. 
Data considered most realistic for the Norwegian exposure were used for «realistic» 
exposure estimation, whereas the «high» exposure scenario was a worst-case estimation 
representing a risk assessment for potentially high consumers. To calculate the total internal 
exposure, absorption factors for BHT uptake from the gastrointestinal tract and skin were 
used.  
BHT reaching the physical barriers in the body was defined as external exposure, and the 
absorbed BHT was defined as total internal exposure. 
The «realistic» total internal exposure from all routes, for the lowest 5 and the highest 95 
percentile, was estimated to be within 1.4 – 9.7 µg BHT/kg bw per day for females and 0.8 – 
9.7 µg BHT/kg bw per day for males. The 50 percentile was estimated to be within 3.5 – 4.2 
and 2.2 – 2.8 µg BHT/kg bw per day (rounded numbers) for females and males, 
respectively. The «high» total internal exposure  from all routes, for the lowest 5 and the 
highest 95 percentile, was estimated to be within 23 – 281 µg BHT/kg bw per day for 
females and 9 - 319 µg BHT/kg bw per day for males. The 50 percentile was estimated to be 
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within 85 – 111 and 46 – 61 µg BHT/kg bw per day (rounded numbers) for females and 
males, respectively. 
The predominant route of exposure is oral intake; on average 80% of the internal exposure 
in females is from food, dust and oral intake of PCPs, while for males even more (92%). 
Sources of BHT exposure were mainly from food through oral intake (females 41%, males 
59%, with substantial contributions also from PCPs through oral uptake (females 38%, males 
34%) and through dermal uptake from PCPs (females 21%, males 7.1%). The main 
contributors to the estimated dietary «realistic» external exposure were the food groups 
«milk, cream, ice cream», followed by «chewing gum» and «fatty fish». The personal care 
product categories «body lotion» and «deodorant»» were the two major contributors to the 
estimated dermal «realistic» external exposure. Oral exposure from personal care products 
was mainly from toothpaste. 
Risk characterisation and conclusions 
Both «realistic» and «high» total internal BHT exposure was used in the risk characterisation. 
The estimated «realistic» exposure was below the ADI for both women and men. The 50 
percentile of the estimated «high» exposure (the worst-case estimation representing a 
cautious risk assessment approach) was below the ADI, whereas the 95 percentile was 
above the ADI. Thus, a small fraction of the population may exceed the ADI and be at risk 
for negative effects on reproductive health. 
The Panel concludes that BHT exposure is unlikely to cause adverse health effects in adults. 
Key words: BHT, butylated hydroxytoluene, cosmetics, external exposure, food, indoor air, 
indoor dust, total internal exposure, Norwegian Scientific Committee for Food and 
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Kort sammendrag 
Butylert hydroksytoluen (BHT, E321) er en syntetisk antioksidant som er tillatt brukt i mat og 
fôr i EU. BHT brukes i tillegg i en rekke andre typer produkter, for eksempel i 
matkontaktmaterialer, kosmetikk og kroppspleieprodukter. 
Siden BHT brukes i så mange ulike typer produkter, er det viktig at hovedkildene til BHT 
eksponering er inkludert når det beregnes hvor mye BHT vi får i oss. På denne måten kan vi 
få et best mulig nøyaktig bilde av befolkningens eksponering. I tillegg bør kildene som bidrar 
mest til eksponeringen identifiseres. 
Toksisitet 
EFSA (2012) etablerte en grense for hva som er et akseptabelt daglig inntak (ADI) basert på 
to 2-generasjonsstudier i mus. ADI-verdien på 0.25 mg/kg kroppsvekt per dag var basert på 
redusert kullsttørrelse og kroppsvekt hos nyfødt avkom. Usikkerhetsfaktoren var 100. Denne 
ADI-verdien ble brukt som referansepunkt for toksisitet i denne risikovurderingen. 
Eksponering 
Eksponering ble beregnet for to ulike scenarioer, henholdsvis «realistisk» og «høy» 
eksponering. Data på inntak/bruk var fra studiene Norkost 3 (mat), EuroMix (mat og 
kosmetikk) og den amerikanske miljøvernetaten Environmental Protection Agency (USA; 
husstøv). Opplysninger om mengde BHT i mat, kosmetikk og husstøv ble funnet i 
vitenskapelig litteratur ved litteratursøk. Mangelen på konsentrasjonsdata ble ansett å være 
den største kilden til usikkerhet i beregningene av eksponering. 
Konsentrasjonsdataene som ble ansett som mest realistiske for norske forhold ble brukt til å 
beregne «realistisk» eksponering. Scenarioet med "høy" eksponering var en verstefalls-
estimat. 
BHT som nådde de fysiske barrierer i kroppen ble definert som ekstern eksponering, mens 
absorbert BHT ble definert som total intern eksponering. 
I beregningen av den totale interne eksponeringen ble det brukt absorpsjonsfaktorer for 
BHT-opptak fra mage-tarmkanalen og for opptak over hud. «Realistisk» total intern 
eksponeringen ble estimert til å være innenfor 1,4 – 9,6 og 0,8 – 9,7 µg BHT/kg kroppsvekt 
per dag for henholdsvis kvinner og menn. 50-persentilen ble estimert til å ligge innenfor 3,5 
- 4,2 og 2,2 - 2,8 µg BHT/kg kroppsvekt per dag for henholdsvis kvinner og menn. «Høy» 
total intern eksponeringen ble estimert til å være innenfor 23 - 281 og 9 - 319 µg BHT/kg 
kroppsvekt per dag for henholdsvis kvinner og menn. 50-persentilen ble estimert til å være 
innenfor henholdsvis 85 - 111 og 46 - 61 µg BHT/kg kroppsvekt per dag (avrundet tall) for 
kvinner og menn. 
Den dominerende eksponeringsveien er oralt inntak; gjennomsnittlig er 80% av den interne 
eksponeringen hos kvinner fra mat, støv og oralt inntak av kosmetikk og 
kroppspleieprodukter, mens for menn enda mer (92%). Kilder til eksponering for BHT var 
hovedsakelig fra mat gjennom oralt inntak (41 % for kvinner, 59 % for menn), med 
betydelige bidrag også fra kosmetikk og kroppspleieporodukter gjennom oralt opptak (38 % 
for kvinner, 34 % for menn) og dermalt opptak (21% for kvinner, 7,1 % for menn). 
 
 
VKM Report 2019:14  11 
Matvaregruppene «melk, fløte, iskrem», fulgt av «tyggegummi» og «fet fisk» var de viktigste 
matvarekildene. Tannkrem var den viktigste kilden til oralt inntak fra kosmetikk og 
kroppspleieprodukter, mens det var produktkategoriene «kroppslotion» og «deodorant» som 
var de to viktigste bidragsyterne til opptak fra hud. 
Risikokarakterisering og konklusjoner 
Risikoen ble vurdert for både «realistisk» og «høy» total intern BHT eksponering. I det 
«realistiske» scenarioet lå den estimerte totale BHT-eksponeringen under ADI for både 
kvinner og menn. I det «høye» scenarioet (verstefalls-estimatet) lå 50 persentilen under 
ADI, mens 95 persentilen lå over. Det vil si at en liten brøkdel av befolkningen kan overstige 
ADI og være utsatt for negative effekter på reproduktiv helse. 
Panelet konkluderer med at det er lite sannsynlig at eksponering for BHT vil forårsake 
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Abbreviations  
ADI acceptable daily intake 
ADME absorption, distribution, metabolism, excretion 
BHT butylated hydroxytoluene 
bw body weight 
DMSO dimethyl sulfoxide 
dw dry weight 
KBS food composition database (in Norwegian: 
kostberegningssystem) 
LB lower bound 
LOD limit of detection 
LOQ limit of quantitation 
MB middle bound 
NOAEL no observed adverse effect level 
OIM observed individual mean 
PCPs personal care products 
RCT 
RoB 
randomised controlled trial 
risk of bias 
UB upper bound 
WoE weight of evidence 
  
Organisations  
EFSA  European Food Safety Authority 
EPA Environmental Protection Agency 
FAO Food and Agriculture Organization of the United Nations 
IARC International Agency for Research on Cancer 
JECFA Joint FAO/WHO Expert Committee on Food Additives 
OECD Organisation for Economic Co-operation and Development 
SCF Scientific Committee for Food 
VKM Norwegian Scientific Committee for Food and Environment 






EtAc ethyl acetate 
EtOH ethanol 
HSSPME headspace-solid-phase microextraction 
HS headspace 
Hx hexane 
MeOH methanol  
SFE supercritical fluid extraction 
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SPME solid-phase microextraction 
  
Method used for 
chemical analysis 
 
GC-FID gas chromatography flame ionisation detector 
GC/MS  gas chromatography mass spectrometry 
GC–MS/MS gas chromatography tandem mass spectrometry 
GC-MS SIM selective ion monitoring gas chromatography mass 
spectrometry 
HPLC-DAD  high-performance liquid chromatography diode-array 
detector 
HPLC-ED high performance liquid chromatography electrochemical 
detection 
HPLC-MS/MS high-performance liquid chromatography tandem mass 
spectrometry 
HPLC-UV  high-performance liquid chromatography ultraviolet 
detection 
HPLC UV+ECD high-performance liquid chromatography ultraviolet 
detection/electrochemical detection 
HPLC UV/VIS high performance liquid chromatography ultraviolet and 
visible light detection 
HS-GC/MS headspace gas chromatography mass spectrometry 
LC/MS liquid chromatography mass spectrometry 
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Definitions 
Food group 
A food group is a collection of foods that share similar nutritional properties and/or have the 
same usage. The food groups used in this assessment are grouped according to the KBS 
food groups (food composition database, University of Oslo).  
Lower bound (LB) 
Lower bound estimates were calculated by substituting values below the limit of detection 
(LOD) or limit of quantification (LOQ) for an analytical method with the number zero.  
Medium bound (MB) 
Medium bound estimates were calculated by substituting values below the LOD or LOQ with 
values set to half of the LOD or LOQ. 
Observed individual means (OIMs) 
Observed individual means refer to chronic exposure estimated by the arithmetic mean 
intake for each individual. The method does not allow the inclusion of covariables and 
cofactors in the exposure assessment, and the method is known to overestimate the upper 
tail of the exposure distribution.  
Upper bound (UB) 
Upper bound estimates were calculated by substituting values below the LOD or LOQ with 
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Background 
Butylated hydroxytoluene (BHT, E321) is a synthetic antioxidant authorised as a food and 
feed additive in the EU. BHT is also used in e.g. personal care products and food contact 
materials (the limit for migration is 3 mg/kg).  
BHT has been assessed/evaluated by several competent bodies, including e.g. the EU 
Scientific Committee for Food (SCF), the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) and the European Food Safety Authority (EFSA). An acceptable daily intake 
(ADI) of 0.25 mg/kg bw per day was established by EFSA (EFSA, 2012) based on effects on 
the litter size and pup body weight. The no observed adverse effect level (NOAEL) of 25 
mg/kg bw per day was derived from two 2-generation studies in rats and application of an 
uncertainty factor of 100. 
To our knowledge, risk assessments including exposure estimates for BHT from all sources 
and exposure pathways have not been performed. The extensive use of BHT necessitates a 
risk assessment for the Norwegian population. Therefore, the Panel on Food Additives, 
Flavourings, Processing Aids, Materials in Contact with Food, and Cosmetics of the 
Norwegian Scientific Committee for Food and environment (VKM) proposed to perform a risk 
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Terms of reference 
The overall aim of this opinion is to assess whether the exposure of BHT from foods, 
personal care products, indoor air and indoor dust constitute a health risk to the Norwegian 
population.  
The sub-objectives are  
• To calculate human BHT exposure from several sources with available concentration 
data.  
• To evaluate the adverse effects of BHT in humans and animals via any relevant route 
of exposure and to characterise the hazard by using benchmark dose modelling if the 
ADI needs to be revised. 
• To evaluate the scientific evidence through a weight of evidence (WoE) approach.  
• To describe the uncertainty both qualitatively and quantitatively and to perform 
sensitivity analyses to identify the parameters that contribute most to the 
uncertainty.  
• To identify and describe knowledge gaps. 
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Assessment 
1 Introduction 
Butylated hydroxytoluene (BHT, E321) is a synthetic antioxidant. The substance is used to 
help preserve and stabilise the flavour, colour, freshness and nutritive value of foods and 
animal feed products. BHT can improve the stability of pharmaceuticals, fat-soluble vitamins, 
personal care products (PCPs), biomaterials, petroleum products, synthetic rubbers and 
plastics, and it serves as an antiskinning agent in paints and inks (EFSA, 2012; IARC, 1987; 
OECD, 2002; Wang et al., 2016b). 
BHT is authorised as a food additive for use in fats and oils (only for the professional 
manufacture of heat-treated food), in frying oil and frying fat (excluding olive pomace oil), in 
lard, fish oil, beef, poultry and sheep fat. BHT is permitted in amounts up to 100 mg/kg fat. 
In addition, BHT is permitted in chewing gum alone or in combination with other antioxidants 
such as gallates, tert-butylhydroquinone and butylated hydroxyanisole at a maximum level of 
400 mg/kg chewing gum (Lovdata, 2008). BHT is authorised for use up to 400 mg/kg in food 
supplements as defined in Directive 2002/46/EC (European Parliament). BHT is also 
authorised for use in feed for all species or categories of animals except dogs (European 
Commission, 2003). Thus, the presence of BHT in foods may be due to its use as food 
additive, by transfer from animal feed to food, by migration from food contact materials or 
from the environment.  
The use of BHT in PCPs must follow the principle that cosmetic products must be safe when 
used under normal or reasonable forseeable conditions of use (Lovdata, 2013). Otherwise, 
there are no specific conditions for BHT use in PCPs.  The presence of BHT in PCPs may be 
due to use as a preservative or due to migration from packaging materials. 
EFSA has established an ADI for BHT of 0.25 mg/kg bw per day (EFSA, 2012). The ADI was 
based on a NOAEL of 25 mg/kg bw per day derived from two 2-generation studies in rats 
based on effects on litter size, sex ratio and pup body weight gain during the lactation 
period, using an uncertainty factor of 100. 
A protocol for the risk assessment of BHT was developed (VKM, 2018) in which the scope 
and sub-objectives of the assessment were described. The protocol also includes the 
literature search strategy, the inclusion/exclusion criteria, the approach for evaluation of the 
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2 General information 




The molecular formula of BHT (E321) is C15H24O and the molecular weight is 220.36 g/mol. 
BHT is a lipophilic compound with an octanol/water partition coefficient (log Pow) of 5.1, 
melting point of 70°C, and a topological polar surface area of 20.2 Å2. The IUPAC name is 
2,6-di-tert-butyl-para-cresol, the CAS Registry Number is 128-37-0 and the EINECS number 
is 204-881-4 (EFSA, 2012; IARC, 1987; OECD, 2002). BHT is classified by IARC in group 3 as 
not classifiable as to its carcinogenicity to humans (IARC, 2019).  
The structural formula is presented in Figure 2-1. 
  
Figure 2-1.  Structural formula of butylated hydroxytoluene (BHT, E321). 
BHT is extensively used as an antioxidant in a wide range of products as described in the 
introduction (Chapter 1). 
Potential oxidation products or transformation products of BHT is not included in the current 
assessment. Compared to other phenolic antioxidants such as BHA (butylated 
hydroxyanisole) and TBHQ (tert-butylhydroquinone), BHT shows relatively stronger 
volatilisation at elevated temperatures during e.g. food baking and frying (Nieva-Echevarria 
et al., 2015). Common routes of BHT oxidation include hydroxylation or hydroperoxylation at 
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3 Hazard identification and 
characterisation 
The hazard identification and characterisation steps were based on previous reports and risk 
assessments of BHT as well as articles retrieved from literature searches.  
An overview of the sub-questions adressed in the hazard identification and characterisation 
steps is given in Table 3-1. 
A full systematic procedure was applied to identify articles reporting on adverse health 
effects in humans and/or animals. A narrative approach was used in the studies on 
genotoxicity and toxicokinetics.  
Table 3-1. Sub-questions addressed in the hazard identification and characterisation steps. 
No. Sub-questions  Approach 
1 Is BHT exposure related to adverse health effects in humans? Identify 
target organs. 
Systematic 
2 Is exposure to BHT related to adverse health effects in animals? Identify 
target organs. 
Systematic 
3 Is BHT associated with changes at the molecular level such as mutation 
and other genotoxicity endpoints? 
Narrative 
4 What is the nature of any dose-response relationship between BHT and 
relevant endpoints in the target organs in human and/or animal studies? 
Systematic 
5 What is the ADME* in humans and in different animal species/strains? Narrative 
6 Is there a difference in ADME* between humans and animals? Narrative 
7 Are the included human/animal studies biased according to the defined 
criteria?  
Risk of bias 
evaluation 
*ADME - absorption, distribution, metabolism, excretion 
 Previous evaluations and assessments 
Several evaluations and assessments of the safety of BHT have been performed. The latest 
is the re-evaluation by the European Food Safety Authority (EFSA, 2012). This assessment 
includes evaluations and assessments performed by the International Agency for Research 
on Cancer (IARC), the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 
Organisation for Economic Co-operation and Development (OECD) and the Scientific 
Committee on Food (SCF) (EFSA, 2012; IARC, 1987; JECFA, 1996; OECD, 2002; SCF, 1989). 
EFSA established an ADI for BHT of 0.25 mg/kg bw per day. The ADI was based on the 
NOAEL of 25 mg/kg bw per day, which was derived from two 2-generation studies in rats, 
using an uncertainty factor of 100. 
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 Articles 
 Literature search, publication selection and data extraction 
Literature searches, from 2012 to the search date (see Appendix 10.1 for detailed 
description), were performed in Ovid MEDLINE(R), Embase, Web of Science, Cochrane 
Database of Systematic Reviews and Epistemonikos to retrieve publications on adverse 
health effects related to BHT exposure. The search strategy, including the time-period for 
the search, is included in the Appendix (Chapter 10.1). Two persons independently selected 
pulications according to the inclusion/exclusion criteria checklists (Appendix, Chapter 10.2.1). 
The first screening, based on analysis of title/abstracts, resulted in 29 articles. The full texts 
of the articles that passed the primary screening were retrieved for the secondary screening, 
with application of the very same inclusion/exclusion criteria. The secondary screening 
resulted in 13 articles. An overview of the publication selection is given in Figure 3.2.1-1.  
 
 
Figure 3.2.1-1. Flow diagram for publication selection (to retrieve articles on adverse health effects 
related to BHT).  
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Ten of the included articles were reviews and risk assessments. The reference lists of these 
articles were screened to check for additional relevant original studies, but no additional 
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Table 3.2.1-1 Overview of the included original studies. 
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Negritto et al. (2017) aimed to delineate the mechanism of phenol toxicity in yeast through 
testing of a series of phenols, including BHT. BHT showed no significant genotoxicity (no 
increase in deletion events) to Saccharomyces cerevisiae and caused only weak growth 
defects (the half maximal inhibitory concentration was 0.13 mM).  
Pop et al. (2013) investigated possible endocrine disruptive effects of BHT using the 
immature rat uterotrophic assay. Wistar female rats, 17-21 days old, were given suspensions 
of BHT (75 mg/kg bw) for three consecutive days. Absolute and relative uterus weights were 
significantly decreased, whereas no significant effect on endometrial epithelium thickness 
was observed.  
The binding properties of BHT, 0 to 3.27x10-5 mol/L, with calf thymus DNA were investigated 
using ethidium bromide dye as a fluorescence probe (Ma et al., 2013). BHT molecules were 
shown to intercalate into the base pairs of calf thymus DNA. This finding was supported by 
the observation of a competitive interaction between BHT and the ethidium bromide probe 
with calf thymus DNA.  
Risk of bias, relevance of endpoint and weight of evidence were evaluated for the original 
study by Pop et al., (2013), but not for the two original studies on genotoxicity as the 
approach for studies on genotoxicity was narrative. 
 Evaluation of risk of bias 
Risk of bias was evaluated for the study by Pop et al. (2013) according to (NTP/OHAT, 
2015). In the evaluation of risk of bias, the following was included:  
• Aspects that introduced a systematic difference between the control and the exposed 
group only (e.g. non-randomised allocation of animals to study groups). 
• Aspects that potentially affected, to the same extent, control and exposed study 
groups (e.g. the reliability of the method used to test the outcome). 
Two members of the project group performed the evaluation independently. The response 
options for each question were «Definitely low risk of bias (++)», «Probably low risk of bias 
(+)», «Probably high risk of bias (-)», «Definitely high risk of bias (--)». The results of the 
evaluation are presented in Table 3.2.2-1. 
Table 3.2.2-1. Evaluation of risk of bias. 
Reference Question Domain Rating 
(++, +, -, --) 
Pop et al. 
(2013) 
 
Were experimental conditions identical across 
study groups?  
Performance ++ 
Were outcome data completely reported without 
attrition or exclusion from analysis?  
Attrition ++ 
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Reference Question Domain Rating 




Can we be confident in the outcome 
assessment?  
Detection + 
Were the statistical methods and the number of 





Conclusion +  
Probably low 
risk of bias 
 Evaluation of relevance of the endpoints for the target population 
Two members of the project group independently evaluated the relevance of the endpoint 
endocrine disruptive effect for the human population studied by Pop et al. (2013). They 
concluded that the endpoint «uterus weight in rats» was considered to be relevant for an 
assessment of potential risks in humans. However, recent reports indicate that the use of 
diverse animal models and various endpoints might be more effective to characterise 
endocrine disruptive effects, thus limiting overreliance when using only one animal model 
(Patisaul et al., 2018). 
 Weighting the body of evidence (WoE) 
To study the strenght of an association between BHT and a subsequent effect, an initial 
confidence rating of the included original studies was performed. The following four 
descriptors were used to determine this initial level of of confidence (NTP/OHAT, 2015):  
• Controlled exposure conditions  
• Exposure preceding the effect onset  
• Outcome being assessed at individual level (i.e. not through population aggregate 
data)  
• Presence of an appropriate comparison group 
Fulfilment of all features received an initial rating of high confidence (++++). Lower ratings, 
i.e. moderate (+++), low (++) or very low (+), correspond to the number of features 
fulfilled. Considerations on whether the exposure preceded the outcome was done at internal 
validity level (RoB, see 3.1.2.3), which fulfilled this aspect. For the included randomised 
controlled trial (RCT) studies, the Panel considered that fulfilment of all features would 
receive an initial rating of high confidence (++++).   
The further procedure for the evaluation of confidence in the evidence was a modified 
version from NTP/OHAT (2015), downgrading or upgrading the confidence in the evidence. 
Risk of bias, relevance of endpoints, unexplained inconsistency and imprecision downgrade 
the confidence in the evidence, whereas large effect (e.g. incidence, degrees of severity), 
dose-response relationship, consistency across study design (dissimilar populations, animal 
models, species or gender), consistency in direction of effect and confounding (if all relevant 
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confounders are described and considered) upgraded the evidence. The overall confidence in 
the evidence was graded into high confidence, moderate confidence, low confidence and 
very low confidence, and were defined as follows:   
• High confidence (++++) in the association between exposure to the substance and 
the outcome. The true effect is highly likely to be reflected in the apparent 
relationship.  
• Moderate confidence (+++) in the association between exposure to the substance 
and the outcome. The true effect may be reflected in the apparent relationship. 
• Low confidence (++) in the association between exposure to the substance and the 
outcome. The true effect may be different from the apparent relationship.  
• Very low confidence (+) in the association between exposure to the substance and 
the outcome. The true effect is highly likely to be different from the apparent 
relationship. This statement may give the impression that a true effect is different 
from the one observed. However, an additional explanation is given in the OHAT 
Handbook (NTP/OHAT, 2015) (in Figure 2, OHAT Framework for Systematic Review 
and Evidence Integration, Step 6): where for low or no evidence for a health effect, 
the evidence is termed «inadequate». Furthermore, it is stated that «… a conclusion 
of «Very Low Confidence» suggests that further research is very likely to have an 
impact on confidence in the apparent relationship». 
The results of the WoE evaluation are presented in Table 3.2.4-1.
 
 
VKM Report 2019:14  27 
Table 3.2.4-1. Weighting the body of evidence. 
Endpoint: Endocrine disruptive effect 
 Elements triggering downgrading Elements triggering upgrading 
Confidence 
level 
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The overall confidence in the evidence for each endpoint/group of endpoints was 
transformed to likelihood as shown in Table 3.2.4-2. 
Table 3.2.4-2. Set of terms used to transform the final rating of confidence in the evidence per 
endpoint of all relevant randomised controlled trials (RCTs) to overall likelihood. 
Likelihood of an association between BHT 
and the effect under consideration 
Summary confidence range levels 
Very likely ++++ 
Likely From ++++ to +++ 
As likely as not From +++ to ++ 
Unlikely From ++ to + 
Very unlikely + 
Since the confidence level in the study by Pop et al. (2013) was ++/+, an association 
between BHT and the reported effect was considered unlikely and the study was not used 
for the hazard identification and characterisation. 
 Absorption, distribution, metabolism and excretion (ADME) 
According to EFSA (2012), absorption, distribution, metabolism and excretion (ADME) of BHT 
have been studied in mice, rats, rabbits, chickens, monkeys and humans.  
BHT is rapidly absorbed from the GI tract after oral exposure, and we therefore assumed a 
100% absorption of BHT in the GI tract.  According to Lanigan et al. (2002), ex vivo and in 
vivo studies indicated that <4% of BHT penetrated the skin. However, the studies cited in 
Lanigan et al. (2002) have weaknesses leading to uncertainties with respect to the dermal 
absorption. Even though dermal application produces systemic exposures to BHT or its 
metabolites, the magnitude of internal exposure is lower than that seen in studies using the 
oral route. 
BHT is generally distributed to the liver and to body fat, and accumulation in fatty tissue in 
rats have been reported. According to EFSA (2012), the accumulation of BHT in fatty tissue 
is higher in humans than rats. 
The BHT metabolism is complex, and important species differences are likely, considering 
the differences reported in the literature. More than 40 metabolites have been identified. 
Oxidation of one or both of the tert-butyl groups of BHT, with a following glucuronidation, is 
seen as one of the main metabolites in humans. It is not known whether the BHT quinone 
methides, a compound likely to be responsible for lung toxicity in mice, is formed in humans.  
After a single BHT dose (20 or 500 mg/kg bw) to mice, the half-life in the stomach, intestine, 
liver and kidney was 9-11 hours. When daily doses (20 mg/kg bw/day) were given to mice 
for 10 days, the half-life in blood, liver, kidney lung and testis was reported to be 5-15 days. 
A daily dietary dose of BHT in rats for 35 days resulted in a maximum concentration of BHT 
in fatty tissue after 10 days.  EFSA (2012) did not report on the half-life of BHT in the fatty 
tissue. The half-life in humans was studied in two men who were given a single oral dose of 
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40 mg/kg [14C] BHT. In the first 24 hours, 50% was excreted, followed by a slower excretion 
that occurred for the next 10 days. In total, 63-67% of the dose was excreted. 
BHT is mainly excreted via urine and faeces, but while excretion in faeces is the dominant 
pathway for rats and mice, including enterohepatic circulation, the main excretion route in 
humans is via the urine. This is likely due to the size of the metabolites, and different cut-off 
in rats and humans regarding the molecular size that can be excreted in the urine. 
 Toxicological data 
A systematic literature search was performed to identify publications indicating that the ADI 
established by EFSA needed to be revised. No such publications were identified. As a result, 
the ADI of 0.25 mg/kg bw per day established by EFSA derived from two 2-generation 
studies (EFSA, 2012), is used for the risk characterisation in the present assessment. Both 
studies are described in EFSA (2012). The short description is from EFSA (2012): 
In the 2-generation study by Olsen et al. (1986), Wistar rats in groups of 60, 40, 40 and 60 
per sex were given 0, 25, 108, or 276 mg BHT/kg bw per day (males) and 0, 26, 106 and 
287 mg BHT/kg bw per day (females) in the diet. After 13 weeks the rats (F0) were mated. 
Offspring (F1) in groups of 100, 80, 80, and 100 per sex were given the same doses as the 
F1 generation, except for the highest dose that was lowered to 250 mg BHT/kg bw per day 
due to effects on the kidney. When the F1 rats were 144 weeks, the study was terminated. 
The number of litters with ten or more pups decreased significantly (P<0.001) with 
increasing BHT dose (10.9, 9.6, 10.3 and 9.1 number of pups), and at weaning the offspring 
showed a reduction of body weight compared to the control animals (7%/5%, 11%/10%, 
and 21%/16% for males/females). A dose-related increase in hepatocellular adenomas 
(males and females) and carcinomas (males only) of the mid and high dose group was 
observed, with a carcinoma incidence of 8-12/99 at the highest dose. Tumours were also 
found in other organs, but their incidence were not statistically significantly different from 
that in controls. The study was terminated when the rats in the F1 generation were 144 
weeks old. 
Based on the study by Olsen et al. (1986; described in the EFSA Opinion), EFSA concluded 
that based on the effects on litter size and pup body weight gain during the lactation period, 
in the reproduction segment of the study, the NOAEL for non-neoplastic effects was 25 
mg/kg bw per day. This NOAEL also covered the observed increase in hepatocellular 
adenomas and carcinomas.  
In the 2-generation study by Price (1994; described in the EFSA Opinion), Wistar rats, 6 
males and 48 females aged 13 and 9 weeks, respectively, were given 0, 25, 100 or 500 mg 
BHT/kg bw in the diet per day for 3 weeks prior to mating. The litters were either culled or 
augmented to comprise eight pups and were fed BHT concentrations corresponding to the 
diets fed to their parents, with the exception that the highest dose was reduced to 250 
mg/kg bw per day. At 22 months, the study was terminated. In the first 5 weeks of BHT 
administration, lower body weight gain was noted in males given the highest-dose. Body 
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weight gain in all other treatment groups was similar to that in controls for both males and 
females. At the sacrifice on day 20 of gestation, both absolute and relative liver weights of 
the dams were increased in a dose-related manner, statistically significant at the high dose. 
No effect of treatment was evident on reproductive parameters. There was a slight decrease, 
but not dose related, in the numbers of pups per litter in the low and high-dose groups. In 
the high-dose group, the body weights of the pups were significantly lower than controls at 
birth (10%), and at days 6 (12%) and 21 (21%) of lactation. A dose-dependent increased 
mortality (2%, 8%, 12% and 15%) of the pups were observed, and body weights of the F1 
males were lower in the high-dose group compared with controls. A dose-related increase 
was observed in relative, but not absolute liver weights at the high dose. At 22 months, 
there was a higher incidence of eosinophilic and basophilic foci in the liver of the high-dose 
group. The study by Price (1994) supported the NOAEL of 25 mg BHT/kg bw per day derived 
from the Olson study (1986), where effects on the litter size and pup body weight were 
confirmed. No increase in hepatocellular adenomas and carcinomas was reported in Price 
(1994). 
 Summary of the hazard identification and characterisation 
The hazard identification and characterisation are based on previous reports and risk 
assessments of BHT and articles retrieved from literature searches. The most recently 
published opinion on BHT is the re-evaluation performed by EFSA (2012). EFSA established 
an ADI for BHT of 0.25 mg/kg bw per day. The ADI was based on a NOAEL of 25 mg/kg bw 
per day derived from two 2-generation studies in rats based on dose-related effects on litter 
size and pup body weight gain during the lactation period, using an uncertainty factor of 
100. This NOAEL also covered the observed increase in hepatocellular adenomas and 
carcinomas. Note that the BHT metabolism is complex and important species differences are 
likely. On main metabolites in humans, one or both of the BHT tert-butyl groups are oxidated 
followed by glucuronidation. The half-life in humans was studied in two men given a single 
oral dose of BHT; 50% was excreted the first 24 hours, followed by a slower excretion for 
the next 10 days. In total, 63-67% of the dose given was excreted.  BHT has been reported 
to accumulate in fatty tissue (EFSA, 2012). 
Systematic literature searches were performed to identify publications potentially indicating 
that the ADI established by EFSA needed to be revised. Thirteen articles of the 936 obtained 
from the literature search were included, and only three were original studies. Risk of bias, 
relevance of endpoint and weight of evidence were evaluated for one of the original studies 
(Pop et al., 2013), but not for the two original studies on genotoxicity as the approach for 
studies on genotoxicity was narrative. The results reported by Pop et al. (2013) did not 
indicate that the ADI established by EFSA needed to be revised.  
Since none of the included studies indicated a need for revision of the ADI established by 
EFSA (2012), the Panel concluded that the ADI of 0.25 mg/kg bw per day will be used in the 
risk characterisation.  
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4 Exposure 
An overview of the sub-questions addressed in the exposure assessment is given in Table 4-
1.  
Table 4-1. Exposure assessment sub-questions. 
No. Sub-questions  
1 What are the exposure levels and sources of BHT from foods? 
2 What are the exposure levels and sources of BHT from personal care products? 
3 What are the exposure levels and sources of BHT from indoor dust? 
4 What are the exposure levels and sources of BHT from indoor air? 
5 What is the total internal exposure to BHT? 
6 What is the total exposure to potential harmful BHT/BHT metabolites? 
BHT reaching the physical barriers in the body was defined as external exposure. The total 
amount of absorbed BHT was defined as total internal exposure. All potential toxic internal 
BHT (BHT and/or toxic BHT metabolites) was defined as total exposure to potential harmful 
metabolites. In order to estimate external exposure, total internal exposure and total 
exposure to potential harmful metabolites (Figure 4-1), the following choices were made in 
accordance with the protocol (VKM, 2018). 
The BHT exposure was estimated for adults,  based on BHT concentrations in food, PCPs 
and indoor dust, data on consumption (food, PCPs and indoor dust) and inhalation (indoor 
dust and indoor air), individual body weights, and data on absorption of BHT from the 
gastrointestinal tract/skin/lungs: 
• Concentration; data on BHT in foods, PCPs and indoor dust, identified through literature 
searches and in previous reports, were compiled in a database. Data on BHT in indoor air 
were not identified, and the exposure level from indoor air was therefore not estimated 
(subquestion 4). 
• Consumption; the national food consumption survey Norkost 3 (n=1787) provided data 
on individual food consumption (Totland et al., 2012), and the human biomonitoring 
study EuroMix (n=144) provided individual data on both food consumption and use of 
PCPs (Husoy et al., 2019). For consumption of indoor dust, standard exposure values 
from EPA were used. 
• Body weight; to calculate BHT exposure per kg body weight per person, individual body 
weights were used for the studies Norkost 3 and EuroMix. Body weights were self 
reported in these studies. If body weights were not given in Norkost 3, mean body 
weights were imputed; 69.2 kg for women (n=29), and 86.2 kg for men (n=1). The 
mean body weight of 65 kg was used for three women in the EuroMix study. 
• Absorption from the gastrointestinal tract/skin/lungs; absorption factors were derived 
from the literature. 
The exposure was estimated for «realistic» and «high» scenarios (Table 4-2). In the 
«realistic» exposure scenario we aimed to use the concentration data considered the most 
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realistic for the Norwegian exposure, whereas more conservative choices were used for the 
«high» exposure scenario. In the «realistic» food exposure scenario, main food groups were 
divided into sub-groups to specify the occurrence estimate for the food groups «cereals, 
bread, and cake», and «fish and seafood». Only concentration data from Europe and USA 
that fulfilled the quality criteria were applied. In the «high» exposure scenario, main food 
groups, and all concentration data that fulfilled the quality criteria, regardless of country of 
origin, were applied. For consumption of indoor dust, a central tendency exposure factor was 
used in the «realistic» scenario whereas the upper percentile was used in the «high» 
exposure scenario (EPA., 2011). The 50 percentile for the applied PCP, as reported in studies 
from Europe and USA, were used in the «realistic» scenario, whereas maximum amounts 
were included in the «high» scenario (Ficheux et al., 2016; Garcia-Hidalgo et al., 2017; 
Loretz et al., 2006). Thus, the «high» exposure scenario is a worst-case estimation 
representing a risk assessment for potentially high consumers. 
 Table 4-2. An overview of the «realistic» and «high» exposure scenarios. 
  «Realistic» exposure scenario «High» exposure scenario 
BHT 
concentrations 
Foods Mean of all concentration data from Europe and USA 
Mean of all identified 
concentration data 
PCPs 
Mean values (only articles from 
Europe and USA included), 
values <LOD were replaced 
with 0 * 
Maximum values (articles from 
Europe, USA and Asia included), 
values < LOD were replaced by 
LOD * 
Dust Greek data (Wang et al., 2016a) 
Japanese data (Wang et al., 
2016a) 
Use/consumption 
Foods Survey data (amount consumed (g)) 
Survey data (amount consumed 
(g)) 
PCPs 
Survey data (frequency of use) 
50 percentiles of amounts used 
(only articles from Europe and 
USA included) ** 
Survey data (frequency of use) 
95 percentiles of amounts used 
(only articles from Europe and 
USA included) ** 
Dust Central tendency exposure factors (EPA; 2011) 
Upper percentile exposure factor 
(EPA, 2011) 
* Data from Europe and USA were prioritised over Asian data (Akkbik et al., 2011b; Alvarez-Rivera et 
al., 2014a; Boussenadji et al., 1993; Capitán-Vallvey et al., 2002; Celeiro et al., 2014; Myers et al., 
2015; Sanchez-Prado et al., 2010).  
**The French study was prioritised over the Swiss study: the Swiss study was prioritised over the US 
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Figure 4-1. An overview of external exposure, total internal exposure (i.e. absorbed dose) and total exposure to potential harmful metabolites (toxic dose) 
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 BHT concentrations in foods, PCPs and indoor dust  
Five reports with relevant BHT concentration data were included in the current assessment. 
In addition, literature searches were performed to retrieve articles with BHT concentration 
data. A BHT concentration data base was created from the included literature. An overview 
of the BHT concentrations in foods and PCPs is given in Tables 4.2.1-1 and 4.3.5-1, 
respectively. 
 Reports 
Exposure of children and unborn children to selected chemical substances. Survey 
of chemical substances in consumer products No. 158 April 2017, Ministry of 
Environment and Food of Denmark (Danish Environmental Protection Agency et 
al., 2017)  
The Danish Environmental Protection Agency assessed whether there may be a risk of the 
overall exposure of children under 3 years and pregnant women/unborn children to 
endocrine disrupting substances and chronic neurotoxic substances. The content of BHT was 
measured in a variety of PCPs, and ranged from (in weight %) 0.0029 to 0.064 in body oil, 
<0.0002-0.23 in body lotion, 0.0071-0.22 in face cream, 0.0009-0.32 in sunscreen/after sun 
and 0.052-0.23 in deodorants. It was concluded that «Among the evaluated substances, the 
most significant endocrine disruptors to which children under 3 years and pregnant 
women/unborn children may be exposed are dioxins/PCBs, phthalates (DEHP, DBP, DiBP), 
bisphenol A, BHA and BHT». 
Report to the Swedish EPA (the Health-Related Environmental Monitoring 
Program) Phenolic substances in food – analytical survey of 11 phenols in 
Swedish Market Basket samples from 1999, 2005 and 2010 (Livsmedelsverket et 
al., 2014)  
The report included food samples for analyses taken from the sample bank of Market Basket 
samples at the Swedish National Food Agency, comprising samples obtained in 1999, 2005 
and 2010. Final analytical determination was made by GC-MS/MS. BHT levels in several 
foods were determined, including cereals, pastries, dairy, eggs, sugar sweets, meat, fats, 
fish, potatoes, vegetables, fruit, and beverages. The limits for detection (LOD) for BHT given 
as ng/g fresh weight, was 0.1 for 10 g, 1 for 5 g and 1 for 1 g fat samples. The limits for 
quantification (LOQ), given as ng/g fresh weight, was 1.5 for 10 g, 3 for 5 g and 15 for 1 g 
fat samples. For beverages (50 mL), LOD was 0.1 and LOQ was 0.3.  
Screening program 2014. Organic phosphites, selected PBT substances and non-
target screening (Norwegian Environment Agency et al., 2014).   
Upon assignment from the Norwegian Environment Agency, the Norwegian Institute for 
Water Research (NIVA) and the Norwegian Institute for Air Research (NILU) performed a 
screening of organic phosphites and selected persistent, bioaccumulative and toxic 
compounds in freshwater and marine environments, including BHT. The analysis was 
performed using an Agilent 5973MSD GC/MS system and a Restek Sil5-MS GC-column. BHT 
was determined in shrimps, herring, cod liver, mysis, whitefish and brown trout.  
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Monitoring Programme for Residues of Therapeutic Agents, Illegal Substances 
and other Undesirable Substances in Farmed Fish, Annual Report 2010, NIFES 
(NIFES et al., 2011) 
BHT was analysed using reverse phase HPLC and fluorescence detection. The concentration 
range for BHT in farmed salmon fillets was <LOQ-8.9 mg/kg, the mean concentration was 
3.7 mg/kg fillet. The concentration of BHT in farmed trout fillet was 0.6 mg/kg wet weight. 
The LOD, wet weight in muscle in µg/kg was 14. The LOQ, wet weight in µg/kg, was 45. The 
results showed that BHT was carried over from the feed to fish fillets. 
Screening of selected new organic contaminants 2004. Brominated flame 
retardants, perfluorinated alkylated substances, irgarol, diuron, BHT and dicofol 
(NIVA et al., 2005) 
The results of a screening survey on contaminants, including BHT, in the Norwegian 
environment were presented in the report. The survey was carried out on behalf of the 
Norwegian Pollution Control Authority by NIVA, NILU and the Norwegian Centre for Soil and 
Environmental Research. The analysis was performed using an Agilent 5973MSD GC/MS 
system and a Restek Sil5-MS GC-column. The concentration of BHT in blue mussels and cod 
liver was analysed. None of the blue mussel samples had BHT concentrations above the 
LOD. For cod liver, the observed concentrations of BHT were 1.4 and 3.1 ng/g wet weight. 
The LOD was 0.1-0.2 ng/g wet weight.  
 Articles 
Literature searches were performed to retrieve publications with data on BHT concentrations 
in foods, PCPs, indoor air and indoor dust. The first searches identified 3711 articles, the 
second identified 708 articles. For search strategies, see Appendix 11 (Chapter 11.1.1 and 
11.1.2). Two persons independently selected pulications according to the inclusion/exclusion 
criteria checklists (Chapter 11.2.1). First, titles and abstracts were screened. Next, the full 
texts of the articles that passed the primary screening were retrieved for screening against 
the inclusion/exclusion criteria checklist. The data quality of the included articles was 
evaluated and rated. This evaluation included rating of the sample extraction method, the 
instrumental analysis, the validation of the method and the data presentation. The rating 
was deduced according to a scale of rates from 1 (lowest quality) to 5 (highest quality). The 
individual rates were weighted as follows to get the total rate: 1/5 from sample extraction, 
1/5 from instrumental analysis, and 3/5 from validation and data presentation. Only articles 
with a total rate of ≥ 3.5 was used for the exposure assessment. The rating of all the 
included studies is shown in Chapter 11.2.2. 
The final database consisted of data from the included reports and data from 29 articles; 20 
which reported concentrations in food-items, nine which reported concentrations in PCPs and 
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Concentrations on BHT in indoor air were not identified; therefore, it was not possible to 
include estimations of BHT exposure from indoor air in the assessment (subquestion 4). 
 External BHT exposure from foods and beverages 
 BHT in foods and beverages 
In the «realistic» exposure scenario only concentrations from Europe and USA were 
included. The number of BHT datapoints included in this scenario were 259. Of the 20 food 
groups with assigned BHT values, 11 had a sample number below ten. The food group 
«cereals, bread and cakes» was divided in the sub groups «bread and cereals» and «cakes 
and biscuits», and «fish and seafood, wild» were divided in the sub food groups «fish, wild», 
«fish, freshwater», «shrimps and mussels», and «fish liver» (Table 4.2.1-1).  
All BHT concentrations were included in the «high» exposure scenario estimations, 
regardless of country of origin. The number of BHT datapoints included in this scenario were 
412. Of the 21 food groups with an assigned BHT value, 14 had a sample number below ten. 
Furthermore, the group «cereals, bread and cakes» was treated as one food group, and 
«fish and seafood, wild» was treated as one food group (Table 4.2.1-1). This implies that all 
foods in the given food group gets the same concentration. 
The food groups «vegetable cream», «cheese», «margarine and butter», «mayonnaise», 
«fish oils», and «starchy snacks» were only included in the «high» exposure scenario due to 
lack of concentration data from Europe and USA. The food groups «various oils», and 
«chewing gum» had concentration values both from within and outside Europe/USA; 
therefore, the concentration values used for the «high» and the «realistic» scenarios were 
different. For the other food groups (Table 4.2.1-1), the BHT concentrations were the same 
for both the «realistic» and the «high» exposure scenarios.     
In the «high» and the «realistic» exposure scenarios, the BHT concentrations were given as 
lower bound, medium bound and upper bound concentrations (Chapter 11.3). The lower 
bound was calculated by substituting values below the limit of detection (LOD) or limit of 
quantification (LOQ) for an analytical method with the number zero. The medium bound was 
calculated by substituting values below the LOD or LOQ with values set to half of the LOD or 
LOQ. The upper bound was calculated by substituting values below the LOD or LOQ with 
values equal to the LOD or LOQ. Concentration values above LOD/LOQ were kept 
unchanged. 
Lower, upper and middle bound concentrations were not very different for most of the foods 
(Table 4.2.1-1), and had little impact on exposure estimates (not shown). The following 
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Table 4.2.1-1 BHT content in different foods and food groups, µg/kg wet weight. 
Food group n Lower bound Middle bound Upper bound 
Cereals, bread and cakes1 11 2.1 15.8 29.4 
Bread and cereals2 4 2.6a 
Cakes, biscuits2 5 2.6 2.9 3.2 
Instant noodles1,2 1 0.7 a 
Potatoes1,2 4 0.5 0.6 0.8 
Vegetables1,2 5 0.1 0.3 0.5 
Fruit1,2 4 1.5 1.5 1.6 
Meat, meat products1,2 6 0.1 0.3 0.5 
Pepperoni1,2 14 23586 a 
Fish and seafood, wild1 76 1.5 1.6 1.6 
Fish, wild2 15 1.6 1.6 1.7 
Fish, freshwater2 24 0.9 0.9 0.9 
Shrimp and mussles2 19 0.5 0.5 0.6 
Fish liver2 18 3.4 3.5 3.5 
Fish, farmed1,2 60 2644 2645 2646 
Egg1,2 4 0.3 0.5 0.6 
Dairy1,2 26 249 a 
Milk, goat1,2 8 147 a 
Coffee creamer1,2 1 0.7 a 
Vegetable cream1 9 45500 a 
Cheese1 2 71900 a 
Margarine and butter1 49 92039 a 
Various oils1 53 43138 43153 43168 
Various oils2 14 6.2 6.2 6.2 
Mayonnaise1 6 48117 a 
Fish oil1 5 144140 a 
Sweets, chocolate1,2 4 3.9 a 
Chewing gum1 35 218232 a 
Chewing gum2 10 135132 a 
Starchy snacks1 7 46200 a 
1 Used in «high» exposure scenario: all concentration data that fulfilled the quality criteria, regardless 
of country of origin. 
2 Used in «realistic» exposure scenario: concentration data from Europe and USA that fulfilled the 
quality criteria. 
a All analysed values were above LOQ.  
 Intake of foods and beverages 
Food intake from the Norkost 3 survey and the EuroMix study was used for the exposure 
estimations (Husoy et al., 2019; Totland et al., 2012).  
The national dietary survey Norkost 3 was conducted in 2010/2011, and 1787 adults (925 
women and 862 men) aged 18-70 participated (Totland et al., 2012). Norkost 3 was based 
on two 24-hour recalls by telephone surveys, performed at least one month apart. Food 
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portions were presented in household measures or estimated from photographs. Norkost 3 
did not include use of PCPs. 
EuroMix is a biomonitoring study (Husøy et al., 2019). The participants were recruited 
among employees from governmental institutes and authorities, and universities in the 
counties Oslo and Akershus in Norway between September 2016 and November 2017. The 
study population of 144 consisted of 100 females aged 24-72 years and 44 males aged 25-
72 years. The recording and sampling period consisted of two times 24 hours, with 2-3 
weeks between the sampling periods. During the two sampling periods, the participants were 
asked to fill in a weighed food diary, a cosmetic diary and a questionnaire with personal 
information. The participants were instructed to weigh and record all intakes of food and 
beverages for 24 hours. The participants did not record the amount of PCP products applied 
in the dairies, only the frequency.  
The EuroMix population represents a healthy group of Norwegians with a high level of 
education whereas Norkost 3 is a national food consumption survey more representative for 
the general population (Husoy et al., 2019; Totland et al., 2012).  
 Exposure estimates from foods and beverages 
The external exposure of BHT from diet, normalised by bodyweight (bw) was summed up for 
all foods and beverages on an individual level: 
External BHT exposure from diet (µg/kg bw per day) = Amount of food and drink consumed 
(g/day) x BHT concentration (µg/g) / individual bw (kg) 
External BHT exposure from dietary intake was estimated using both Norkost 3 and EuroMix. 
For both studies, individual exposures were calculated for «realistic» and «high» exposure 
scenarios using summary statistics on the observed individual means (OIM) (Table 4.2.3-1). 
This is the classical approach for exposure estimation. In the «high» exposure scenario, the 
estimated exposure was 1-2 orders of magnitude higher than in the «realistic» exposure 
scenario.  
Table 4.2.3-1. External exposure to BHT from foods and beverages based on observed individual 
means (OIMs) and middle bound concentrations. 
Survey – exposure scenario Mean 5 percentile Median 
(50 percentile) 
95 percentile 
µg BHT/kg bw per day 
EuroMix (n=144) – «realistic»  1.6 0.09 1.0 4.7 
EuroMix (n=144)– «high»  71 12 56 188 
Norkost 3 (n=1787) – «realistic»  2.5 0.14 1.6 8.0 
Norkost 3 (n=1787) – «high»  75 19 65 164 
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The mean contribution of BHT from foods and beverages, in µg BHT/day and in percentage, 
is shown in Table 4.2.3-2. The mean contribution from the food groups «milk, cream, ice 
cream», «chewing gum» and «fatty fish» is approximately similar for the «high» and 
«realistic» exposure scenarios and ranges from 30 to 119 µg BHT per day. The mean 
contribution from the food groups «cheese» and «margarine and butter» is around 2000 µg 
BHT per day for the «high» exposure scenario, whereas it is not included in the «realistic» 
estimates. BHT is not authorised for use in cheese in EU (Directive No 95/2/EC). Although 
BHT is permitted as an additive in amounts up to 100 mg/kg fat in frying fat/margarine and 
frying oils, excluding olive oil, we did not identify any studies reporting concentrations of 
BHT in these foods in Europe/USA. In 2012 the industry did not report any use of BHT in 
frying oil and fat (EFSA, 2012).  
If «cheese» and «margarine and butter» in Norway contain BHT, whether it be as additive or 
transferred from feed, the «realistic» exposure scenario leads to underestimation. For 
chewing gum, we assumed that all BHT from the chewing gum was absorbed. This is very 
likely an overestimation (Lin et al. 2003; Nunn 1991; Verhagen et al. 1991).  
Table 4.2.3-2 Contribution of BHT from different food groups to the estimated «realistic» and 
«high» BHT exposure (in %). Consumption is based on Norkost 3. 
Dietary sources Contribution of different food groups 
to the estimated mean «realistic» 
BHT exposure  
Contribution of different food groups 
to the etimated mean «high» BHT 
exposure  
Cheese na 46% 
Margarine and 
butter na 41% 
Fish oil na 5% 
Milk, cream, ice 
cream 43% 3% 
Chewing gum 40% 2% 
Fatty fish 17% 1% 
na: No concentration data from Europe/USA. 
In the «realistic» exposure scenario the two food groups «milk, cream, ice cream» and 
«chewing gum» are the main BHT sources. In the «high» exposure scenario, the two food 
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Figure 4.2.3-1. Histograms of observed individual mean exposures from diet using the «realistic» 
middle bound exposure dose (in µg BHT/kg bw per day) in Norkost 3 (Totland et al., 2012) and 
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 External BHT exposure from PCPs 
PCPs were divided in product categories as predefined in EuroMix (Husøy et al., 2019). Only 
products used by the EuroMix participants for which concentration data had been found were 
included in the exposure estimation. 
 Frequency of use 
In EuroMix, the frequency of use was recorded in a diary which allowed for detailed 
description of time of application and brand names of the PCPs used. The reported 
frequencies were used in both the «realistic» and «high» exposure scenarios.  
 BHT in PCPs 
Concentrations of BHT in PCPs were obtained from the literature (see Chapter 4.1). When 
multiple data were available for a product, data from Europe and USA were prioritised based 
on the assumption that products available in Europe and USA are similar to products on the 
Norwegian market. Other concentration data were only used if no data from Europe and USA 
were available.  
For the «realistic» exposure scenario, the mean BHT concentrations were used and the non-
detects were replaced by 0. For the «high» exposure scenario, the highest BHT 
concentrations were used and the non-detects were replaced by the LOD value.  
Concentration data for BHT in facial moisturiser and mouthwash were not identified. These 
products were reported used by the EuroMix participants, but not included in the exposure 
assessment due to the lack of concentration data.    
 Amount per application 
PCP amounts used per application were not recorded in the EuroMix study and had to be 
obtained from the literature. Only publications reporting amounts used per application were 
considered, and those with separate data for men and women were prioritised. If multiple 
data on amounts used per product were available, we assumed that Norwegian PCP use 
might be closest to other European countries, and the data were prioritised as follows: 1) 
French, 2) Swiss, 3) USA and 4) Japanese. The French data by Ficheux et al. (2016) were 
prioritised over the Swiss data by Garcia-Hidalgo et al. (2017)  because the weight of PCP 
products before and after use was reported, which we considered being a more precise 
metod than the picture method used by Garcia-Hidalgo et al. (2017). Note that the amount 
of product used per application in some cases can be sex-specific, e.g. men use more 
shower-gel and less shampoo than women do. If the amount applied was measured for 
more than one product in a category within a study, the mean of the 50-percentile and the 
95-percentile were used for the «realistic» and the «high» exposure scenarios, respectively 
(Table 4.5.3-1), from that study. 
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Data for amount applied of antibacterial hand sanitisers were not identified. In the exposure 
estimations, we assumed that the amount applied was similar to the amount applied of hand 
cream. 
 Retention factors (RFs) 
The retention factor (RF) is the fraction of a PCP available for uptake after application. 
Dermal and oral RFs depend on how products are applied (i.e. leave-on or rinse-off 
products) and are therefore given for product categories and are independent of the 
chemical. The mean values for the RFs were adopted from the Scientific Committee on 
Consumer Safety Notes of guidance  (SCCS, 2018) and Dudzina et al. (2015), and are shown 
in Table 4.3.5-1. 
 Exposure estimates from personal care products (PCPs) 
The external BHT exposure from PCPs, normalised by body weight (bw) was calculated using 
the following equation, summing over all products: 
External BHT exposure from PCP (µg / kg bw per day) = Frequency of application (per day) 
x Amount per application (g) x BHT concentration (µg/g) x Retention factor (oral and/or 
dermal) / Individual bodyweight (kg) 
An overview of the parameters used to estimate exposure from PCPs is given in Table 4.3.5-
1. In the table, the realistic and high amount applied per application (for males and 
females), the realistic and high concentrations, and the retention factors for each product 
category are given. Lastly, the percentage of users and mean number of applications per day 
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Table 4.3.5-1. The parameters used to calculate BHT exposure from PCPs. A detailed description of the parameters are given in 4.3.1, 4.3.2, 4.3.3 and 














factors Usage in EuroMix 
  Females Males Females Males Realistic High Dermal Oral Users (%) 
Mean number 
of applications 
per day for 
users 
Shower gel Dermal 8 8.5 23.2 26.2 0.16 0.16 0.01 – 75.7 0.9 
Shampoo Dermal 8.1 5.1 25.3 13.9 0 4.1 0.01 – 61.1 0.7 
Conditioner Dermal 7.5 5.2 27 7.2 71.1 71.1 0.01 – 41.7 0.7 
Deodorant Dermal 0.8635 0.96375 2.5549 2.67945 269.78 700 1.00 – 86.1 1.0 
Facial cleanser Dermal 2.7287 2.789 8.0408 6.753 85.2 85.2 0.01 – 41.7 1.1 
Body lotion Dermal 7.55 5.1 23.55 19.6 285.734 2201 1.00 – 36.8 0.8 
Anti-wrincle 
cream Dermal 0.512 0.725 1.8997 0.7708 13.405 26.81 1.00 – 9.7 1.0 
Sunscreen Dermal 1.45 2.35 7.9 4.8 7.4225 14.5 1.00 – 13.2 0.7 
Toothpaste Oral 1.085 1.4155 3.004 2.8143 200 200 – 0.20 98.6 1.7 
Lip gloss/ 
stick/balm Oral 0.0125 0.02 0.0357 0.0458 1201.88 2996 0.10 0.90 38.2 1.8 
Foundation Dermal 0.091 0.6 0.370725 1.2 50 100 1.00 – 27.8 0.8 
Intimate soap Dermal 2 – 6.5 NA 0.16 0.16 0.01 – 4.9 0.6 
Hand cream Dermal 0.877 1.39 2.734 3.0622 187.76 354.24 1.00 – 22.2 1.3 
Foot cream Dermal 2.734 3.312 8.3724 8.4868 187.76 354.24 1.00 – 4.9 0.6 
Hair styling 
products Dermal 2.8653 1.9295 8.4952 6.5691 183.33 220 0.10 – 18.8 1.0 
Hair treatment 
rinse off Dermal 10.8 – 37.7 – 183.33 220 0.01 – 5.6 0.7 
 
 














factors Usage in EuroMix 
Eye make-up 
products Dermal 0.0068 – 0.02285 – 34.5 34.5 1.00 – 38.2 1.2 
Rouge and 
powder Dermal 0.0093 – 0.0349 – 34.5 34.5 1.00 – 14.6 0.8 
Make-up 
remover Dermal 2.0114 0.3 5.3226 0.8 43.9 43.9 1.00 – 6.2 0.7 
Shaving 
products Dermal 7.5333 2.82 25.3667 10.04 30.6 30.6 0.01 – 7.6 0.7 
Antibac Dermal 0.877 1.39 2.734 3.0622 200 200 1.00 – 3.5 6.9 
Oils Dermal 1.8012 2.0975 3.9967 9.007 863.33 1540 1.00 – 4.9 0.7 
Handsoap Dermal 1.9875 2.9 4.8952 7.261 31,3 93,3 0.01 – 95.1 9.1 
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Oral and dermal external exposure to BHT through PCPs were estimated for the «realistic» 
and the «high» exposure scenario for all individuals in the EuroMix study (Table 4.3.5-2). To 
quantify the different sources of BHT from PCPs, we summed up exposure from each 
category across all individual-days for dermal exposure. 
Table 4.3.5-2. Oral and dermal external exposure to BHT through PCPs. Exposures are observed 
individual mean using parameters for «realistic» and «high» exposure given in Table 4.3.5-1 with 
reported frequencies of use. 
 
Route - exposure scenario  
Mean 5 percentile 50 percentile (median) 95 percentile  
µg/kg bw per day 
Dermal – «realistic»  16 0.12 5.2 50 
Dermal – «high»  270 0.88 37 985 
Oral – «realistic»  1.3 0.59 1.3 2.4 
Oral - «high»  4.1 1.3 3.4 8.9 
«Body lotion» and «deodorant» were the two major contributors to the dermal «realistic» 
exposure scenario for both females and males. For females, exposure from «body lotion» 
and «deodorant» were 63% and 18% respectively. For males, exposure from «body lotion» 
and «deodorant» were 47% and 42%, respectively. Other minor sources were hand cream 
(females: 5%, males: 5%), oils (females: 6%, males: 0%), antibac (females: 4%. males: 
3%), hand soap (females: <1%, males: 1%) and foot cream (females: 2%, males: 0%).  
Oral exposure from PCPs is mainly from toothpaste (females: 85% and males 100%) with a 
smaller contribution (15 %) from lip gloss/stick/balm for females.  
Overall, the main route of external BHT exposure from PCPs (i.e. oral vs dermal) is dermal 
for both males and females, with only 6.7% of all BHT exposure from PCPs through oral 
intake in females and 15.9% in males. Note however, that this is not accounting for different 
levels of absorption of BHT through dermal and oral exposure (see below).  
 External BHT exposure from indoor dust 
The external BHT exposure from dust was estimated as follows: 
External BHT exposure from dust (µg/kg bw per day) = BHT concentration in dust (µg/mg 
dry weight) x Intake of settled indoor dust (mg/day) / body weight (kg) 
Due to lack of data on intake of settled indoor dust, the standard factors for intake of settled 
indoor dust of 20 mg/day (central tendency) or 60 mg/day (upper percentile) for adults in 
EPA’s exposure toolbox were used (EPA., 2011). The intake of 20 mg/day (central tendency) 
settled indoor dust was used for the «realistic» exposure scenario whereas the intake of 60 
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mg/day (upper percentile) settled indoor dust were used for the «high» exposure scenario 
(EPA, 2011). 
Wang (2016a) reported concentrations of BHT in house dust from 12 different countries, 
including median, minimum and maximum values. We assumed that the samples from 
Greece were most likely to be similar to Norwegian conditions and these were therefore used 
in the «realistic» exposure scenario, whereas the Japanese values were used in the «high» 
exposure scenario. The median, minimum and maximum values reported in Wang et al. 
(2016) indicated that the distribution of BHT concentrations in dust deviated from a normal 
distribution and had a right skew. This means that the average (or expected) BHT 
concentration, i.e. the arithmetic mean, was higher than the median. To properly account for 
variability and to arrive at chronic levels of exposure from dust particles, the values reported 
in Wang et al. (2016) were therefore used to estimate a log-normal distribution for 
concentrations in dust. The mean of the log-normal (not to be confused with the mean of 
the values; it refers to the mean on the log-scale) was set to log(median). The standard 
deviation was then estimated by optimisation, finding the value most likely to produce a 
maximum or minimum equal to that reported by Wang et al. (2016), given the number of 
samples reported. For the Greek data, these standard deviations were 0.65 and 1.75. We 
used the midpoint of the two standard deviations found by optimisation to approximate the 
mean concentration of BHT in dust. In realistic exposure from dust, the mean concentration 
was estimated to be 2652 µg BHT / kg dust (dry weight; dw), using parameters [µ = 
log(1330) and σ = 1.175], and for high levels of exposure (Japanese values, µ = log(8210), 
σ = 0.85), the concentration was 11782 µg BHT/kg dust dw. Thus, the average exposure 
from dust, used as input to the combined exposure (see below), was set to 0.053 µg / day 
for all adult individuals assuming a daily dust ingestion of 20 mg and an expected 
concentration of 2652 µg BHT/kg dust. Note that table 4.4-1 gives exposure both per 
individual and per standard kg body weight (70 kg). The exposure per individual was used in 
the combined exposure (see below), where individual body weights from the Euromix survey 
was used for normalisation. 
The estimated external exposure to BHT through indoor dust is shown in Table 4.4.1.  
Table 4.4-1. External exposure to BHT through settled indoor dust. Using concentrations of BHT in 
dust from Greece (realistic) and Japan (high), a log-normal distribution was assumed to arrive at 
‘mean’ concentrations.). Following standard values for dust intake from EPA, exposure in µg/ per day 
















body weight (µg / 
kg bw per day) 
Greek 
concentrations 2.652 
0,020 (low) 0.053 (low) 0.00076 (low) 
0,060 (high) 0.16 (high) 0.0023 (high) 
Japanese 
concentrations 11.782 
0,020 (low) 0.24 (low) 0.0034 (low) 
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 Total internal exposure  
Bivariate statistical models fitted to oral and dermal intakes were utilised to estimate total 
internal exposure. We added the dietary intake from food, the oral intake from PCPs (in 
EuroMix) and an average ingestion of dust for the oral route, resulting in 284 (140 
individuals on two days + 4 individuals on 1 day) individual-day exposures of both oral and 
dermal routes. The goal of analysing oral and dermal exposure together was to determine 
whether individuals who have above average intake of BHT through their diet also have an 
above average exposure through the dermis. If there is a correlation (or covariance) 
between these routes, treating routes as independent will bias the estimates. We use the 
fitted models to draw daily exposures for many individuals over 365 days to predict chronic 
exposures for both pathways. These are finally added to yield a distribution of total internal 
exposure. 
 Absorption factors for BHT 
BHT is rapidly absorbed in the gastrointestinal tract after oral exposure, and we therefore 
assumed a 100% absorption of BHT in the gastrointestinal tract (EFSA, 2012).  
The studies on dermal absorption cited in Lanigan et al. (2002) showed absorption values 
ranging from 0.4% to 14.4%. The original studies were not available, thus, the Panel could 
not adequately assess the strengths and weaknesses of the studies to be able to define a 
key study. The three studies used ex vivo pig or rat skin models or in vivo guinea pig model. 
Pig skin resembles human skin and is thus a better model than ex vivo rat and in vivo guinea 
pig. Using the ex vivo pig skin model, the absorption value was found to be 0.4% (without 
adding 1-2 standard deviations to the final absorption value). However, the exposure period 
before wash-off of the test solution was only 30 minutes and not 8 hours that better 
resembles exposure from leave-on cosmetic products. A longer exposure period would likely 
result in a higher absorption value than 0.4%. Physical and chemical properties such as 
molecular weight > 500 Da, octanol/water partition coefficient (log Pow) ≤ -1 or ≥4, 
topological polar surface area > 120 Å2 and melting point > 200 °C indicate a very low 
dermal absorption. With regard to BHT, the log Pow is 5.1, however the other properties are 
not indicative of a very low dermal absorption. The Panel therefore decided to use the 
absorption factor of 4% as indicated in Lanigan et al. (2002). 
 Modelling approach 
Exposure from dietary intake and PCPs (both from EuroMix) and assumed exposure from 
dust were analysed using a generalised linear mixed model framework implemented in the R 
statistical software (R Core Team, 2018). Bayesian statistical models were used to remove 
the day-to-day variation that has a tendency to lead to overestimation of variability, and 
particularly the tails of the exposure distribution, when using OIMs. Using a multivariate 
model (i.e. a model predicting oral and dermal exposure) also allows for appropriate 
quantification of the potential covariance between exposure from diet and other sources. 
This is detailed below. 
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The basics of the statistical model is to predict all the individual-day datapoints of oral intake 
and dermal uptake using a model with fixed and random effects. Fixed effects refer to 
parameters that are estimated to predict the exposures. In the presented models we utilise 
sex as a fixed effect for dermal exposure (for other models tested see 4.5.3). This means 
that the model quantifies how males and females differ on average in their daily exposure 
levels for oral exposure. When having estimated such an effect of sex it is easier to predict 
population relevant exposures; in the case of EuroMix, 100 of 144 participants are females, 
and just presenting the OIMs for the intake (as in Table 4.2.2.2) is misleading, particularly if 
females have a different intake on average. By estimating the effect of being male or female 
on exposure we can correct for this bias in the representativeness of the survey.  
The second part of a mixed model is the random effects. Most basic statistical models 
assume that differences between a prediction and a data-point is distributed according to 
some density (usually the normal distribution). A hierarchical model, on the other hand, 
assumes that the difference between a prediction based on the fixed effects and the actual 
observations can be partitioned into several sources of variability. In trying to arrive at 
exposure estimates that represent chronic exposure, i.e. long-term level of exposure, an 
ideal model should remove variability in exposure from day to day within individuals, but 
keep variability between individuals as we wish to characterise the exposure for the whole 
population. Using a hierarchical model we will not only be able to estimate the effect of (and 
thus correct for) males and females being different on average in their exposure, we will also 
be able to estimate whether or not males and females differ in their variability in exposure. 
In other words, we can correct for the possibility that male individuals vary more in their 
chronic exposures than females.  
Finally, when applying multivariate models with fixed and random effects, we can also 
directly estimate the covariance between oral and dermal exposure between individuals. This 
is necessary to evaluate whether individuals with high oral exposure also have high dermal 
exposure, and whether females and males differ in the correlation between exposure routes.  
These corrections (based on mean/fixed effects and variances/random effects) were 
performed by simulating data according to the estimated parameters. Just as one can draw 
random numbers from a normal distribution with a given mean and standard deviation one 
can also draw exposures according to a model fit. In all models we partition variability in 
observation into variance between individuals (as random effects) and variance between 
days (as residuals). While our data was only collected for 2 days, we can simulate a large 
number of individuals and simulate 365 daily exposures, of which we calculate an individual 
mean. We thus arrive at a distribution of expected chronic exposures. These simulations 
were implemented using custom made functions in R. 
 Models of BHT exposure 
4.5.3.1  Fixed effects and model selection 
Initially 12 models were fitted to the data with four different structures assumed for the 
variances (see 4.5.3.2 and Table 4.5.3.2-1) combined with three model structures of fixed 
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effects. Daily exposure were normalised by body weight (yielding two variables; oral and 
dermal exposure in µg BHT/kg bw) and then log-transformed. For each variance structure a 
model with fixed effects of sex and age within each sex for both variables (oral and dermal) 
was fitted. In all cases, the parameter estimates for age effects overlapped with 0. A model 
with no age effects but with fixed effect for oral exposure, indicating that males and females 
do differ in both oral and dermal exposure, on average. We also tested models with no fixed 
effect of sex on exposure, but they had a worse fit in terms of DIC (deviance information 
criterion). There is also little evidence for exposure to BHT having a relationship with age, 
both for dermal and oral exposure. The four final models (with different variance structures 
only) included fixed effects of sex on dermal exposure and oral exposure. Models with fixed 
effects of age and fixed effect only for oral exposure are not further discussed and were not 
used for simulating chronic exposures. 
4.5.3.2  Random effects 
The hierarchical model posits two levels of variability; one among individuals and one among 
observations (i.e. days) per individual.  
Model 1 assumes no difference in the degree to which males and females vary; four variance 
parameters were estimated: variance among individuals for oral (1) and dermal (2) route 
and variance between days for oral (3) and dermal (4) exposure. In this model, the only 
difference between males and females is in their mean exposure levels forexposure. In other 
words, exposure estimates using model 1 will not take into account the possibility that 
dermal and oral exposure correlate. Estimates using this model would be the same as 
modelling oral and dermal route independently. 
Model 2 posits that variation between individuals are the same for males and females, but 
explicitly estimates the covariance, i.e. to which degree individuals who have «high» 
exposure through the oral route also have high (or low) exposure through the dermis. In this 
case, we directly estimate if there is a correlation between BHT exposures orally and 
dermally, but assume that males and females vary in the same manner. 
Models 3 and 4 posits that the error structures are similar as models 1 and 2, but that these 
(co-)variances are potentially different between males and females.  
Model 3 ignores correlation in exposures between the oral and dermal route, but allows 
males and females to have different level of variance(s) between individuals. 
Model 4 is similar to model 2, where the covariance/correlation between oral and dermal 
exposure is explicitly estimated. However, in model 4 the covariance routes can differ 
between the sexes. In other words, females can potentially have a positive correlation 
between oral and dermal exposure, while males have a negative correlation. 
The fit of all four models with fixed effect of sex on oral and dermal exposure and different 
variance structures are shown in Figure 4.5.3-1, and detailed in Table 4.5.3-1. 
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Figure 4.5.3-1. Results from models 1- 4 with contribution to internal exposure from oral intake on 
the x-axis and dermal exposure on the y-axis (adjusted for adsorption). The strongly coloured crosses 
are observed individual means (OIMs), whereas the lightly coloured dots are simulated/drawn from 
the model fit (red – females, blue – males). The ellipses encircle the 95-percentile for the predicted 
chronic exposures. Assuming the same structure of variability in males and females (Model 1 & 2) 
leaves the ellipses identical in shape, and the sexes differ only in mean exposures. In model 3 & 4 
males and females were assumed to have different levels of variability among days and among 
individuals. As seen by the wider ellipse, males vary much more in both exposure routes. Note that all 
models use a log-transformation of the daily exposures. According to the Deviance information 
criterion (DIC) model 3 and 4 fits the data best with similar DIC values outperforming models with 
same variances for both sexes. 
After the models were fitted to the data and model checks were performed, we utilised the 
estimated parameters to perform posterior predictive simulations. Essentially, we simulated 
exposures according to the model to form more robust exposure estimates. The OIMs 
approach will reduce the variability in exposure slightly compared to using all person-day 
exposure (i.e. not calculating individual means), but the modelling approach allows us to 
sample any number of days to estimate long-term average exposures. In our simulations we 
draw 50 000 «individuals» for each sex and draw 365 «daily» exposures (in µg BHT/kg bw) 
for each individual, and then calculate a mean exposure for each individual (Figure 4.5.3-1). 
We thus capture the variability between individuals, but reduce the variability between days 
to approximate a chronic exposure given the data and our model.  
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Table 4.5.3-1. Model summary: Models 1-4 differ in the variance/covariance structure estimated. The simplest model (Model 1) does not differentiate 
individual level effects between sexes, i.e. males and females were assumed to have the same variation in exposure between days and between individuals. 
For all models we assumed that the residual variance, i.e. the variability within individuals but between days, were the same for females and males. All 
models were analysed with exposure on a log scale, but simulated exposures are on the real scale. The Deviance information criterion indicates that models 3 
& 4 fit the data better. We simulate chronic exposures based on all four models. 
Model Variance between individuals Rationale/assumption 
Fixed 
effects DIC Notes of variances 
1 Same for females and males, one variance for each route 
Males and females exhibit same degree of variability of 
exposure Sex 1751   
2 
Same for females and males, 
one variance for each route 
and a covariance between 
routes 
Males and females exhibit same degree of variability, 
and individuals with high/low exposure through the oral 
route can also have high/low exposure through the 
dermal route 
Sex 1750   
3 
Males and females have 
different between- individual 
variances (no covariance) 
Males and females differ in their variance for each route Sex 1739 
Males vary about twice as much 
between individual and between 
days as females for both oral and 
dermal exposure 
4 
Males and females have 
different between-individual 
variances and covariance 
Males and females differ in their variance and covariance 
for each route Sex 1738 
Both males and females show 
tendency of positive individual level 
covariance between exposure 
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Figure 4.5.3-2. Total internal exposure using the EuroMix study and realistic middle bound 
concentrations for diet, realistic exposure assumptions for PCPs and Greek concentrations for mean 
oral exposure from dust. Histograms show the OIMs for females (top) and males (bottom). Lines are 
density distributions for the four different models presented in Table 4.5.3-1. Model 1 (full line), model 
2 (dashed line), model 3 (dotted line), model 4 (dash-dotted line). The different models does not 
affect the estimates for females (lines are almost entirely overlapping), but models with variance 
parameters for each sex leads to more variation in exposures for males (dotted and dash-dotted 
lines). While the simulated exposures are from four different assumption on the variance structure, 
the predicted chronic exposures are remarkably similar 
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Total internal exposure as estimated through OIMs and the four statistical models (1-4) 
applied on the EuroMix survey is shown in Table 4.5.3-2. All four models were applied to 
daily oral and dermal exposures normalised by weight, using the most realistic combination 
of parameters for diet, PCPs and dust.  
In addition to the «realistic» exposure scenarios we also calculated «high» exposure, 
combining the upper bound from the concentrations found in food (Table 4.2.1-1), the 
«high» exposure scenario of amounts and concentrations for PCP exposures (Table 4.3.1-1) 
and concentrations in dust from a ese study (Table 11.6-1). Results from this «high» 
exposure scenario is given in Table 4.5.3-3. 
Table 4.5.3-2. «Realistic» total internal exposure, in µg BHT/kg bw per day, as estimated through 
observed individual means (OIMs) and the four statistical models (1-4). 
«Realistic» 
exposure 
Mean 5 percentile 50 percentile 
(median) 
95 percentile 
OIMs – females 3,8 1,4 3,5 7,0 
OIMs – males  3,2 0,8 2,2 7,2 
Model 1 – females 5,3 2,1 4,5 11 
Model 1 – males 3,0 1,3 2,7 5,8 
Model 2 – females 5,3 1,9 4,3 12 
Model 2 – males  3,0 1,2 2,6 6,0 
Model 3 – females  4,9 2,3 4,3 9,1 
Model 3 – males  3,7 0,9 2,8 9,2 
Model 4 – females  4,9 2,2 4,2 9,6 
Model 4 – males  3,7 0,8 2,7 9,7 
Overall using the OIMs and the two best fitting models (3 and 4), the «realistic» total 
internal exposure from all routes was estimated to be within 1.4 – 9.6 µg BHT/kg bw per day 
for females and 0.8 – 9.7 µg BHT/kg bw per day for males. The 50 percentile was estimated 
to be within 3.5 – 4.2 and 2.2 – 2.8 µg BHT/kg bw per day for females and males, 
respectively. Note that males have on average lower exposure, but vary more between 
individuals and have similar upper tails as females. 
The predominant route of exposure is oral intake; on average 80% of the internal exposure 
in females is from food, dust and oral intake of PCPs, while for males even more (92%). 
Note that the models explicitly estimating the covariance between oral and dermal intake 
show a positive correlation for both males and females, i.e. «high» exposure dermally was 
correlated with higher exposure through the oral route. 
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Figure 4.5.3-3. «High» exposure, combining the upper bound from the concentrations found in food, 
the «high» exposure scenario of amounts and concentrations for PCP exposures and concentrations in 
dust from a Japanese study (Wang et al., 2016a). Red is ADI of 250 µg/kg bw per day. Histograms 
are OIMs and lines show distributions of the simulated exposures (full line: model 1, dashed line: 
model 2, dotted line: model 3 and dashed dotted line: model 4). 
Table 4.5.3-3. «High» total internal exposure (food, PCPs, and dust), in µg BHT/kg bw per day. 
OIMs: Observed individual means. 
«High» exposure Mean 5 percentile 50 percentile 
(median) 
95 percentile 
OIMs – females 94 23 85 224 
OIMs - males 64 9 44 190 
Model 1 – females 146 39 114 347 
 
 
VKM Report 2019:14  56 
«High» exposure Mean 5 percentile 50 percentile 
(median) 
95 percentile 
Model 1 – males 74 20 59 176 
Model 2 – females 147 40 115 349 
Model 2- males 74 20 59 174 
Model 3 – females 132 48 110 277 
Model 3 – males 102 13 60 309 
Model 4 – females 134 48 111 281 
Model 4 - males 104 13 61 319 
Including estimates from OIMs and the two best fitting models, the «high» total internal 
exposure from all routes was estimated to be within 23 – 281 µg BHT/kg bw per day for 
females and 9 – 319 µg BHT/kg bw per day for males. The 50 percentile was estimated to 
be within 85 – 111 and 46 – 61 µg BHT/kg bw per day for females and males, respectively. 
 Contributions to exposure 
 
To evaluate the relative contributions to exposure, dermal exposure was corrected using the 
absorption factor (0.04) and the four different routes (diet/oral, PCP/oral, dust/oral and 
PCP/dermal) on exposure were normalised by individual body weight. Their overall 
contribution to total exposure was then quantified (i.e. all absorption corrected internal 
exposure across all 144 individuals in Euromix). The percentage contributions to overall 
exposure of BHT is given in Table 4.5.4-1.  
Table 4.5.4-1. Contributions to internal exposure calculated by taking the overall percentage 





Diet / oral (%) PCP / oral (%) Dust / oral (%) PCP / dermal (%) 
All 46 37 0.02 17 
Females 41 38 0.02 21 
Males 59 34 0.02 7.1 
Sources of BHT exposure were mainly from food through oral intake (females 41%, males 
59%, see Table 4.5.4-1), with substantial contributions also from PCPs through oral uptake 
(females 38%, males 34%) and through dermal uptake from PCPs (females 21%, males 
7.1%).  
The best fitting model predicted that for males, about 82% of the total internal exposure 
were derived from oral ingestion, and among individuals the median percentage from oral 
ingestion was 93% (median within males) and similarly for females (69% and 79%). This 
clearly showed that the main route for exposure to BHT was oral. The models did not 
distinguish the different sources for the oral intake. 
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 Total exposure to harmful metabolites 
Due to the complex metabolism of BHT, the total exposure to potential harmful metabolites 
was not estimated.  
 Summary of the exposure estimations  
Due to lack of concentration data, BHT exposure from indoor air (sub-question 4) was not 
estimated. Due to the complex metabolism of BHT, the total exposure to potentially harmful 
BHT metabolites (sub-question 6) was not estimated. 
The exposure was estimated for «realistic» and «high» exposure scenarios. The BHT 
concentrations in foods were identified in literature. In the «high» exposure scenario, all 
concentration data were included regardless of country of origin. In the «realistic» exposure 
scenario, only concentration data from Europe and USA were included. The consumption 
data used were from Norkost 3 and EuroMix. The concentrations of BHT in PCPs were 
identified through literature searches, and the consumption data were from EuroMix. The 
concentrations of BHT in indoor dust were identified through literature searches, and the 
consumption was based on standard exposure factors from EPA (2011).  
External exposure - BHT reaching the physical barriers in the body  
The food group «milk, cream, ice cream», followed by «chewing gum» and «fatty fish» were 
the main contributors to the estimated dietary «realistic» external exposure. The two food 
groups «cheese» and «margarine and butter» were not included due to lack of concentration 
data from Europe/USA. However, these two food groups contributed most to the BHT 
exposure in the «high» exposure scenario. The main route of BHT exposure from PCPs (i.e. 
oral vs dermal) was dermal. The PCP categories «body lotion» and «deodorant» were the 
two major contributors to the estimated dermal «realistic» external exposure.  
Total internal exposure – absorbed BHT  
To calculate the total internal exposure, absorption factors for BHT uptake from the 
gastrointestinal tract and dermal BHT uptake were derived from the literature.  
Overall, the «realistic» total internal exposure from all routes was estimated to be within 1.4 
– 9.6 µg BHT/kg bw per day for females and 0.8 – 9.7 µg BHT/kg bw per day for males. The 
50 percentile was estimated to be within 3.5 – 4.2 and 2.2 – 2.8 µg BHT/kg bw per day for 
females and males, respectively.  
Overall, the «high» total internal exposure from all routes was estimated to be within 23 – 
281 µg BHT/kg bw per day for females and 9 - 319 µg BHT/kg bw per day for males. The 50 
percentile was estimated to be within 85 – 111 and 46 – 61 µg BHT/kg bw per day for 
females and males, respectively. 
The predominant route of exposure is oral intake; on average 80% of the internal exposure 
in females is from food, dust and oral intake of PCPs, while for males even more (92%). 
Sources of BHT exposure were mainly from food through oral intake (females 41%, males 
59%, with substantial contributions also from PCPs through oral uptake (females 38%, males 
34%) and through dermal uptake from PCPs (females 21%, males 7.1%).   
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5 Risk characterisation  
As reference points for BHT toxicity, the Panel used the ADI of 0.25 mg/kg bw per day 
established by EFSA (EFSA, 2012), based on effects on the litter size and pup body weight. 
Both «realistic» and «high» total internal BHT exposure was used in the risk characterisation.  
The «realistic» total internal exposure, from all routes, was estimated to be within 1.4 – 9.6 
µg BHT/kg bw per day for females and 0.8 – 9.7 µg BHT/kg bw per day for males. The 50 
percentile was estimated to be within 3.5 – 4.2 and 2.2 – 2.8 for females and males, 
respectively. The «high» total internal exposure from all routes was estimated to be within 
23 – 281 µg BHT/kg bw per day for females and 9 - 319 µg BHT/kg bw per day for males. 
The 50 percentile was estimated to be within 85 – 111 and 46 – 61 for females and males, 
respectively. Figure 5-1 gives an overview of the estimated exposure compared to the ADI. 
 
Figure 5-1. The total internal BHT exposure (from food, PCPs and indoor dust), both «realistic» and 
«high» exposure scenario (in µg/kg bw/day), for women and men. On the high end of the high 
scenario both males and females are predicted to exceed the ADI. 
 
The estimated «realistic» BHT exposure is below the ADI for both women and men. The 50 
percentile of the estimated «high» exposure for both men and women is below the ADI, 
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6 Uncertainties 
 Uncertainties in the hazard identification and 
characterisation  
The main sources to uncertainty in the hazard identification and characterisation are 
presented qualitatively in Table 6.1-1. The possible impact on the hazard identification and 
characterisation was evaluated by expert judgement, and both the main sources to 
uncertainty and the possible effects are presented in the table. 
Table 6.1-1. Qualitative evaluation of uncertainties in the hazard identification and characterisation. 
Endpoint Source of uncertainty Direction  
ADME 
The BHT metabolism is complex and differs 
considerably between rats and humans. Rats 
mainly excrete BHT in the feeces, while BHT is 
mainly excreted in the urine in humans. BHT is also 
shown to accumulate to a higher degree in fatty 
tissue in humans than in rats. 
- 
Hepatocellular adenomas and 
carcinomas 
The duration of the study by Olsen et al. (1986) 
was 144 weeks, which is considerably longer than 
indicated in the OECD guidelines. This may 
influence the outcome of the study. However, this 
is mostly relevant for the development of 
hepatocellular adenomas and carcinomas, and not 
the reproduction effects (litter size and pup body 




 Uncertainties in the exposure estimation 
The main sources to uncertainty in the exposure estimates are presented in Table 6.2-1. The 
possible impact of the uncertainty on the exposure estimates was evaluated by expert 
judgement, and both the main sources to uncertainty and the possible effect on the 
exposure estimates are presented in the table. A tabular format similar to suggestions from 
EFSA (EFSA et al., 2018) was used, and the impact of the uncertainty was expressed using 
symbols defined on a quantitative scale. A dot (•) indicates that the impact of the 
uncertainty is less than +/- 20%, one plus symbol (+) indicates that the true value could be 
up to twice as high as the estimate, and two plus symbols (++) indicates that the true value 
could be 10 times higher. One minus symbol indicates that the true value could be as low as 
half of the estimate, and two minus symbols (- -) indicates that the true value could be 1/10 
of the estimate. Each symbol represents a range of possible values. Pairs of symbols are 
used when the uncertainty spans a larger range: -/+ indicates that the true exposure is 
expected to be between half and twice the estimate.  
Table 6.2-1. Uncertainties in the external exposure estimates. 
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Source of 













Few datapoints for most of the food groups, 
resulting in uncertain values for all foods 
and food groups. The variation is likely to 
be higher than shown in a few samples. 
However, BHT can be found in many food 
groups and the overall exposure uncertainty 
may then be reduced since both too high 
and too low values will be part of the 
consumption of the same person.  
-/+ -/+ 
The lack of BHT data from Europe and USA 
for the food groups «margarine and butter» 
and «cheese» may give an underestimation 
of the «realistic» exposure.  
--/●  
In the «high» scenario the food groups 
«margarine and butter» and «cheese» are 
the main contributors to the exposure. 
Especially the food group «cheese» with 
only two analyses, are highly uncertain 
when used for the whole food group 
«cheese» consumed in Norkost 3 and 
EuroMix. 
 ●/++ 
Scenarios on brand loyal consumers are not 
included in this assessment, due to lack of 
specific data.  
-/+ -/+ 
Each food group has been assigned the 
mean concentration identified for that food 
group. This can be an overestimation if not 
all foods in the food group contain BHT. 
In the «realistic» exposure scenario, data 
from Europe/USA were used. 
In the «high» exposure scenario, all 
identified concentration data were included. 
This implies that high concentration data 
from outside Europe and USA are used, and 
the uncertainty related to this scenario is 





The effect of cooking/processing on the 
BHT concentration in foods was not taken 
into account. Sampled foods were assumed 
to represent consumed foods, which could 
lead to both over- and underestimation of 
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Source of 









BHT available for 
uptake 
The extraction of BHT from chewing gum is 
set to 100% in this assessment. Several 
studies have shown that the actual 
excretion from chewing gum is lower, 
depending on chewing time. For those who 
reported using chewing gum this will lead to 
an overestimation of BHT exposure.  
+ ● 
Classification of 
concentration data to 
foods/food groups 
Compiling the database for BHT occurrence 
by expert judgement.  -/+ -/+ 
Dietary surveys 
 
Two recording days; some foods/food 
groups have high concentrations of BHT, 
and the long term consumption of these 
high occurrence products (e.g. chewing 
gum, pepperoni) will not be reflected in two 
days records for one person.  
-/+ -/+ 
Different dietary assessment methods, with 
24-h recalls for Norkost 3 and 2 days 
weighed record for Euromix. The methods 
were not interchangable, but the mean 
energy intake in the two studies indicates 
that the studies are comparable. 
● ● 
Concentration of BHT 
in PCPs 
Concentration of BHT in personal care 
products, and variability in concentrations 
between brands. 
+/-  
Concentration data for BHT in facial 
moisturiser and mouthwash were not 
identified. 
-  
Dermal BHT uptake  
Original articles on dermal absorption of 
BHT cited in Lanigan et al. (2002) were not 
available for the Panel. Thus, it was not 
possible to evaluate the qualitity of the 
articles and thereby verify the absorption 
value of 4% used in the risk assessment. 
+/- +/- 
Use: Frequency and 
amount  






Limited number of predefined categories of 
personal care products leads to not covering 
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Source of 









Decoding individual handwriting in reports. -/+ -/+ 
There is some uncertainty in seasonal use 
of personal care products. +/-  
Products seldom used may be missed on 
the two study days. -  
The retention factors can vary between 






Pairs of symbols are used where the uncertainty spans a larger range. 
++ The true value could be 10 times higher. 
+The true value could be up to two times higher than the estimate (> 20%). 
-- The true value could be 1/10 of the estimate. 
-The true value could be as low as half of the estimate (> 20%). 
• The impact of the uncertainty is less than +/– 20%. 
* Reducing tails means the factor leads to upper and lower percentiles closer to the mean/median, i.e. 
underestimating variability among individuals. 
 Uncertainties in the exposure modelling 
In addition to the uncertainties arising from the data itself, the modelling of exposure (and 
simulated output from these models) also have inherent uncertainties. To be able to model 
intakes using formal frameworks we assume that exposures can be treated on a log-scale, 
i.e. all daily exposures are log-transformed before fitting the statistical model. While this 
might be the most parsimonious transformation, others have also been suggested (e.g. 
variation around the Box-Cox transformation implemented in the MCRA software). This also 
means that we model individual differences (i.e. the random effects) and the day-to-day 
differences within individuals (the residuals) on a log-scale. Implicitly we are then assuming 
that an individual with twice the mean exposure is as likely as an individual with half the 
exposure. Whether day-to-day variability in usage follow such a distributional assumption is 
hard to assess using the data available. 
While Norkost 3 gives a larger data set for estimating and modelling intake of BHT through 
the diet, our analysis of the EuroMix data shows that there is probably a correlation between 
intake of BHT through diet and through the use of personal care products.  
 
The different ways to partition variance, either between sexes or with explicit incorporation 
of covariance (model 1-4), shows that ignoring differences between the sexes in how they 
vary over days and individuals can be misleading (models 3 and 4 fit the data much better). 
The Euromix study is rich in detail but not in sample size, and this is still reflected in the 
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7 Summary, discussion and conclusion 
The aim was to assess whether the exposure of BHT from foods, PCPs and indoor dust 
constitutes a health risk to the Norwegian population and to compare the contribution from 
different sources and exposure pathways.  
 Hazard identification and characterisation 
 Literature 
To evaluate whether the ADI established by EFSA (2012) needed revision, literature 
searches, from 2012 to the search date (see Appendix 11 for detailed description) were 
performed to retrieve articles reporting on adverse health effects related to BHT. Only three 
original articles were included, namely, two studies on genotoxicity and one on endocrine 
disruption. The hazard identification and characterisation were therefore based on these 
three studies and the EFSA opinion of BHT as a food additive.  
 Toxicological data 
The ADI of 0.25 mg/kg bw per day, established by EFSA (2012), based on effects on the 
litter size and pup body weight was used for the risk characterisation. The ADI was based on 
a NOAEL of 25 mg/kg bw per day derived from two 2-generation studies in rats, applying an 
uncertainty factor of 100. No studies retrieved through the systematic literature searches 
indicated that this ADI needed revision.     
 Exposure 
 BHT concentrations, consumption and absorption 
The BHT exposure was estimated using i) data on BHT concentrations in foods, PCPs and 
indoor dust, ii) data on consumption of foods, frequency of PCP use and generic assumptions 
on intake of dust, and iii) data on BHT absorption. The exposure was estimated for 
«realistic» and «high» exposure scenarios (Table 4-2).  
Concentration data for BHT analysed in foods, PCPs and indoor dust were identified through 
literature searches. Articles were screened against the inclusion/exclusion criteria, and the 
data quality was evaluated and rated to make sure that the quality of the concentration data 
used for the exposure assessment was satisfactory. No concentration data on indoor air were 
identified, and BHT reaching the lungs was therefore not included in the exposure 
estimation. Food consumption data were obtained from EuroMix and Norkost 3. The dietary 
intake method used in Norkost 3 and EuroMix is well established, and recorded the intake 
over two days. The same food composition database was used for Norkost 3 and EuroMix, 
which enabled a direct comparison of these food intake data. Frequency data of PCP use 
were from EuroMix, whereas the data on dust consumption were derived from EPA’s 
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exposure toolbox (EPA, 2011). Data on PCP amount used per application and data on BHT 
absorption were obtained from the literature. 
In the «realistic» food exposure scenario, the concentration data considered to be the most 
representative for Norwegian exposure were used. To specify the food consumption 
estimate, two main food groups were divided into sub-groups, and only concentration data 
from Europe and USA that fulfilled the quality criteria were applied. A standard exposure 
factor was used for consumption of indoor dust (EPA, 2011). The 50 percentile for the 
applied PCPs, as reported in studies from Europe and USA, were used in the «realistic» 
scenario (Ficheux et al., 2016; Garcia-Hidalgo et al., 2017; Loretz et al., 2006).  
In the «high» food exposure scenario, main food groups and all concentration data that 
fulfilled the quality criteria, regardless of country of origin, were applied. The included foods 
were divided in broad groups giving a rougher estimate. In the «high» exposure scenario for 
dust and PCPs, the highest reported BHT concentrations were used. Upper percentile 
exposure factors (EPA) was applied for consumption of indoor dust. The maximum amounts 
were included for PCP use. The «high» exposure scenario is a worst-case estimation 
representing a risk assessment for potentially high consumers. 
The number of BHT datapoints included in the «realistic» exposure scenario were 259. Of 
the 20 food groups with assigned BHT values, 11 had a sample number below ten. The low 
sample numbers indicate that the whole diet was not covered. There were 412 datapoints in 
the «high» exposure scenario, which constitute a low number of analyses to cover the whole 
diet. Of the 21 food groups with an assigned BHT value, 14 had a sample number below ten. 
The concentration data for the exposure estimation from foods were limited and therefore 
considered to be the largest source of uncertainty. 
 
The «realistic» scenario do not include concentration data for the food groups «margarine 
and butter» and «cheese», due to lack of data from Europe and USA. In this scenario, it is 
assumed 100% excretion of BHT from «chewing gum», and it contributed to about 40% of 
the BHT exposure (Table 4.2.3-2). However, several studies have shown that the actual 
excretion from chewing gum is lower than 100%, dependent on chewing time, and the 
exposure is therefore most likely an overestimate.  
  
In the high scenario, the food groups «margarine and butter» and «cheese» were the main 
contributors to the exposure (Table 4.2.3-2). Especially the food group «cheese» with only 
two analyses, are highly uncertain when used for the whole food group «cheese» consumed 
in Norkost 3 and EuroMix. 
The realistic and high concentrations in most PCP categories differed by a factor from two to 
ten. The data on usage are considered to be the largest source of uncertainty in the 
estimates; some PCPs are rarely used (or frequently by few individuals) and the data are 
insufficient to allow for the use of models to strengthen inferences about frequency of use. 
Amounts of PCPs used per application were obtained from the literature, and the between-
individual variability in usage habits was not taken into account. Variability in concentrations 
between brands and in amounts among individuals as well as infrequently used categories 
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contribute to the uncertainty in the exposure estimation of PCPs, and is expected to lead to 
less extreme values in the presented estimates 
 Results of the exposure estimation 
7.2.2.1  External exposure 
BHT reaching the physical barriers in the body was defined as external exposure. An 
overview of the mean oral and mean dermal external exposure is given in Table 7.2.2.1-1.  
Table 7.2.2.1-1. Mean oral and dermal external BHT exposure using observed individual means 
(OIMs).  
 Mean oral exposure  
(µg/kg bw per day) 
Mean dermal exposure  











Foods (Norkost 3) 2.5 76 - - 
Foods (EuroMix) 1.7 69 - - 
Personal care 
products (EuroMix) 1.3 4.1 16 270 
Indoor dust (EPA) 0.00076 0.010 - - 
Based on Norkost 3 the mean BHT exposure from foods was 2.5 µg/kg bw per day for the 
«realistic» exposure scenario and 76 µg/kg bw per day for the «high» exposure scenario. 
Based on EuroMix, the mean BHT exposure from foods was 1.6 µg/kg bw per day for the 
«realistic» exposure scenario and 71 µg/kg bw per day for the «high» exposure scenario. 
The mean dermal BHT from PCP exposure was 16 µg/kg bw per day for the «realistic» 
exposure scenario and 270 µg/kg bw per day for the «high» exposure scenario. The mean 
oral BHT exposure from PCPs was 1.3 µg/kg bw per day for the «realistic» exposure scenario 
and 4.1 µg/kg bw per day for the «high» exposure scenario. The mean BHT exposure from 
indoor dust was 0.00076 µg/kg bw per day for the «realistic» exposure scenario and 0.010 
µg/kg bw per day for the «high» exposure scenario. 
The food group «milk, cream, ice cream», followed by «chewing gum» and «fatty fish» were 
the main contributors to the estimated dietary «realistic» external exposure. Note that the 
two food groups «cheese» and «margarine and butter» were not included due to lack of 
concentration data from Europe/USA. The main route of BHT exposure from PCPs (i.e. oral 
vs dermal) was dermal. The PCP categories «body lotion» and «deodorant» were the two 
major contributors to the estimated dermal «realistic» external exposure.  
EFSA and the VKM Panel had different approaches toward the exposure estimates for foods. 
EFSA used conservative estimates with maximum reported use levels in foods, whereas VKM 
used concentration data from the literature. EFSA included only foods where BHT was 
authorised as a food additive, whereas VKM also included other foods containing BHT. In 
addition, VKM also included BHT sources other than foods. EFSA (2012) estimated the 
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average adult BHT exposure from foods to be 10 - 30 µg/kg bw/day and the 95 percentile 
exposure to be 30 - 170 µg/kg bw perday. 
7.2.2.2  Total internal exposure  
Absorbed BHT was defined as total internal exposure. The total internal exposure was 
modelled summing up exposure through the gastrointestinal tract and skin, multiplied by 
absorption factors of 100% and 4% for gastrointestinal and dermal absorption of BHT, 
respectively. Using individual data for usage frequency for PCPs and consumption for foods 
from EuroMix with generic intakes from dust, the total internal exposure was modelled in an 
attempt to partition the variance in exposure between and within individuals (i.e. between 
days). Using a generalised linear mixed model, both mean differences between sexes, as 
well as different structures of variability, were estimated. These model fits were then used to 
«simulate» chronic exposures through both routes.  
The EuroMix study is small and relatively unrepresentative of the general population. 
However, it can be utilised to directly quantify one of the structural uncertainties when 
performing exposure estimates with compounds that enter the body through several routes; 
namely, the common assumption of independence. 
Overall, the total internal BHT exposure was predominantly from the oral route and uptake 
by the gastrointestinal tract. From the total internal exposure modelling, oral exposure 
constituted approximately 93% for males and 80% for females (median percentage of oral 
route across 50 000 simulated individuals, assuming the most complex model). Exposure 
from the diet was the dominant source for males (59%, Euromix OIMs, Table 4.5.4-1), 
whereas for females diet and oral exposure from PCPs were of similar magnitude (41% and 
38%, respectively, Euromix OIMs). Exposure to BHT through the skin contributed less (21% 
for females and 7.9 % for males), whereas the exposure from dust was even smaller 
(0.02%).  
 Modelling 
While our modelling approach was performed using the statistical software R, the approach 
is very similar to other models implemented in more standard risk-assessment tools, such as 
Monte Carlo Risk Assessment (MCRA). However, while MCRA use statistical models to 
improve exposure estimates, the software still lacks the ability to structure variance in 
different sub-populations. Males and females differ in their average exposures, but the 
similar performance of the more complex models indicates that males and females 
potentially are different in their level of variability in exposure both within and between 
individuals. Furthermore, across males and females, there are different signs of covariation 
in exposures, model 4 used in this assessment captures these differences. 
Table 4.5.3-2. shows the estimated internal exposure levels for both the observed individual 
means (OIMs) approach and for multivariate generalised linear mixed models (GLMMs) for 
realistic exposure parameters (realistic amounts and concentrations of BHT in PCPs, realistic 
levels of BHT in dust and narrow middle bound concentrations in food). When utilising 
statistical models to decompose variance between individuals and between days, the internal 
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exposure estimates for both males and females are estimated to be higher than mean and 
medians of OIMs estimates (see Table 4.5.3-2). While still being in the same order of 
magnitude, this suggests that using OIMs can underestimate chronic exposure compared to 
simulated exposures from GLMMs. However, the difference in numbers is relatively small, 
and for all «realistic» exposure scenarios, all below the ADI. 
While applying GLMMs to daily exposures can increase robustness and uncertainty 
quantification, there are also several aspects that could be improved in the presented 
models. For instance, while the models applied estimates of individual level variance for 
males and females independently (i.e. how much exposure varies among females relative to 
males), we still assume that the day-to-day variance is similar for both males and females.  
This assumption is necessecary due to the limitations in the data; EuroMix has very few 
individuals and only 2 days of exposures, which is not sufficient to allow the day-to-day 
variability to differ between the sexes. Note that all exposure models treat exposure on a 
log-scale, so variance is proportional. In other words, male and female exposures vary 
similarly (days with twice the average exposure exposure is as likely as half the average 
exposure), and not in absolute terms (days with 0.1 µg less exposure is not as likely as days 
with 0.1 µg more exposure). 
 Conclusions  
BHT is characterised by extensive use and multiple exposure sources and routes. Therefore, 
it is important that these sources and routes are included in the estimations to arrive at the 
most accurate picture of the population's exposure.  
As reference point for BHT toxicity, the Panel used the ADI of 0.25 mg/kg bw per day (EFSA, 
2012). 
Both estimated «realistic» and «high» total internal BHT exposures were used in the risk 
characterisation. The «realistic» total internal exposure was estimated to be within 1.4 – 9.6 
µg BHT/kg bw per day for females and 0.8 – 9.7 µg BHT/kg bw per day for males. The 50 
percentile was estimated to be within 3.5 – 4.2 and 2.2 – 2.8 µg BHT/kg bw per day for 
females and males, respectively. The high total internal exposure from all routes was 
estimated to be within 23 – 281 µg BHT/kg bw per day for females and 9 - 319 µg BHT/kg 
bw per day for males. The 50 percentile was estimated to be within 85 – 111 and 46 – 61 µg 
BHT/kg bw per day (rounded numbers) for females and males, respectively.  
The estimated «realistic» total BHT exposure is below the ADI for both women and men. 
The 50 percentile of the estimated «high» total exposure is below the ADI, whereas the 95 
percentile is above the ADI. Thus, a small fraction of the population may exceed the ADI and 
be at risk for negative effects on reproductive health. Note that the «high» total internal BHT 
scenario represents a risk assessment for potentially high consumers.  
The Panel concludes that BHT exposure is unlikely to cause adverse health effects in adults.   
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8 Data gaps 
To perform «realistic» exposure estimates, well described concentration data for all food 
groups are needed. More detailed information on differences between brands and type of 
products would give better estimates. Especially data on BHT in food groups with no 
concentration data from Europe/USA, such as «margarine and butter» and «cheese», are 
needed  
To perform realistic exposure estimates for PCPs, data on BHT concentrations in products 
and amounts used for different products are needed. Brand-loyalty (i.e. that individuals 
prefer to use the same e.g. deodorant and shampoo) together with variability in BHT 
concentrations across brands could not be considered, but would impact the variability 
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10 Appendix - Hazard 
 Literature search hazard 
The search was performed by Johanne Longva (Norwegian Institute of Public Health, the library) 
07.05.2018 and 08.05.2018. 
The total result was 936. 
Database: Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, 
Ovid MEDLINE(R) Daily, Ovid MEDLINE and Versions(R) <1946 to May 02, 2018> 
Result:  270 
 
1 Butylated Hydroxytoluene/  2073  
2 
("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" or 
"2,6 di tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert butyl) 
1,4 cresol" or "2,6 ditert. butyl 4 methylphenol" or "2,6 ditert.butyl 4 methylphenol" or 
"2,6 ditert.butyl para cresol" or "3,5 di tert butyl 4 hydroxytolu*" or "4 methyl 2,6 di(tert 
butyl)phenol" or "4-methyl-2" or "4 Methyl 2,6 ditertbutylphenol" or "6‐
ditertiarybutylphenolor" or "2,6 Di t butyl 4 methylphenol" or "2,6 Di tert butyl p cresol" 
or butylcresol or "butyl hydroxy tolu*" or "butylated 4 hydroxytolu*" or "butylated 
hydroxytolu*" or "butylhydroxy tolu*" or "butylhydroxytolu*" or "butyloxytolu*" or 
"dalpac" or "dbpc" or "dibunol" or "dibutyl 4 hydroxytolu*" or "dibutylhydroxytolu*" or 
"hydroxybutyltolu*" or "impruvol" or "ionol" or "vianol" or "E321" or "CAS 128‐37‐0").mp.  
4944  
3 adverse effects.fs.  1573516  
4 exp HEMATOLOGIC DISEASES/ or HEMATOLOGY/ or exp Thyroid Neoplasms/ or exp thyroid gland/ or "ALLERGY AND IMMUNOLOGY"/ or Allergens/ or exp Reproduction/  1653197  
5 
("risk*" or "safety" or "adverse" or "side-effect*1" or "hazard*" or "harm*" or "negative" 
or "interact*" or "toxicity" or "toxic" or ("health" adj2 "effect?") or ("hemoglobin" or 
"haematolog*" or "thyroid*" or "tyrosine" or "allerg*" or "reproduct*" or "pregnan*" or 
"fetal*" or "fertal*" or "pollinat*")).tw.  
5996408  
6 1 or 2  4944  
7 3 or 4 or 5  7701192  
8 6 and 7  1252  




Database: Embase <1974 to 2018 May 07> 
Result:  529 
 
1 butylcresol/  5150  
2 
("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" or 
"2,6 di tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert butyl) 
1,4 cresol" or "2,6 ditert. butyl 4 methylphenol" or "2,6 ditert.butyl 4 methylphenol" or 
"2,6 ditert.butyl para cresol" or "3,5 di tert butyl 4 hydroxytolu*" or "4 methyl 2,6 di(tert 
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"2,6 Di tert butyl p cresol" or butylcresol or "butyl hydroxy tolu*" or "butylated 4 
hydroxytolu*" or "butylated hydroxytolu*" or "butylhydroxy tolu*" or butylhydroxytolu* 
or butyloxytolu* or dalpac or dbpc or dibunol or "dibutyl 4 hydroxytolu*" or 
dibutylhydroxytolu* or hydroxybutyltolu* or impruvol or ionol or vianol or E321).mp.  
3 exp adverse event/  525854  
4 hematology/ or exp hematologic disease/ or exp thyroid gland/ or allergen/ or allergy/ or allergic reaction/ or exp reproduction/  3342682  
5 
("risk*" or "safety" or "adverse" or "side-effect*1" or "hazard*" or "harm*" or "negative" 
or "interact*" or "toxicity" or "toxic" or ("health" adj2 "effect?") or ("hemoglobin" or 
"haematolog*" or "thyroid*" or "tyrosine" or "allerg*" or "reproduct*" or "pregnan*" or 
"fetal*" or "fertal*" or "pollinat*")).tw.  
7813876  
6 1 or 2  6481  
7 or/3-5  9816411  
8 6 and 7  1691  
9 limit 8 to yr="2012 -Current"  529   
 
 
Database:  Web of Science - Indexes: SCI-EXPANDED, SSCI, A&HCI, ESCI 
Result:  218 
 
((("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" or "2,6 di tert 
butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert butyl) 1,4 cresol" or "2,6 ditert. 
butyl 4 methylphenol" or "2,6 ditert.butyl 4 methylphenol" or "2,6 ditert.butyl para cresol" or "3,5 di 
tert butyl 4 hydroxytolu*" or "4 methyl 2,6 di(tert butyl)phenol" or "4 Methyl 2,6 ditertbutylphenol" or 
"2,6 Di t butyl 4 methylphenol" or "2,6 Di tert butyl p cresol" or butylcresol or "butyl hydroxy tolu*" or 
"butylated 4 hydroxytolu*" or "butylated hydroxytolu*" or "butylhydroxy tolu*" or butylhydroxytolu* 
or butyloxytolu* or dalpac or dbpc or dibunol or "dibutyl 4 hydroxytolu*" or dibutylhydroxytolu* or 
hydroxybutyltolu* or impruvol or ionol or vianol or E321))) AND TOPIC: ("risk*" or "safety" or 
"adverse" or "side-effect*1" or "hazard*" or "harm*" or "negative" or "interact*" or "toxicity" or 
"toxic" or "hemoglobin" or "haematolog*" or "thyroid*" or "tyrosine" or "allerg*" or "reproduct*" or 
"pregnan*" or "fetal*" or "fertal*" or "pollinat*" or allerg* or ("health" NEAR/2 "effect*"))  
Timespan: 2012-2018. Indexes: SCI-EXPANDED, SSCI, A&HCI, ESCI.  
 
 
Database:  Cochrane Database of Systematic Reviews  
 
Result:  138 (CDSR: x, DARE: x, Trials: x, Method: x, Tech ass: x, Eco: x) 
 
ID Search Hits 
#1 [mh ^"Butylated Hydroxytoluene"]  8 
#2 ("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" or "2,6 di 
tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert butyl) 1,4 cresol" or "2,6 
ditert. butyl 4 methylphenol" or "2,6 ditert.butyl 4 methylphenol" or "2,6 ditert.butyl para cresol" or 
"3,5 di tert butyl 4 hydroxytolu*" or "4 methyl 2,6 di(tert butyl)phenol" or "4 Methyl 2,6 
ditertbutylphenol" or "2,6 Di t butyl 4 methylphenol" or "2,6 Di tert butyl p cresol" or butylcresol or 
"butyl hydroxy tolu*" or "butylated 4 hydroxytolu*" or "butylated hydroxytolu*" or "butylhydroxy 
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tolu*" or butylhydroxytolu* or butyloxytolu* or dalpac or dbpc or dibunol or "dibutyl 4 hydroxytolu*" 
or dibutylhydroxytolu* or hydroxybutyltolu* or impruvol or ionol or vianol or E321):ti,ab  135 
#3 ("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" or "2,6 di 
tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert butyl) 1,4 cresol" or "2,6 
ditert. butyl 4 methylphenol" or "2,6 ditert.butyl 4 methylphenol" or "2,6 ditert.butyl para cresol" or 
"3,5 di tert butyl 4 hydroxytolu*" or "4 methyl 2,6 di(tert butyl)phenol" or "4 Methyl 2,6 
ditertbutylphenol" or "2,6 Di t butyl 4 methylphenol" or "2,6 Di tert butyl p cresol" or butylcresol or 
"butyl hydroxy tolu*" or "butylated 4 hydroxytolu*" or "butylated hydroxytolu*" or "butylhydroxy 
tolu*" or butylhydroxytolu* or butyloxytolu* or dalpac or dbpc or dibunol or "dibutyl 4 hydroxytolu*" 
or dibutylhydroxytolu* or hydroxybutyltolu* or impruvol or ionol or vianol or E321) in Other Reviews, 
Technology Assessments and Economic Evaluations  2 
#4 [mh /AE]  125659 
#5 [mh "HEMATOLOGIC DISEASES"]  11620 
#6 [mh ^HEMATOLOGY]  32 
#7 [mh "Thyroid Neoplasms"]  600 
#8 [mh " thyroid gland"]  526 
#9 [mh ^"ALLERGY AND IMMUNOLOGY"]  11 
#10 [mh ^Allergens]  1755 
#11 [mh Reproduction]  8723 
#12 ("risk*" or "safety" or "adverse" or "side-effect*1" or "hazard*" or "harm*" or "negative" or 
"interact*" or "toxicity" or "toxic" or "hemoglobin" or "haematolog*" or "thyroid*" or "tyrosine" or 
"allerg*" or "reproduct*" or "pregnan*" or "fetal*" or "fertal*" or "pollinat*" or allerg* or ("health" 
near/2 "effect*")):ti,ab  407093 
#13 ("risk*" or "safety" or "adverse" or "side-effect*1" or "hazard*" or "harm*" or "negative" or 
"interact*" or "toxicity" or "toxic" or "hemoglobin" or "haematolog*" or "thyroid*" or "tyrosine" or 
"allerg*" or "reproduct*" or "pregnan*" or "fetal*" or "fertal*" or "pollinat*" or allerg* or ("health" 
near/2 "effect*")) in Other Reviews, Technology Assessments and Economic Evaluations  266 
#14 #1 or #2 or #3  138 
#15 #4 or #5 or #6 or #7 or 8 or #9 or #10 or #11 or #12 or #13 or #14  651116 
#16 #14 and #15  138 
 
Database:  Epistemonikos 
Result:  2 
(title:((title:(("1,3 di tert butyl 2 hydroxy 5 methylbenzene" OR "2,3 di tert butyl 4 methylphenol" OR 
"2,6 di tert butyl 4 methylphenol" OR "2,6 di tert butyl para cresol" OR "2,6 di(tert butyl) 1,4 cresol" 
OR "2,6 ditert. butyl 4 methylphenol" OR "2,6 ditert.butyl 4 methylphenol" OR "2,6 ditert.butyl para 
cresol" OR "3,5 di tert butyl 4 hydroxytolu*" OR "4 methyl 2,6 di(tert butyl)phenol" OR "4 Methyl 2,6 
ditertbutylphenol" OR "2,6 Di t butyl 4 methylphenol" OR "2,6 Di tert butyl p cresol" OR butylcresol OR 
("butyl hydroxy" AND tolu*) OR ("butylated 4" AND hydroxytolu*) OR (butylated AND hydroxytolu*) 
OR (butylhydroxy amd tolu*) OR butylhydroxytolu* OR butyloxytolu* OR dalpac OR dbpc OR dibunol 
OR ("dibutyl 4" AND hydroxytolu*) OR dibutylhydroxytolu* OR hydroxybutyltolu* OR impruvol OR 
ionol OR vianol OR E321) AND ("risk*" OR "safety" OR "adverse" OR "side-effect*1" OR "hazard*" OR 
"harm*" OR "negative" OR "interact*" OR "toxicity" OR "toxic" OR "health effect*" OR "hemoglobin" 
OR "haematolog*" OR "thyroid*" OR "tyrosine" OR "allerg*" OR "reproduct*" OR "pregnan*" OR 
"fetal*" OR "fertal*" OR "pollinat*")) OR abstract:(("1,3 di tert butyl 2 hydroxy 5 methylbenzene" OR 
"2,3 di tert butyl 4 methylphenol" OR "2,6 di tert butyl 4 methylphenol" OR "2,6 di tert butyl para 
cresol" OR "2,6 di(tert butyl) 1,4 cresol" OR "2,6 ditert. butyl 4 methylphenol" OR "2,6 ditert.butyl 4 
methylphenol" OR "2,6 ditert.butyl para cresol" OR "3,5 di tert butyl 4 hydroxytolu*" OR "4 methyl 2,6 
di(tert butyl)phenol" OR "4 Methyl 2,6 ditertbutylphenol" OR "2,6 Di t butyl 4 methylphenol" OR "2,6 
Di tert butyl p cresol" OR butylcresol OR ("butyl hydroxy" AND tolu*) OR ("butylated 4" AND 
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hydroxytolu*) OR (butylated AND hydroxytolu*) OR (butylhydroxy amd tolu*) OR butylhydroxytolu* 
OR butyloxytolu* OR dalpac OR dbpc OR dibunol OR ("dibutyl 4" AND hydroxytolu*) OR 
dibutylhydroxytolu* OR hydroxybutyltolu* OR impruvol OR ionol OR vianol OR E321) AND ("risk*" OR 
"safety" OR "adverse" OR "side-effect*1" OR "hazard*" OR "harm*" OR "negative" OR "interact*" OR 
"toxicity" OR "toxic" OR "health effect*" OR "hemoglobin" OR "haematolog*" OR "thyroid*" OR 
"tyrosine" OR "allerg*" OR "reproduct*" OR "pregnan*" OR "fetal*" OR "fertal*" OR "pollinat*"))) AND 
(title:(("risk*" OR "safety" OR "adverse" OR "side-effect*1" OR "hazard*" OR "harm*" OR "negative" 
OR "interact*" OR "toxicity" OR "toxic" OR "hemoglobin" OR "haematolog*" OR "thyroid*" OR 
"tyrosine" OR "allerg*" OR "reproduct*" OR "pregnan*" OR "fetal*" OR "fertal*" OR "pollinat*" OR 
allerg* OR "health effect*")) OR abstract:(("risk*" OR "safety" OR "adverse" OR "side-effect*1" OR 
"hazard*" OR "harm*" OR "negative" OR "interact*" OR "toxicity" OR "toxic" OR "hemoglobin" OR 
"haematolog*" OR "thyroid*" OR "tyrosine" OR "allerg*" OR "reproduct*" OR "pregnan*" OR "fetal*" 
OR "fertal*" OR "pollinat*" OR allerg* OR "health effect*")))) OR abstract:((title:(("1,3 di tert butyl 2 
hydroxy 5 methylbenzene" OR "2,3 di tert butyl 4 methylphenol" OR "2,6 di tert butyl 4 methylphenol" 
OR "2,6 di tert butyl para cresol" OR "2,6 di(tert butyl) 1,4 cresol" OR "2,6 ditert. butyl 4 
methylphenol" OR "2,6 ditert.butyl 4 methylphenol" OR "2,6 ditert.butyl para cresol" OR "3,5 di tert 
butyl 4 hydroxytolu*" OR "4 methyl 2,6 di(tert butyl)phenol" OR "4 Methyl 2,6 ditertbutylphenol" OR 
"2,6 Di t butyl 4 methylphenol" OR "2,6 Di tert butyl p cresol" OR butylcresol OR ("butyl hydroxy" AND 
tolu*) OR ("butylated 4" AND hydroxytolu*) OR (butylated AND hydroxytolu*) OR (butylhydroxy amd 
tolu*) OR butylhydroxytolu* OR butyloxytolu* OR dalpac OR dbpc OR dibunol OR ("dibutyl 4" AND 
hydroxytolu*) OR dibutylhydroxytolu* OR hydroxybutyltolu* OR impruvol OR ionol OR vianol OR 
E321) AND ("risk*" OR "safety" OR "adverse" OR "side-effect*1" OR "hazard*" OR "harm*" OR 
"negative" OR "interact*" OR "toxicity" OR "toxic" OR "health effect*" OR "hemoglobin" OR 
"haematolog*" OR "thyroid*" OR "tyrosine" OR "allerg*" OR "reproduct*" OR "pregnan*" OR "fetal*" 
OR "fertal*" OR "pollinat*")) OR abstract:(("1,3 di tert butyl 2 hydroxy 5 methylbenzene" OR "2,3 di 
tert butyl 4 methylphenol" OR "2,6 di tert butyl 4 methylphenol" OR "2,6 di tert butyl para cresol" OR 
"2,6 di(tert butyl) 1,4 cresol" OR "2,6 ditert. butyl 4 methylphenol" OR "2,6 ditert.butyl 4 
methylphenol" OR "2,6 ditert.butyl para cresol" OR "3,5 di tert butyl 4 hydroxytolu*" OR "4 methyl 2,6 
di(tert butyl)phenol" OR "4 Methyl 2,6 ditertbutylphenol" OR "2,6 Di t butyl 4 methylphenol" OR "2,6 
Di tert butyl p cresol" OR butylcresol OR ("butyl hydroxy" AND tolu*) OR ("butylated 4" AND 
hydroxytolu*) OR (butylated AND hydroxytolu*) OR (butylhydroxy amd tolu*) OR butylhydroxytolu* 
OR butyloxytolu* OR dalpac OR dbpc OR dibunol OR ("dibutyl 4" AND hydroxytolu*) OR 
dibutylhydroxytolu* OR hydroxybutyltolu* OR impruvol OR ionol OR vianol OR E321) AND ("risk*" OR 
"safety" OR "adverse" OR "side-effect*1" OR "hazard*" OR "harm*" OR "negative" OR "interact*" OR 
"toxicity" OR "toxic" OR "health effect*" OR "hemoglobin" OR "haematolog*" OR "thyroid*" OR 
"tyrosine" OR "allerg*" OR "reproduct*" OR "pregnan*" OR "fetal*" OR "fertal*" OR "pollinat*"))) AND 
(title:(("risk*" OR "safety" OR "adverse" OR "side-effect*1" OR "hazard*" OR "harm*" OR "negative" 
OR "interact*" OR "toxicity" OR "toxic" OR "hemoglobin" OR "haematolog*" OR "thyroid*" OR 
"tyrosine" OR "allerg*" OR "reproduct*" OR "pregnan*" OR "fetal*" OR "fertal*" OR "pollinat*" OR 
allerg* OR "health effect*")) OR abstract:(("risk*" OR "safety" OR "adverse" OR "side-effect*1" OR 
"hazard*" OR "harm*" OR "negative" OR "interact*" OR "toxicity" OR "toxic" OR "hemoglobin" OR 
"haematolog*" OR "thyroid*" OR "tyrosine" OR "allerg*" OR "reproduct*" OR "pregnan*" OR "fetal*" 
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  Publication selection and data extraction  
 Publication selection 
The aim of this literature search was to retrieve publications on adverse health effects 
related to BHT. Since EFSA published an opinion on BHT safety in 2012, articles published 
before 2012 were excluded. The literature search identified 936 articles. 
Two persons independently compared the identified articles with the inclusion/exclusion 
criteria checklist (Table 10.2.1-1 for human studies, 10.2.1-2 for animal studies and 10.2.1-3 
for in vitro and in vivo genotoxicity studies). The first screening, based on analysis of 
title/abstracts, resulted in 29 articles. The full texts of the articles that passed the primary 
screening were retrieved for the secondary screening, with application of the very same 
inclusion/exclusion criteria. The secondary screening resulted in 13 articles; however, only 
three articles were original studies. An overview of the publication selection is given in Figure 
10.2.1-4.  
Table 10.2.1-1. Inclusion/exclusion criteria for human studies in the hazard identification and 
characterisation steps. 
Literature screening for data related to the following sub-questions: 
1: Is exposure to BHT related to adverse health effects in humans? Identify target organs. 
4: What is the nature of any dose–response relationship between BHT and relevant endpoints in 
the target organs in human studies? 
5: What is the ADME* in humans? 
6: Is there a difference in ADME between humans and animals? 
Study design Inclusion 
Human studies, including cohort studies, case-control 
studies (prospective, retrospective and nested), and 
toxicokinetic biomonitoring studies on any route of 
exposure 
Exclusion Animal studies and in vitro/in silico studies 
Population 
 
Inclusion Children (>1 - ≤14 years), adolescents (>14-<18 years) and adults (≥18 years) 
Exclusion Infants 




Inclusion All reported adverse health effects 
Exclusion 
Studies reporting exclusively preventive/beneficial 
effects on the target organs and studies reporting 
exclusively on the antioxidant properties/activities of 
BHT 
Language of 




Inclusion E.g. primary research studies, systematic reviews, meta-analyses and risk assessments 
Exclusion 
Editorials 
Letters to the editor 
Book chapters 
Meeting abstracts and posters 
 
 
VKM Report 2019:14  81 
*ADME - absorption, distribution, metabolism, excretion 
 
Table 10.2.1-2 Inclusion/exclusion criteria for animal studies in the hazard identification and 
characterisation steps. 
Literature screening for data related to the following sub-questions: 
2: Is BHT exposure related to adverse health effects in animals? Identify target organs. 
4: What is the nature of any dose-response relationship between BHT and relevant endpoints in the 
target organs in animal studies? 
5: What is the ADME* in different animal species/strains? 
6: Is there a difference in ADME between humans and animals? 
Study design Inclusion 
In vivo studies on animals not examining genotoxicity. 
Toxicokinetic studies (narrative approach) 
Exclusion Human studies and in vitro/in silico studies 
Population Inclusion All mammalian animals  Exclusion Non-mammalian animals 
Exposure 
 
Inclusion All routes of exposure 
Exclusion Studies where BHT is a part of a mixture and not tested alone 
Outcome of 
interest 
Inclusion All reported adverse health effects excluding genotoxicity 
Exclusion Studies reporting exclusively on the antioxidant properties/activities of BHT or studies on genotoxicity 
Language of 
the full text  Inclusion English, Norwegian, Swedish, Danish, German 
Publication 
type 
Inclusion E.g. primary research studies, systematic reviews, meta-analyses and risk assessments 
Exclusion 
Editorials 
Letters to the editor 
Book chapters 
Meeting abstracts and posters 
*ADME - absorption, distribution, metabolism, excretion  
  
Table 10.2.1-3. Inclusion/exclusion criteria for studies on genotoxicity. 
Literature screening for data related to the following sub-question:  





Inclusion In vitro studies on genotoxicity  In vivo studies on genotoxicity 
Exclusion 
Test systems: Drosophila melanogaster, Vicia faba, Allium cepa, 
fish 




Route of exposure for animal in vivo studies: oral, subcutaneous, 
intraperitoneal  
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Literature screening for data related to the following sub-question:  




DNA damage (mutations, strand breaks, unscheduled DNA 
syntehis (UDS)/DNA repair, reactivity towards DNA) and 
chromosomal damage (chromosomal aberrations, sister 




the full text  Inclusion English, Norwegian, Swedish, Danish, German 
Publication 
type 
Inclusion E.g. primary research studies, systematic reviews, meta-analyses and risk assessments 
Exclusion 
Editorials 
Letters to the editor 
Book chapters 
Meeting abstracts and posters 
 
 Data extraction 
Data were extracted from the included original study by Pop et al. (2013), but not for the 
two original studies on genotoxicity as the approach for studies on genotoxicity was narrative 
(Table 10.2.2-1).  
Table 10.2.2-1. Data extraction. -: Not reported. 
Study ID 
Reference: Pop et al. (2013) 
Year the study was conducted (start, if available): 
Health outcome category: Endocrine disruptive effects 
Funding Funding source: Support by the POSDRU Project number 6/1.5/S/3 Public/private: - 
Type of study and 
guideline 
Good laboratory practice (yes/no): - 
Guideline studies (if yes, specify): - 
Type of study: - 
Animal model Species/(sub-)strain/line: Wistar rats Disease models (e.g. infection, diabetes, allergy, obesity): 
Housing condition 
Housing condition (including cages, bottles, bedding): Standard 
conditions of temperature, humidity, day/night cycle, access to food 
and water ad libitum throughout the experiment. Body weight and 
clinical signs were recorded daily. 
Diet name and source: - 
Background levels of phytoestrogens in the diet (type and levels): 
Exposure 
BHT provider: - 
Compound purity: - 
Vehicle used: 17-beta estradiol (positive control) at a dose of 20 μg/kg 
in sun flower oil. 
Dose regimen (dose level or concentration of BHT per group, and 
frequency): 75 mg/kg bw 
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Study ID 
Reference: Pop et al. (2013) 
Year the study was conducted (start, if available): 
Health outcome category: Endocrine disruptive effects 
Route of administration (diet, drinking water, gavage, subcutaneous, 
intraperitoneal, dermal, inhalation): Oral suspension. The positive 
control was given by subcutaneous injection into dorsal surface 
Period of exposure (pre-mating, mating, gestation, lactation, adult):  
Duration of the exposure: BHT was administrated once per day for 
three consecutive days in the morning between 9-10 a.m. The rats 
were weighed and sacrificed using diethyl ether at 24 hours after the 
last treatment 
Study design 
Sex and age of the initially exposed animals: Female, 17-21 days old 
Number of groups/number of animals per group: 2 control groups; 3 
experimental groups; 10 animals in each group 
Randomisation procedures at start of the study: - 
Reducing (culling) of litters and method: - 
Number of pups per litter for next generation and methodology: - 
Number of pups per litter/animals for certain measurements and 
methodology: - 
Time of measurement/Observation period (premating, mating, 
gestation, lactation, adult): - 
Endpoints measured: The genital tract (ovaries, oviduct, uterine horns, 
body, cervix and vagina), the liver, spleen and kidneys were removed 
and weighed. The endometrial epithelium thickness was measured 
Methods to measure endpoints: Tissue collection, histopathological 
(H&E staining). Morphometric analysis was performed on midhorn 
cross sections of both uterine horns for all animals (n = 10 per 
treatment group) using Olympus Stream Basic image analysis software 
Estimated dietary exposure and method used (validation of the 
method, measures to avoid contamination of samples, limit of 
quantification and limit of detection, etc.) 
Statistical analysis 
Statistical methods: Statistical analysis on all morphometry data were 
performed using Shapiro-Wilk normality test followed by one way 
ANOVA and by the two-sample t-test, using R’ software 
Results 
 
Concentration of the test compound in vehicle (analysed, stated, 
ambigous):  
Documentation of details for dose conversion when conducted: - 
Level of test compound in tissue or blood: - 
Results per dose or concentration (e.g. mean, median, frequency, 
measures of precision or variance): - 
No observed adverse effect level, lowest observed adverse effect level, 
benchmark dose/benchmark dose lower bound, and statistical 
significance of other dose levels (author’s interpretation): Possible 
endocrine disruptive effects at the dose of 3x NOAEL 
Shape of dose response if reported by the authors: - 
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11 Appendix - Exposure 
  Literature search exposure 
  First literature search 
The search was performed by Marita Heinz (Norwegian Institute of Public Health, the library) October 
3 2017. The total result was 3711. 
Database: Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, 
Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) <1946 to Present> 
Result:  1470 
 
1 Butylated Hydroxytoluene/  2155  
2 
("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" or 
"2,6 di tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert butyl) 
1,4 cresol" or "2,6 ditert. butyl 4 methylphenol" or "2,6 ditert.butyl 4 methylphenol" or 
"2,6 ditert.butyl para cresol" or "3,5 di tert butyl 4 hydroxytolu*" or "4 methyl 2,6 di(tert 
butyl)phenol" or "4 Methyl 2,6 ditertbutylphenol" or "2,6 Di t butyl 4 methylphenol" or 
"2,6 Di tert butyl p cresol" or butylcresol or "butyl hydroxy tolu*" or "butylated 4 
hydroxytolu*" or "butylated hydroxytolu*" or "butylhydroxy tolu*" or butylhydroxytolu* 
or butyloxytolu* or dalpac or dbpc or dibunol or "dibutyl 4 hydroxytolu*" or 
dibutylhydroxytolu* or hydroxybutyltolu* or impruvol or ionol or vianol or E321).mp.  
3805  
3 1 or 2  3805  
4 Food Contamination/ or Food Packaging/ or exp Food/ or exp Cosmetics/ or Air Pollution/ or Air/ or Air Pollution, Indoor/ or Dust/  1310497  
5 
(food? or oil? or migration? or "contact material?" or cosmetic? or "care product?" or 
sunscreen* or "skin cream?" or "skin lotion?" or "body lotion?" or "dermal cream?" or 
"skin care" or lipstick? or "lip gloss*" or "lip balm?" or mascara? or eyeliner? or "eye 
shadow?" or "eyebrow pencil?" or blush* or "face powder?" or foundation* or perfume? 
or moisturi?er? or "skin cleanser*" or deodourant? or deodorant? or "hair care" or air or 
dust or housedust).tw. 
1061604  
6 4 or 5  2152126  
7 3 and 6  1530  
 
Database: Embase <1974 to 2017 October 02> 
Dato:   October 3 2017 
Antall treff:  1518 
 
1 butylcresol/  5036  
2 
("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" or 
"2,6 di tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert butyl) 
1,4 cresol" or "2,6 ditert. butyl 4 methylphenol" or "2,6 ditert.butyl 4 methylphenol" or 
"2,6 ditert.butyl para cresol" or "3,5 di tert butyl 4 hydroxytolu*" or "4 methyl 2,6 
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methylphenol" or "2,6 Di tert butyl p cresol" or butylcresol or "butyl hydroxy tolu*" or 
"butylated 4 hydroxytolu*" or "butylated hydroxytolu*" or "butylhydroxy tolu*" or 
butylhydroxytolu* or butyloxytolu* or dalpac or dbpc or dibunol or "dibutyl 4 
hydroxytolu*" or dibutylhydroxytolu* or hydroxybutyltolu* or impruvol or ionol or vianol 
or E321).mp.  
3 1 or 2  6346  
4 exp food/ or food packaging/ or food contamination/ or exp cosmetic/ or air pollution/ or air/ or air pollutant/ or indoor air pollution/ or house dust/  1090660  
5 
(food? or oil? or migration? or contact material? or cosmetic? or "care product?" or 
sunscreen* or "skin cream?" or "skin lotion?" or "body lotion?" or "dermal cream?" or 
"skin care" or lipstick? or "lip gloss*" or "lip balm?" or mascara? or eyeliner? or "eye 
shadow?" or "eyebrow pencil?" or blush* or "face powder?" or foundation* or perfume? 
or moisturi?er? or "skin cleanser*" or deodourant? or deodorant? or "hair care" or air or 
dust or housedust).tw.  
1362547  
6 4 or 5  2120223  
7 3 and 6  1918  
8 elsevier.cr.  22844501  
9 7 and 8  1557  
 
 
Database: ISI Web of Science 
Result:  1349 
 
# 3 1,349  #2 AND #1  
Indexes=SCI-EXPANDED, SSCI, A&HCI, ESCI Timespan=All years 
# 2 2,214,869  TOPIC: ((food$ or oil$ or migration$ or "contact material$" or cosmetic$ or "care 
product$" or sunscreen* or "skin cream$" or "skin lotion$" or "body lotion$" or 
"dermal cream$" or "skin care" or lipstick$ or "lip gloss*" or "lip balm$" or mascara$ 
or eyeliner$ or "eye shadow$" or "eyebrow pencil$" or blush* or "face powder$" or 
foundation* or perfume$ or moisturizer$ or moisturiser$ or "skin cleanser*" or 
deodourant$ or deodorant$ or "hair care" or air or dust or housedust))  
Indexes=SCI-EXPANDED, SSCI, A&HCI, ESCI Timespan=All years 
# 1 3,794  TOPIC: (("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 
methylphenol" or "2,6 di tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" 
or "2,6 di(tert butyl) 1,4 cresol" or "2,6 ditert. butyl 4 methylphenol" or "2,6 
ditert.butyl 4 methylphenol" or "2,6 ditert.butyl para cresol" or "3,5 di tert butyl 4 
hydroxytolu*" or "4 methyl 2,6 di(tert butyl)phenol" or "4 Methyl 2,6 
ditertbutylphenol" or "2,6 Di t butyl 4 methylphenol" or "2,6 Di tert butyl p cresol" or 
butylcresol or "butyl hydroxy tolu*" or "butylated 4 hydroxytolu*" or "butylated 
hydroxytolu*" or "butylhydroxy tolu*" or butylhydroxytolu* or butyloxytolu* or 
dalpac or dbpc or dibunol or "dibutyl 4 hydroxytolu*" or dibutylhydroxytolu* or 
hydroxybutyltolu* or impruvol or ionol or vianol or E321))  
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Result:  1562 
 









ABS ( ( foundation*  OR  perfume*  OR  moisturizer*  OR  moisturiser*  OR  
"skin cleanser*"  OR  deodourant*  OR  deodorant*  OR  "hair 





TITLE ( ( foundation*  OR  perfume*  OR  moisturizer*  OR  moisturiser*  O
R  "skin cleanser*"  OR  deodourant*  OR  deodorant*  OR  "hair 





ABS ( ( lipstick*  OR  "lip gloss*"  OR  "lip 
balm*"  OR  mascara*  OR  eyeliner*  OR  "eye shadow*"  OR  "eyebrow 





TITLE ( ( lipstick*  OR  "lip gloss*"  OR  "lip 
balm*"  OR  mascara*  OR  eyeliner*  OR  "eye shadow*"  OR  "eyebrow 





ABS ( ( cosmetic*  OR  "care product*"  OR  sunscreen*  OR  "skin 
cream*"  OR  "skin lotion*"  OR  "body lotion*"  OR  "dermal 





TITLE ( ( cosmetic*  OR  "care product*"  OR  sunscreen*  OR  "skin 
cream*"  OR  "skin lotion*"  OR  "body lotion*"  OR  "dermal 
















8 ABS ( ( hydroxybutyltolu*  OR  impruvol  OR  ionol  OR  vianol  OR  e321 ) )   
625 document 
results  




ABS ( ( butylcresol  OR  "butyl hydroxy tolu*"  OR  "butylated 4 
hydroxytolu*"  OR  "butylated hydroxytolu*"  OR  "butylhydroxy 
tolu*"  OR  butylhydroxytolu*  OR  butyloxytolu*  OR  dalpac  OR  dbpc  OR  





TITLE ( ( butylcresol  OR  "butyl hydroxy tolu*"  OR  "butylated 4 
hydroxytolu*"  OR  "butylated hydroxytolu*"  OR  "butylhydroxy 
tolu*"  OR  butylhydroxytolu*  OR  butyloxytolu*  OR  dalpac  OR  dbpc  OR  
dibunol  OR  "dibutyl 4 hydroxytolu*"  OR  dibutylhydroxytolu* ) )   
866 document 
results  
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butyl)phenol"  OR  "4 Methyl 2,6 ditertbutylphenol"  OR  "2,6 Di t butyl 4 
methylphenol"  OR  "2,6 Di tert butyl p cresol" ) )   
3 
TITLE ( ( "2,6 ditert.butyl 4 methylphenol"  OR  "2,6 ditert.butyl para 
cresol"  OR  "3,5 di tert butyl 4 hydroxytolu*"  OR  "4 methyl 2,6 di(tert 
butyl)phenol"  OR  "4 Methyl 2,6 ditertbutylphenol"  OR  "2,6 Di t butyl 4 




ABS ( ( "1,3 di tert butyl 2 hydroxy 5 methylbenzene"  OR  "2,3 di tert butyl 
4 methylphenol"  OR  "2,6 di tert butyl 4 methylphenol"  OR  "2,6 di tert 
butyl para cresol"  OR  "2,6 di(tert butyl) 1,4 cresol"  OR  "2,6 ditert. butyl 4 




TITLE ( ( "1,3 di tert butyl 2 hydroxy 5 methylbenzene"  OR  "2,3 di tert 
butyl 4 methylphenol"  OR  "2,6 di tert butyl 4 methylphenol"  OR  "2,6 di 
tert butyl para cresol"  OR  "2,6 di(tert butyl) 1,4 cresol"  OR  "2,6 ditert. 





Database: Cochrane Database of Systematic Reviews : Issue 10 of 12, October 2017, Database 
of Abstracts of Reviews of Effect : Issue 2 of 4, April 2015, Cochrane Central Register 
of Controlled Trials : Issue 9 of 12, September 2017, NHS Economic Evaluation 
Database : Issue 2 of 4, April 2015, Health Technology Assessment Database : Issue 
4 of 4, October 2016 
Result:  37  
 
ID Search Hits 
#1 [mh ^"Butylated Hydroxytoluene"]  8 
#2 ("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" 
or "2,6 di tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert 
butyl) 1,4 cresol" or "2,6 ditert. butyl 4 methylphenol" or "2,6 ditert.butyl 4 
methylphenol" or "2,6 ditert.butyl para cresol" or "3,5 di tert butyl 4 hydroxytolu*" 
or "4 methyl 2,6 di(tert butyl)phenol" or "4 Methyl 2,6 ditertbutylphenol" or "2,6 Di 
t butyl 4 methylphenol" or "2,6 Di tert butyl p cresol" or butylcresol or "butyl 
hydroxy tolu*" or "butylated 4 hydroxytolu*" or "butylated hydroxytolu*" or 
"butylhydroxy tolu*" or butylhydroxytolu* or butyloxytolu* or dalpac or dbpc or 
dibunol or "dibutyl 4 hydroxytolu*" or dibutylhydroxytolu* or hydroxybutyltolu* or 
impruvol or ionol or vianol or E321):ti,ab  
112 
#3 ("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" 
or "2,6 di tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert 
butyl) 1,4 cresol" or "2,6 ditert. butyl 4 methylphenol" or "2,6 ditert.butyl 4 
methylphenol" or "2,6 ditert.butyl para cresol" or "3,5 di tert butyl 4 hydroxytolu*" 
or "4 methyl 2,6 di(tert butyl)phenol" or "4 Methyl 2,6 ditertbutylphenol" or "2,6 Di 
t butyl 4 methylphenol" or "2,6 Di tert butyl p cresol" or butylcresol or "butyl 
hydroxy tolu*" or "butylated 4 hydroxytolu*" or "butylated hydroxytolu*" or 
"butylhydroxy tolu*" or butylhydroxytolu* or butyloxytolu* or dalpac or dbpc or 
dibunol or "dibutyl 4 hydroxytolu*" or dibutylhydroxytolu* or hydroxybutyltolu* or 
impruvol or ionol or vianol or E321) in Other Reviews, Technology Assessments and 
Economic Evaluations 
2 
#4 #1 or #2 or #3  115 
#5 [mh ^"Food Contamination"]  62 
#6 [mh ^"Food Packaging"]  25 
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#7 [mh Food]  27607 
#8 [mh Cosmetics]  2754 
#9 [mh ^"Air Pollution"]  77 
#10 [mh ^Air]  520 
#11 [mh ^"Air Pollution, Indoor"]  173 
#12 [mh ^Dust]  287 
#13 (food or food? or oil or oil? or migration or migration? or "contact material*" or 
cosmetic* or "care product*" or sunscreen* or "skin cream*" or "skin lotion*" or 
"body lotion*" or "dermal cream*" or "skin care" or lipstick* or "lip gloss*" or "lip 
balm*" or mascara* or eyeliner* or "eye shadow*" or "eyebrow pencil*" or blush* 
or "face powder*" or foundation* or perfume* or moisturizer* or moisturiser* or 
"skin cleanser*" or deodourant* or deodorant* or "hair care" or air or dust or 
housedust):ti,ab  
43564 
#14 (food or food? or oil or oil? or migration or migration? or "contact material*" or 
cosmetic* or "care product*" or sunscreen* or "skin cream*" or "skin lotion*" or 
"body lotion*" or "dermal cream*" or "skin care" or lipstick* or "lip gloss*" or "lip 
balm*" or mascara* or eyeliner* or "eye shadow*" or "eyebrow pencil*" or blush* 
or "face powder*" or foundation* or perfume* or moisturizer* or moisturiser* or 
"skin cleanser*" or deodourant* or deodorant* or "hair care" or air or dust or 
housedust) in Other Reviews, Technology Assessments and Economic Evaluations 
3692 
#15 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14  69104 






("1,3 di tert butyl 2 hydroxy 5 methylbenzene" or "2,3 di tert butyl 4 methylphenol" or "2,6 
di tert butyl 4 methylphenol" or "2,6 di tert butyl para cresol" or "2,6 di(tert butyl) 1,4 cresol" 
or "2,6 ditert. butyl 4 methylphenol" or "2,6 ditert.butyl 4 methylphenol" or "2,6 ditert.butyl 
para cresol" or "3,5 di tert butyl 4 hydroxytolu*" or "4 methyl 2,6 di(tert butyl)phenol" or "4 
Methyl 2,6 ditertbutylphenol" or "2,6 Di t butyl 4 methylphenol" or "2,6 Di tert butyl p cresol" 
or butylcresol or ("butyl hydroxy" and tolu*) or ("butylated 4" and hydroxytolu*) or 
(butylated and hydroxytolu*) or (butylhydroxy amd tolu*) or butylhydroxytolu* or 
butyloxytolu* or dalpac or dbpc or dibunol or ("dibutyl 4" and hydroxytolu*) or 
dibutylhydroxytolu* or hydroxybutyltolu* or impruvol or ionol or vianol or E321) AND (food 
or foods or oil or oils or migration or migrations or "contact material" or "contact materials" 
or cosmetic* or "care product" or "care products" or sunscreen* or "skin cream" or "skin 
creams" or "skin lotion" or "skin lotions" or "body lotion" or "body lotions" or "dermal cream" 
or "dermal creams" or "skin care" or lipstick* or "lip gloss" or "lip glosses" or "lip balm" or 
"lip balms" or mascara* or eyeliner* or "eye shadow" or "eye shadows" or "eyebrow pencil" 
or "eyebrow pencils" or blush* or "face powder" or "face powders" or foundation* or 
perfume* or moisturizer* or moisturiser* or "skin cleanser" or "skin cleansers" or 
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  Second literature search  
The search was performed by Jens Rohloff January 30th 2018. 
Database: SciFinder, American Chemical Society (ACS) 
Result:  708 
SEARCH METHOD 
1. «128-37-0» «food» 
• 1137 references received 
• remove duplicates (1136 refs) 
• Refine search 
                - Language: English (563 refs) 
                - Reference type: inclusion of books, clinical trials, dissertations, journal articles, 
     reports and reviews (403 refs) 
 
2. «128-37-0» «cosmetic» 
• 1470 references received 
• remove duplicates (1456 refs) 
• Refine search 
                - Language: English (700 refs) 
                - Reference type: inclusion of books, clinical trials, dissertations, journal articles, 
     reports and reviews (195 refs) 
 
3. «128-37-0» «care» 
• 715 references received 
• remove duplicates (714 refs) 
• Refine search 
                - Language: English (387 refs) 
                - Reference type: inclusion of books, clinical trials, dissertations, journal articles, 
     reports and reviews (110 refs) 
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  Publication selection, evaluation of data quality and data 
extraction 
 Publication selection 
The first literature search, performed by a librarian October 3 2017, identified 3711 articles. 
Several publications focusing on antioxidant properties/antioxidant activity were identified 
electronically and were excluded. Titles and abstracts of 411 articles were screened against 
the inclusion/exclusion criteria checklist (Table 11.2.1-1). Two persons performed this 
primary screening. Articles that did not meet the inclusion criteria were excluded. The full 
texts of the 47 articles that passed the primary screening were retrieved for screening 
against the inclusion/exclusion criteria checklist (Table 11.2.1-1). Two persons performed 
this screening.  
The second literature search was performed by a member of the project group January 30 
2018, in SciFinder, and 708 articles were identified. Titles and abstracts were screened 
against the inclusion/exclusion criteria checklist (Table 11.2.1-1). The full texts of the 32 
articles that passed the primary screening were retrieved for screening against the 
inclusion/exclusion criteria checklist (Table 11.2.1-1). Two persons performed the screening.  
Reference lists in some review articles identified in the literature searches were screened, 
and studies from this manual search were screened against the inclusion/exclusion criteria 
checklist (Table 11.2.1-1). Seven articles were included.  
Table 11.2.1-1. Inclusion/exclusion criteria for the exposure assessment study selection. 
Literature screening for concentration data related to the following sub-questions: 
1: What is the exposure to BHT from foods? 
2: What is the exposure to BHT from PCPs? 
3: What is the exposure to BHT from indoor dust? 
4: What is the exposure to BHT from indoor air? 
Study design Inclusion All publications that address analyses of BHT as 
concentrations 
Exclusion Human studies, animal studies, in vitro studies 
Study characteristics Inclusion Studies presenting analytical data and 
biomonitoring data on BHT 
Analytical method Inclusion All methods 
Sources and outcome of interest 
 
Inclusion BHT concentrations in foods, PCPs, indoor dust 
and indoor air 
Exclusion Studies reporting exclusively on toxicity or 
preventive/beneficial effects 
Studies reporting exclusively on the antioxidant 
properties/activities 
Studies reporting exclusively on BHT in 
pharmaceuticals or other sources 
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Literature screening for concentration data related to the following sub-questions: 
1: What is the exposure to BHT from foods? 
2: What is the exposure to BHT from PCPs? 
3: What is the exposure to BHT from indoor dust? 
4: What is the exposure to BHT from indoor air? 
Language of the full text  Inclusion English, Norwegian, Swedish, Danish, German 
Publication type 
 
Inclusion Primary research articles 
Risk assessments and reports 
Exclusion Editorials 
Letters to the editor 
Book chapters 
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 Result of the evaluation of data quality 
An overview of the included articles, all with a total score of 3.5 or higher, is given in Table 11.2.2-1. Articles with a total score of 3.5 or higher, 
but which were not included is shown in Table 11.2.2-2 (justification is given below the table). An overview of articles excluded due to a total 
score less than 3.5 is shown in Table 11.2.2-3. 
Table 11.2.2-1. An overview of included articles.ACN = acetonitrile; CAN:Pen = acetonitrile:Pentane; DCM = dichloromethane; EtAc = ethyl acetate; EtOH = 




was the solvent 
used for the 
extraction 
method (diethyl 
ether = hexane > 
EtOH > MeOH not 








Which validation method 
has been used, and how 
were the data presented 
(LOD/LOQ, 
internal/external 
calibration, number of 
samples, statistical 
methods)? 









Liu et al. 
(2017) DCM/Hx 4.0 3.5 5.0 4.5  
Cacho et al. 
(2016) Hx:ACN 3.0 5.0 4.0 4.0 




Wang et al. 
(2016a) DCM:Hx 4.0 5.0 4.0 4.2  
Myers et al. 
(2015) MeOH:ACN 3.5 4.5 4.0 4.0  
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Reference Solvent 
How appropriate 
was the solvent 
used for the 
extraction 
method (diethyl 
ether = hexane > 
EtOH > MeOH not 








Which validation method 
has been used, and how 
were the data presented 
(LOD/LOQ, 
internal/external 
calibration, number of 
samples, statistical 
methods)? 










Rivera et al. 
(2014b) 
SPME/HSSPME 3.5 5.0 4.5 4.4 
Test of fibres, 
solution conc. 
and a wide 




Celeiro et al. 
(2014) 
EtAc or 
Hx:Acetone 3.5 4.5 4.0 4.0  
Shasha et al. 
(2014) MeOH:ACN 3.0 3.5 4.0 3.7  
Lin et al. 
(2013) MeOH 2.0 3.5 4.0 3.5 
MeOH too polar 
for suitable 
extraction 
Akkbik et al. 
(2011a) Hx:ACN 3.0 4.0 5.0 4.4 





Prado et al. 
(2011) 
Hx:Acetone 4.5 4.0 4.5 4.4  
Edin et al. 
(2010) 
ACN + di-tert 
butylphenol 3.0 4.0 3.5 3.5  
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Reference Solvent 
How appropriate 
was the solvent 
used for the 
extraction 
method (diethyl 
ether = hexane > 
EtOH > MeOH not 








Which validation method 
has been used, and how 
were the data presented 
(LOD/LOQ, 
internal/external 
calibration, number of 
samples, statistical 
methods)? 










al. (2010) ACN 3.0 4.5 5.0 4.5  
Medeiros et 
al. (2010) EtOH 2.5 3.5 4.0 3.6 




Prado et al. 
(2010) 
Hx:Acetone 4.0 4.0 4.5 4.3  




Hx+MeOH 3.0 4.0 3.5 3.5  
Pattono et 
al. (2009) MeOH:Hx 3.0 4.0 3.5 3.5  
Saad et al. 
(2007) MeOH:ACN 3.5 3.5 4.0 3.8  
Lee et al. 
(2006) MeOH + SFE 4.0 4.5 3.0 3.5  
Lin et al. 
(2003) 
Different 
solvents 4.0 4.0 3.0 3.5 Relevant data 
Yang et al. 
(2002) EtAc 3.0 3.5 4.0 3.7  
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Reference Solvent 
How appropriate 
was the solvent 
used for the 
extraction 
method (diethyl 
ether = hexane > 
EtOH > MeOH not 








Which validation method 
has been used, and how 
were the data presented 
(LOD/LOQ, 
internal/external 
calibration, number of 
samples, statistical 
methods)? 










al. (2001) ACN 3.0 3.5 5.0 4.3 
Intake data 
presented 
Ni et al. 
(2000) MeOH 2.0 3.5 4.0 3.5 
MeOH too polar 
for suitable 
extraction 
Ruiz et al. 
(1999) EtAc 3.0 4.0 4.0 3.8  
DeWitt and 
Finne (1996) ACN:Hx 3.5 3.0 4.0 3.7  
Boussenadji 
et al. (1993) MeOH 2.0 4.0 4.0 3.6 




Table 11.2.2-2. An overview of excluded articles, with a total score of 3.5 or higher. 
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Reference Solvent 
How appropriate 
was the solvent 
used for the 
extraction method 
(diethyl ether = 
hexane > EtOH > 
MeOH not H2O)?   
Which 
instrumental 




Which validation method 
was used, and how was the 
datapresented (LOD/LOQ, 
internal/external calibration, 
number of samples, 
statistical methods)? 








Suh et al. 
(2005) ACN:Pen 3.5 3.5 4.0 3.8  
Ishiwata et 









SPME 3.5 3.5 3.5 3.5  
 
Three reports that got a total score of 3.5 or higher were excluced for other reasons. Suh et al. (2005) was excluded due to lacking LOD/LOQ. 
Ishiwata et al. (2003) had a large number of analysed samples, but the quality of analysis was not verifiable due to lack of LOD and LOQ 
values.  
The article by Tombesi and Freije (2002) analysed drinking water in Argentina. We decided not to include the measured BHT levels in our 
exposure estimates, not even in the high concentration dataset, because Argentina was considered to be too distant from Norway to be a 





VKM Report 2019:14  98 
Table 11.2.2-3. Articles excluded due to a total score less than 3.5. 
Reference 
How appropriate was the 
solvent used for the 
extraction method 
(diethyl ether = hexane 
> EtOH > MeOH not 
H2O)?   
Which 
instrumental 




Which validation method was 
used, and was the data 
presented (LOD/LOQ, 
internal/external calibration, 
number of samples, statistical 
methods)? 
Total score (1/5 x sample 
extraction+1/5 x instrumental 
analysis+3/5 x validation and 
data presentation) 
Wang and Liu (2017) 2.5 2.0 2.0 2.1 
Sun et al. (2017) 2.0 5.0 1.0 2.0 
Haitao et al. (2015) 1.0 3.0 2.0 2.0 
Liu et al. (2015) 2.0 4.0 1.0 1.8 
Chang et al. (2013) 3.0 4.0 1.0 2.0 
Beldi et al. (2012) 5.0 4.0 1.5 2.7 
Chen et al. (2012) 1.0 3.0 1.0 1.4 
Vaghela et al. (2011) 2.5 4.5 2.0 2.6 
Akkbik et al. (2011a) 3.0 4.0 1.0 2.0 
Darji et al. (2010) 3.0 3.5 1.0 1.9 
Soliman et al. (2007) 4.0 5.0 1.0 2.4 
Guan et al. (2006) 2.5 3.5 1.0 1.8 
Ding et al. (2006) 2.0 3.5 1.0 1.7 
Guan et al. (2005) 2.5 3.5 1.0 1.8 
Pinho et al. (2000) 3.0 3.5 1.0 1.9 
Riber et al. (2000) 2.0 4.0 1.0 1.8 
Sarbach et al. (1996) 3.5 4.0 1.0 2.1 
Ceballos and Fernandez (1995) 3.0 2.5 1.0 1.7 
Waseem and Kaw (1994) 1.0 3.0 2.0 2.0 
Marin and Shlyapnikov (1991) 2.0 2.0 1.0 1.4 
Llaurado (1985) 1.0 1.0 1.0 1.0 
Buttery and Stuckey (1961) 4.0 3.0 1.0 2.0 
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 Data extraction 
An overview of the included studies with data on BHT concentrations in foods, PCPs, air and 
dust is given in Table 11.2.3-1. Description of the studies follows after the table. 










Cacho et al. 
(2016) Spain Vegetable oils GC/MS 4.0 
Shasha et al. 
(2014) Zimbabwe 
Oils, butter, margarine and 
starch-based snacks HPLC-UV 3.7 
Lin et al. 
(2013) China Blend vegetable oil 
Voltametry, 
HPLC-DAD 3.5 
Edin et al. 
(2010) USA Chewing gum GC-MS SIM 3.5 
Lundebye et 
al. (2010) Norway Farmed fish HPLC-UV 4.5 
Medeiros et 
al. (2010) Brazil Mayonnaise 
HPLC-UV + 
Voltametry 3.6 
Yuan (2010) USA 
Crackers, coffee creamer, 
instant noodles, sausage 







Spain Chewing gum HPLC/DAD 3.5 
Pattono et al. 




Saad et al. 
(2007) Malaysia 
Cooking oil, margarine and 
butter, and cheese HPLC-UV 3.8 
Suh et al. 
(2005) Korea 
Chewing gum, breakfast 
cereal GC-FID 3.8 
Ishiwata et 
al. (2003) Japan 
Fats and oils, dried marine 
products, chewing gum, 
confectionary "kashi" 
HPLC 4 
Lin et al. 
(2003) Taiwan Chewing gum GC-FID 3.5 
Tombesi and 
Freije (2002) Argentina Drinking water GC-MS 3.5 
Yang et al. 
(2002) Taiwan 
Soybean oil, olive oil, 
vegetable oil, blended oil, 
sunflower oil, fish oil, peanut 
oil, butter, cheese, 












Maziero et al. 
(2001) Brazil 
Soybean oil, corn oil, 
hydrogenated vegetable fat, 
margarine, vegetable cream, 
halvarina 
HPLC-UV 4.3 
Ni et al. 
(2000) China 
Peanut oil, sesame oil, salad 
oil, cake, biscuit, milk candy Voltammetry 3.5 
Ruiz et al. 
(1999) Spain Chewing gum HPLC-ED 3.8 
DeWitt and 










Myers et al. 
(2015) USA 
Deodorant, foundation, 
toothpaste, hand sanitiser, 






Facial cleansing milk, eye 
make-up remover, 
deodorant, baby body milk, 
sunscreen, after shave, baby 
after sun, make-up, hair 
conditioner 
GC–MS/MS 4.4 
Celeiro 2014 Spain 
Shower gel, liquid soap, 
baby moisturising lotion, 
sunblock, lipstick, gloss, 
deodorant 
GC-MS SIM 
or GC-MS/MS 4.0 
Akkbik 2011 Malaysia Sunscreen cream, milk lotion, hair gel, hair oil HPLC-UV/Vis 4.4 
Sanchez-
Prado 2011 Spain 
Hand soaps, liquid soaps, 
shampoo GC-MS 4.4 
Sanchez-
Prado 2010 Spain 
Moisturising cream, 
moisturising lotion, 
antiwrinkle cream, hand 
cream, sunscreen cream, 
baby moisturising lotion, 





Spain Body oil HPLC/DAD 3.5 
Lee (2006) Taiwan Lanoline cream, skin milk, cream LC/MS 3.5 
Boussenadji 
(1993) France Skin care gel 
HPLC 
UV+ECD 3.6 
Liu et al. 
(2017) China 
Indoor dust (rural and 
urban) HPLC-MS/MS 4.5 
 
 




















Liu et al. (2017) collected 75 dust samples from urban and rural homes in Shandong 
Province of China. Seven synthetic phenolic antioxidants were detected in most of the 
samples by HPLC-MS/MS. BHT constituted 74% and 43% of the synthetic phenolic 
antioxidants found in urban indoor dust and in rural indoor dust, respectively. Three BHT 
transformation products, 2,6-di-tert-butyl-1,4-benzoquinone (BHT-Q), 2,6-di-tert-butyl-4-
hydroxy- 4-methyl-2,5-cyclo-hexadienone (BHT-quinol) and 3,5-di-tert-butyl-4-
hydroxybenzal-dehyde (BHT-CHO), were also detected in most of the urban and rural indoor 
dust samples (>97%).   
 
 
Cacho et al. (2016) determined BHT in several vegetable edible oil samples. The analyses 
were carried out by gas chromatography–mass spectrometry (GC–MS) using microvial insert 
large volume injection. The reported mean values, in ng/g, were 1.51 in corn oil, ranged 
from 0.64 to 5.00 in olive oil, 0.68 in peanut oil and 0.75 in sesame oil. In sunflower oil, BHT 
ranged from not detected to 12.7. The LOD was 0.04 ng/g, the LOQ was 0.10 ng/g. 
 
Study ID 
Reference: Liu et al. (2017) 
Year the study was conducted/published: - 
Source category: Indoor dust urban and indoor dust rural 
Funding 
Funding source: The National Natural Science Foundation (21622705, 21577151), 
the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant 
No. XDB14010400), and Youth Innovation Promotion Association CAS projects 
Public/private: Public 








Sample extraction: DCM/Hx 
Calibration: The linearity of the calibration curve (r2) was >0.99 
LOD: 10 µg/kg DW 
Recovery data: Average recovery was 89% 
Instrument/detector: HPLC-MS/MS 
Results 
Number of samples: 55 (urban) and 20 (rural) 
Concentration: In µg/kg dry weight 
Indoor dust urban:  median=1880; min=852; max=18400 
Indoor dust rural: median=998; min=163; max=2330  
Other 
comments   
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Wang et al. (2016a) determined the concentration of nine synthetic phenolic antioxidants, 
including BHT, and their metabolites/degradation products in 339 indoor dust samples from 
homes and microenvironments collected from 12 countries. BHT was analysed using GC/MS 
SIM. BHT was found in 99.5% of the samples at concentrations that ranged from <LOQ to 
118 μg/g in samples from homes and 0.10 to 3460 μg/g in samples from microenvironments. 
The major BHT derivatives found in dust samples were BHT−CHO, BHT−OH and BHT−Q. 
The LOD was not reported. The LOQs was 1.2 ng/g for BHT. 
 
Study ID 
Reference: Cacho et al. (2016) 
Year the study was conducted/published: not specified 
Source category: Food 
Funding 
Funding source: Financial support of the Comunidad Autónoma de la Región de 
Murcia (Fundación Séneca 19888/GERM/15 and Project 19462/PI/14). J.I. Cacho also 
acknowledges a fellowship from the University of Murcia. 
Public/private: Public 








Sample extraction: Hx:ACN 
Calibration: 
LOD: 0.04 ng/g 
LOQ: 0.10 ng/g 
Recovery data: 
Instrument/detector:  GC/MS 
Results 
Number of samples: 12 
Concentration: Olive oil – mean=2.68 µg/kg; min=0.64 µg/kg; max=5.00 µg/kg.  




Potential loss of BHT through 2-phase Hx:ACN extraction 
Study ID 
Reference: Wang et al. (2016a) 
Year the study was conducted/published: - 
Source category:  Indoor dust 
Funding 
Funding source: Grant (1U38EH000464-01) from the Centers for Disease Control and 
Prevention (CDC, Atlanta, GA) to Wadsworth Center, New York State Department of 
Health 
Public/private: Public 








Sample extraction: DCM:Hx 
Calibration: 
LOD: - 
LOQ: 1.2 µg/kg 
Recovery data: Recovery from spiked dust was 106±12% 
Instrument/detector:  GC/MS SIM 
Results Number of samples: 339 samples from 12 countries 
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To determine preservatives, including BHT, in cosmetics and personal care products, an LC-
MS/MS method was developed (Myers et al., 2015). Cosmetic and personal care samples 
were purchased from local stores. The reported BHT concentrations, in %[w/w], was 0.07 in 
deodorant, 0.00 and 0.01 in foundation, 0.02 in toothpaste, 0.02 in hand sanitiser, 0.06 in 
lipstick and 0.02 in hand lotion. The LOD was 4.02 µg/mL and the LOQ was 13.4 µg/mL. 
 
 
BHT in cosmetic products was analysed using a methodology based on solid-phase 
microextraction followed by GC–MS/MS (Alvarez-Rivera et al., 2014b). The reported 
concentrations of BHT, in µg per 100g, was 85.2 in facial cleansing milk, 43.9 in eye make-
up remover, 53.6 in deodorant, 1830 in baby body milk, 14.1 in sunscreen, 30.6 in after 
shave, 1990 in baby after sun, 34.5 in make-up and 71.1 in hair conditioner (rinse of 
product). LOD was 0.04 µg/g, LOQ was 0.13 µg/g. 
 
Concentration: BHT ranged from 0.01 to 35.1 µg/g. The median ranged from 0.17 to 
13.7 
Other 
comments  MeOH too polar for suitable extraction 
Study ID 
Reference: Myers et al. (2015) 
Year the study was conducted/published: - 
Source category:  Cosmetics and health care 
Funding 
Funding source: The Forensic Science Program in the Chemical and Physical Sciences 
Department of Cedar Crest College and the 2014 Carol DeForest Research Grant, 
Northeastern Association of Forensic Scientists 
Public/private: 








Sample extraction: MeOH:ACN 
Calibration: R2=0.9943 
LOD: 4.02 µg/mL 
LOQ: 13.4 µg/mL 
Recovery data: - 
Instrument/detector:  LC-MS/MS 
Results 
Number of samples: 
Concentration: The reported BHT concentrations, in %[w/w], was 0.07 in deodorant, 
0.00 and 0.01 in foundation, 0.02 in toothpaste, 0.02 in hand sanitiser, 0.06 in 
lipstick and 0.02 in hand lotion 
Other 
comments   
Study ID 
Reference: Alvarez-Rivera et al. (2014b) 
Year the study was conducted/published: - 
Source category:  Cosmetics 
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BHT in cosmetics was determined using GC-MS SIM or GC-MS/MS (Celeiro et al., 2014). The 
reported concentrations of BHT, in µm/g, was 0.160 in shower gel, 0.130 in liquid soap, 
1057 in baby moisturising lotion, 14.5 in sunblock, 2996 in lipstick, 9.63 in gloss lipstick, 




Reversed phase HPLC-UV quantification was used to determine BHT in food items sold in 
supermarkets in Zimbabwe (manufacturing countries were Zimbabwe and South Africa) 







Sample extraction: SPME/HSSPME 
Calibration: R2=0.9999 
LOD: 0.04 µg/g 
LOQ: 0.13 µg/g 
Recovery data: 
Instrument/detector:  GC–MS/MS 
Results 
Number of samples: 19 
Concentration:  BHT concentration in µg/g. BHT in facial cleansing milk 85.2; 43.9 in 
eye make-up remover; 53.6 in deodorant; 1830 in baby body milk; 14.1 in sun 
screen; 30.6 in after shave;  1990 in baby after sun; 34.5 in make-up; 71.1 in hair 
conditioner (rinse of product). In the rest of the samples BHT was below LOQ 
Other 
comments   
Study ID 
Reference: Celeiro et al. (2014) 
Year the study was conducted/published: - 
Source category:  Cosmetics 
Funding 
Funding source: FEDER funds and projectsCTQ2010-19831 (Ministerio de Ciencia e 
Innovacion, Spain) andCN 2012/299 (Research group’s consolidation program, Xunta 
deGalicia, Spain) 
Public/private: Public 








Sample extraction: EtAc or Hx:Acetone 
Calibration: The correlation coefficient was 0.9990 
LOD: 0.006 µg/g 
LOQ: 0.31 µg/g 
Recovery data: 
Instrument/detector:  GC-MS SIM or GC-MS/MS 
Results 
Number of samples: 17 
Concentration: BHT in µm/g. Concentration in shower gel was 0.160; 0.130 in liquid 
soap; 1057 in baby moisturising lotion; 14.5 in sunblock; 2996 in lipstick; 9.63 in 
gloss lipstick; 6.23, 174, 13.4 and 29.4 in deodorant. In the rest of the samples BHT 
was not detected 
Other 
comments   
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(Shasha et al., 2014). The level of BHT in vegetable oils, in mg/kg, ranged from not detected 
to 67.3. The level of BHT in butter and margarine, in mg/kg, ranged from 7.8 to 158.6. In 
starch-based snacks the level of BHT, in mg/kg, ranged from 1.8 to 151.3. The LOD was 
0.132 mg/kg. The LOQ was not reported. 
 
 
Lin et al. (2013) developed a quantitative electroanalytical method for simultaneous 
determination of the antioxidants BHA, BHT and TBHQ. Using this method, BHT in corn oil, 
camellia oil, sesame oil, rapeseed oil and blend oil were analysed. BHT concentrations (in 
µg/g) was 29.1 in corn oil, 28.5 in camellia oil, 27.8 in sesame oil, 27.7 in rapeseed oil and 
49.6 in blend oil. The LOD was 0.08 mg/L. The LOQ was not reported. 
Study ID 
Reference: Shasha et al. (2014) 
Year the study was conducted/published: November 2013 to March 2014 
Source category:  Food 
Funding Funding source: Not given Public/private: - 








Sample extraction: MeOH:ACN 
 
Calibration: Calibration curves R2 were above 0.996 for all standards. Regression 
equations were y=13245x + 2657 for BHT 
LOD: 0.132 mg/kg 
Recovery data:  Percentage recovery ranged from 74.5-89.9%.  
Instrument/detector:  
Results 
Number of samples: 23 
Concentration:  Six cooking oil samples - BHT ranged from 9.8 to 67.3 mg/kg.  Seven 
margarine types - BHT ranged from 10.4 to 158.6 mg/kg. Seven starch based-snacks 
samples – BHT ranged from 1.8 to 151.3 mg/kg. 
Other 
comments   
Study ID 
Reference: Lin et al. (2013) 
Year the study was conducted/published: - 
Source category:  Food 
Funding 
Funding source:  The National Natural Science Foundation of China (NSFC-
21065007), the State Key Laboratory of Food Science and Technology of Nanchang 
University (SKLF-MB-201002 and SKLFTS-200919). 
Public/private: - 








Sample extraction: MeOH 
Calibration:  Calibrations was linear in the concentration range 0.20–2.20 µg/mL 
LOD: 0.08 µg/mL 
Recovery data:  Recovery ranged from 96.3 to 102.6% 
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Akkbik et al. (2011a) developed an analytical method for evaluation and quality control of 
BHT by HPLC-UV/Vis in personal care products. Four types of personal care products, sun 
cream, milk lotion, hair gel and hair oil were purchased from several local supermarkets in 
Malaysia. For each type of personal care product, three commercial brands were collected. 
The concentration of BHT in 12 commercial personal care samples ranged from 0.16 to 2.30 
mg/g. The LOD was 0.170 mg/L and the LOQ was 0.515 mg/L. 
 
 
BHT in cosmetics from national and international brands, purchased from local sources, was 
analysed by GC-MS (Sanchez-Prado et al., 2011).  The BHT concentrations, given in % w/w, 
were 0.00933 and 0.000061 in hand soaps, and 0.000022 and 0.0010 in liquid soaps. The 
BHT concentration was below LOD in one sample of hand soap, in one sample of shampoo 
and one sample of liquid soap. The LOD was 0.3 µg/g and the LOQ was 0.99 µg/g. 
 
Instrument/detector: HPLC-DAD 
Results Number of samples: 5 
Concentration:  Five edible oil samples – BHT ranged from 28.1 to 50.2 µg/g 
Other 
comments   
Study ID 
Reference: Akkbik et al. (2011a) 
Year the study was conducted/published: - 
Source category:  Cosmetics 
Funding Funding source: Syrian Ministry of Higher Education (a scholarship) Public/private: Public 








Sample extraction: Hx:ACN 
Calibration: Standards solution of BHT with concentrations of 1, 10, 25, 50, 75, 100, 
125 and 250 mg/L were prepared. The calibration curves were obtained by plotting 
the peak area of chromatograms for BHT against the concentration in four replicates. 
Correlation coefficients (R2) were 0.999 
LOD: 0.170 mg/L  
LOQ: 0.515 mg/L 
Recovery data: The recovery for BHT ranged from 83.2-108.9% 
Instrument/detector: HPLC UV/VIS 
Results Number of samples: 12 
Concentration: The concentration ranged from 0.16 to 2.30 mg/g 
Other 
comments  Potential loss of BHT through 2-phase Hx:ACN extraction 
Study ID 
Reference: Sanchez-Prado et al. (2011) 
Year the study was conducted/published: - 
Source category:  Cosmetics 
Funding Funding source: FEDER funds and project CTQ2010-19831 (Ministerio de Ciencia e Innovacion, Spain). Xunta de Galicia (postdoctoral contracts), Ministerio de Ciencia e 
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BHT in chewing gum was determined using GC-MS SIM (Edin et al., 2010). The reported 
concentrations of BHT, in µg/g, was 92.3008, 128.4153, 150.2563, 136.0807, 131.8883 and 
174.3833. The LOD and the LOQ was not reported. 
 
Innovación (FPI grant) 
Public/private: - 








Sample extraction: Hx:Acetone 
Calibration: Calibration standards were prepared covering a concentration range from 
0.02 to 10 μg/mL. The correlation coefficient (R) was 0.9987 
LOD: 0.3 µg/g  
LOQ: 0.99 µg/g 
Recovery data: The recovery studies on leave-on and rinse-off cosmetics gave 
satisfactory values 
Instrument/detector:  GC-MS 
Results 
Number of samples: 
Concentration: BHT concentrationsare given in %, w/w. Hand soaps: 0.00933 and 
0.000061; liquid soaps: 0.000022 and 0.0010 in liquid soaps. The BHT concentration 
was below LOD in one sample of hand soap, in one sample of shampoo and one 
sample of liquid soap. 
Other 
comments   
Study ID 
Reference: Edin et al. (2010) 
Year the study was conducted/published: - 
Source category: Food 
Funding Funding source: - Public/private: - 


















Recovery data: Recovery ranged from 6.2738 to 57.1267 
Instrument/detector:  GC-MS SIM 
Results 
Number of samples: 6 
Concentration: BHT ranged from 92.3008 to  174.3833 µg/g 
Other 
comments   
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Lundebye et al. (2010) examined levels of BHT in farmed Atlantic salmon, farmed Atlantic 
halibut, farmed cod and farmed rainbow trout. The highest BHT level, 7.6 mg/kg, was found 
in farmed Atlantic salmon fillets. The lowest BHT level, <40 µg/kg, was found in cod fillets. 
In salmon fillets, the mean BHT concentration was 3.9 mg/kg (n=24). In trout fillets, the 
mean BHT concentration was 2.6 mg/kg (n=16). In halibut fillets, the mean BHT 
concentration was 1.7 mg/kg. The LOD was 0.04 mg/kg. The LOQ was not reported. 
 
 
Medeiros 2010 used HPLC-UV + voltammetry to determinate BHT in mayonnaise. Three 
measurements of four samples were performed, and the BHT concentrations in mayonnaise, 
in mg/100g, ranged from 1.1 to 1.8. The LOD was 0.4 µmol/L. The LOQ was not reported. 
Study ID 
Reference: Lundebye et al. (2010) 
Year the study was conducted/published: 
Source category: Food 
Funding 
Funding source: Research Council of Norway (Project Numbers 143314/130 and 
173287 
Public/private: Public 








Sample extraction: ACN 
Calibration: 
LOD: 0.04 mg/kg 
Recovery data: 
Instrument/detector:  HPLC-UV 
Results 
Number of samples: Farmed salmon – n=24; farmed trout – n=16; halibout – n=15; 
cod – n=4 
Concentration: Concentration in wet weight in fillets. Salmon - mean BHT 
concentration was 3.9 mg/kg (n=24); trout - mean BHT concentration was 2.5 
mg/kg (n=16); halibut - mean BHT concentration was 1.7 mg/kg; cod – mean 
BHT<40 
Other 
comments   
Study ID 
Reference: Medeiros et al. (2010) 
Year the study was conducted/published: - 
Source category: Food 
Funding Funding source: The Brazilian funding agencies FAPESP, CNPq and CAPES Public/private: - 








Sample extraction: EtOH 
Calibration: 
LOD: 0.4 µmol/L 
Recovery data: 
Instrument/detector:  HPLC-UV + voltametry 
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BHT in cosmetics was analysed using GC-MS (Sanchez-Prado et al., 2010). Different 
cosmetics from national and global companies were purchased from local stores. They 
included moisturising and antiwrinkle creams and lotions, hand creams, sunscreen and after-
sun creams, and baby lotions. BHT concentrations given in %, w/w, were ranged from below 
LOD to 0.000027 in moisturising cream, was below LOD and 0.000010 in moisturising lotion, 
below LOD and 0.002681 in antiwrinkle cream, 0.035424 and 0.000905 in hand cream, 
0.000109 in sunscreen cream, 0.034710 and 0.000070 in baby moisturising lotion, 0.000316 
in hair conditioning lotion, and below LOD in shampoo and after-sun cream. The LOD was 
0.0000041 (%, w/w) and the LOQ was 0.000013 (%, w/w). 
 
 
BHT in food was determined using HS-GC/MS (Yuan, 2010). The BHT concentration was 
given as mean value (n=3) in ng/g, and were 0.58 in crackers, 0.69 in coffee creamer, 0.68 
in instant noodles, 0.59 in sausage and 0.56 in tea leaves. The LOD was not reported. The 
LOQ was 1 ng/g. 
 
Results Number of samples: 4 
Concentration: BHT concentration,in mg/100g, ranged from 1.1 to 1.8 
Other 
comments  EtOH too polar for suitable extraction 
Study ID 
Reference: Sanchez-Prado et al. (2010) 
Year the study was conducted/published: 
Source category:  Cosmetics 
Funding Funding source: Public/private: 








Sample extraction: Hx:Acetone 
Calibration: 
LOD: 0.0000041 (%, w/w) 
LOQ: 0.000013 (%, w/w) 
Recovery data: 
Instrument/detector:  GC-MS 
Results 
Number of samples: 
Concentration: In %, w/w. In moisturising cream 0.000027, 0.000012 and 0.000015; 
0.000010 in moisturising lotion; 0.002681 in antiwrinkle cream; 0.035424 and 
0.000905 in hand cream; 0.000109 in sunscreen cream; 0.034710 and 0.000070 in 
baby moisturising lotion; and 0.000316 in hair conditioning lotion. The BHT 
concentration was below LOD in two samples of moisturizing cream, one sample of 
moisturising lotion, one sample of antiwrinkle cream, one sample of after-sun cream 
and one sample of shampoo 
Other 
comments   
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Garcia-Jimenez et al. (2009) used an ultra-short C18 monolithic column combined with flow 
injection analysis for the determination of BHT inn food and cosmetic samples. BHT values, 
the mean from three determinations in mg/kg, was 505.0 in body oil, 139.0 in chewing gum 
and 194.1 in bouillon cube spiked with BT (spiked with 200 mg/kg). The LOD was 0.55 
µg/mL and the LOQ was 1.83 µg/mL. 
 
Study ID 
Reference: Yuan (2010) 
Year the study was conducted/published: 
Source category: Food 
Funding Funding source: Perkin Elmer Public/private: 








Sample extraction: HS on-site 
Calibration: The instrument calibration included seven calibration levels in the 
working curve; the response of this calibration curve was linear (Table 2). 
Additionally, the method is precise throughout the calibration range, as demonstrated 
by the relative standard deviation of 3.2% at the calibration limit (1 ng, n=5) and 
1.9% at 10 ng (n=5) 
LOD: - 
LOQ: 1 ng/g 
Recovery data: 
Instrument/detector:  HS-GC/MS 
Results 
Number of samples: 5 
Concentration: BHT mean concentration (n=3) in ng/g, were 0.58 in crackers, 0.69 in 
coffee creamer, 0.68 in instant noodles, 0.59 in sausage and 0.56 in tea leaves 
Other 
comments   
Study ID 
Reference: Garcia-Jimenez et al. (2009) 
Year the study was conducted/published: 
Source category:  Food 
Funding 
Funding source: The Ministerio de Educación y Cultura, Dirección General de 
Enseñanza Superior (Spain) (Projects CTQ2005-09060-CO2-01 and CTQ2005-09060-
CO2-02) 
Public/private: 








Sample extraction: Hx+MeOH 
Calibration: To obtain the calibration functions, five different concentration levels and 
three replicates of each one of the standards were analysed using the peak area as 
the analytical parameter. 
LOD: 0.55 µg/mL 
LOQ= 1.83 µg/mL 
Recovery data: 
Instrument/detector:  HPLC/DAD 
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BHT in organic and conventional milk was determined using HPLC (Pattono et al., 2009). 
Samples of conventional milk (n=11) and samples of organic milk (n=81) were analysed. 
The BHT concentrations in conventional milk, in µg/100 mL milk, ranged from not detected 
to 130.4. BHT-CHO was analysed in the same samples, and the concentrations ranged from 
not detected to 30.4 µg/100 mL. Organic bovine milk, organic goat milk and organic sheep 
milk were analysed for BHT and BHT-CHO. In bovine milk, the BHT concentrations in µg/100 
mL milk, ranged from not detected to 23.0. BHT-CHO was determined in the same samples, 
and the concentrations, in µg/100 mL milk, ranged from not detected to 24.0. In sheep milk, 
the BHT concentrations in µg/100 mL milk were 21.9 and 0.9, and in the same samples, the 
BHT-CHO concentrations were 2.1 and not detected. In goat milk, the BHT concentrations in 
µg/100 mL milk ranged from 0.5 to 29.0. In the same samples, the BHT-CHO concentrations 
ranged from not detected to 4.5. BHT and BHT-CHO in organic milk from retail trade was 
also analysed. The BHT concentrations, in µg/100 mL milk, ranged from not detected to 
141.2. The BHT-CHO concentrations ranged from not detected to 11.8. The LOD was 1 
µg/kg. The LOQ was not reported. 
 
 
BHT in Malaysian food items were analysed using HPLC-UV (Saad et al., 2007). BHT 
concentrations, in mg/kg, ranged from not detected to 88.9 in refined palm olein, from 14.4 
Results 
Number of samples: six 
Concentration: BHT mean in chewing gum = 139; in bouillon cube spiked with BT 
(spiked with 200 mg/kg) = 194.1. BHT was not detected in the rest of the samples 
Other 
comments   
Study ID 
Reference: Pattono et al. (2009) 
Year the study was conducted/published: 
Source category: Food 
Funding Funding source: A grant from the Italian Health Ministry. Public/private: Public 








Sample extraction: MeOH:Hx 
Calibration: All standard curves showed good linearity (R2 > 0.99) 
LOD: 1 ppb 
LOQ: - 
Recovery data: The recoveries at a concentration of 0.25 ppm was 61.5 ± 1.2%, at a 
concentration of 5 ppm the recoveries was 84.3 ± 7.5% 
Instrument/detector:  GC/MS 
Results 
Number of samples: 11 samples of conventional milk, 81 samples of organic milk 
Concentration: BHT concentrations are given in µg/100 mL milk. BHT in conventional 
milk ranged from not detected to 130.4. The BHT in organic bovine milk ranged from 
not detected to 23.0; in organic sheep milk BHT ranged from 0.9 to 21.9; in organic 
goat milk BHT ranged from 0.5 to 28.4; BHT in organic milk from retail trade ranged 
from not detected to 141.2. 
Other 
comments   
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to 38.6 in butter, and from 53.5 to 154.2 in margarine. The LOD was 0.5 mg/L. The LOQ 
was not reported.  
 
 
BHT in cosmetic products was determined using LC–MS (Lee et al., 2006). The reported 
concentrations of BHT, in mg/kg, was 49 in lanoline cream, 86 in skin milk and 56 in cream. 
The LOD was 87 ng/g. The LOQ was not reported. 
Study ID 
Reference: Saad et al. (2007) 
Year the study was conducted/published: - 
Source category: Food 
Funding 
Funding source: National Science Foundation, Malaysia (a scholarship for one of the 
participants) 
Public/private: 








Sample extraction: MeOH:ACN 
Calibration: 
LOD: 0.5 mg/L 
LOQ: 
Recovery data: Recoveries of the synthetic phenolic antioxidants when spiked to 
cooking oil, margarine, butter and cheese at 50 and 200 mg/L ranged from 73.9–
94.6% for BHT 
Instrument/detector:  HPLC-UV 
Results 
Number of samples: 16 cooking oils, ten margarine, six butter and six cheese 
samples 
Concentration: BHT concentrations, in mg/kg, ranged from not detected to 88.9 in 
refined palm olein; ranged from 14.4 to 42 in butter; ranged from 53.3 to 154.2 in 
margarine  
Other 
comments   
Study ID 
Reference: Lee et al. (2006) 
Year the study was conducted/published: - 
Source category:  Cosmetics 
Funding 
Funding source: The National Science Council of the Republic of China (under 
contract no. NSC 90-2113-M-005-029) 
Public/private: Public 








Sample extraction: MeOH + SFE 
Calibration: The correlation coefficient (R2) was 0.9989 
LOD: 87 ng/g 
LOQ: - 
Recovery data: - 
Instrument/detector:  LC/MS 
Results Number of samples: 3 
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BHT in foods was determined by GC-FID (Suh et al., 2005). In total, 133 food samples from 
twelve food categories were analysed for BHT. The samples included soybean oil, corn oil, 
other vegetable oil, shortening, margarine, seasoned dried fish, dried fish, salted fishery 
product, frozen fishery product, chewing gum, mayonnaise and breakfast cereal. BHT was 
detected in margarine and chewing gum. In margarine, BHT was detected in one of seven 
samples and in chewing gum BHT was detected in three of seven samples. The mean 
concentration of BHT in margarine and chewing gum were 1.29 and 25.95mg/kg, 
respectively. The LOD was 3 mg/kg. The LOQ was not reported. 
 
 
Ishiwata et al. (2003) determined the mean concentration of BHT in foods using HPLC. BHT 
was not detected in frozen marine products (n=10), salted marine products (n=20) or in 
butter (n=20). In fats and oils, the mean concentration was 0.002 g/kg. In dried marine 
products, the mean concentration was 0.0006 g/kg (n=872). In chewing gum, the mean 
concentration was 0.0525 (n=13). BHT analysis details were not reported. 
 
Concentration: BHT, in mg/kg, was 49 in lanoline cream, 86 in skin milk and 56 in 
skin? cream 
Other 
comments   
Study ID 
Reference: Suh et al. (2005) 
Year the study was conducted/published: - 
Source category: Food 
Funding 
Funding source: The article was the part of the project Daily Intake Estimate for 
Food Additives in Korea, which was supported by the Health Technology Planning 
and Evaluation Board, Ministry of Health and Welfare in Korea. 
Public/private: - 








Sample extraction: ACN:Pen 
Calibration: 
LOD: 3 mg/kg 
Recovery data:  Oil and butter recovery and CV% for BHT were 94.5% and 3.5, 
respectively. Solid food recovery and CV% for BHT were 92.6% and 5.8, respectively 
Instrument/detector:  GC-FID 
Results 
Number of samples: 133 food samples among 12 food categories 
Concentration: BHT was detected i two of the twelve food categories. In margarine, 
BHT ranged from not detected to 9.05 mg/kg; in chewing gum BHT ranged from not 
detected to 150.88mg/kg 
Other 
comments   
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BHT in chewing gum was determined using GC-FID (Lin et al., 2003). The reported BHT 




BHT in drinking water in Argentina was analysed using GC-MS (Tombesi and Freije, 2002). 
Concentrations of BHT were determined in 15 samples of commercial mineral and 
Study ID 
Reference: Ishiwata et al. (2003) 
Year the study was conducted/published: 1998 
Source category: Food 
Funding 
Funding source: Partly supported by the «Health Science Research Grants, 2000 and 
2001, from the Ministry of Health, Labour and Welfare». 
Public/private: - 












Instrument/detector:  HPLC 
Results 
Number of samples: Frozen marine products (n=10), salted marine products (n=20), 
butter (n=20), dried marine products (n=872), chewing gum (n=13) 
Concentration: BHT was not detected in frozen marine products, salted marine 
products or in butter. In fats and oils, the mean concentration was 0.002 g/kg. In 
dried marine products, the mean concentration was 0.0006 g/kg. In chewing gum, 
the mean concentration was 0.0525 
Other 
comments  Intake from other studies also presented 
Study ID 
Reference: Lin et al. (2003) 
Year the study was conducted/published: 
Source category: Food 
Funding Funding source: TaJen Institute of Technology (No 88012) Public/private: - 












Recovery data: The recovery of BHT was 99 to 101% (CV: 1.5 to 3.2%) 
Instrument/detector:  GC-FID 
Results Number of samples: 15 
Concentration: BHT ranged from 0 to 296 µg/g 
Other 
comments  After chewing for 15 min, 50% BHT was released from the chewing gum 
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mineralszed drinking water. In eight samples, no BHT signal was detected. In one sample, 
the signal was below the LOD and in another sample, the signal was below the LOQ. In the 
rest of the samples, the BHT concentrations in µg/L ranged from 21.5 to were 38.0. The LOD 




BHT in lipid containing food was determined using GC-FID (Yang et al., 2002). The BHT 
concentrations, given as mean (n=2) in µg/g, was 120.3 and 136.4 in soybean oil, 172.0 in 
one sample of olive oil, whereas it was not detectable in another sample, 43.5 and 146.4 in 
vegetable oil, 272 and 135.2 in blended oil, 277.4 and 168.5 in sunflower oil, ranged from 
51.9 to 304.4 in fish oil, not detectable in  the two peanut oil samples, 319.0 and 251.4 in 
butter, 56.7 and 87.1 in cheese, 164.2 and 251.6 in margarine, 108.0 and 124.7 in 




Reference: Tombesi and Freije (2002) 
Year the study was conducted/published: - 
Source category: Drinking water 
Funding Funding source: - Public/private: - 








Sample extraction: HS-SPME 
Calibration: The calibration curve was drawn using five points at a concentration 
range 12.8–64.0 mg/L 
LOD: 4.2 µg/L 
LOQ: 13.9 µg/L 
Recovery data: Recoveries of BHT from spiked mineral drinking water samples added 
25.5, 38.3 and 51.1 µg/L ranged from 84 to 119% 
Instrument/detector:  GC-MS 
Results 
Number of samples: 15 
Concentration: In eight samples, no BHT signal was detected. In the rest of the 
samples, BHT ranged from below LOD to 38.0 µg/L 
Other 
comments   
Study ID 
Reference: Yang et al. (2002) 
Year the study was conducted/published: - 
Source category: Food 
Funding Funding source: Supported by Project 88016 from Ta-Jen Institute of Technology Public/private: - 





Sample extraction: EtAc 
Calibration: Standard solutions of seven concentrations were prepared and analyzed 
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Maziero et al. (2001) determined the level of BHT in selected food categories in Brazil. The 
concentrations, in mg/kg, were 81.8 in soybean oil, 18.9 in corn oil, 63.7 in hydrogenated 
vegetable fat, 33.5 in margarine, 45.5 in vegetable cream and 151.7 in halvarina. The LOD 
was 2.7 mg/kg. The LOQ was not reported. 
 
 
Ni et al. (2000) determinated antioxidants, including BHT, in food samples using a 
chemometric approach. The concentrations of BHT, in mg/g, were 0.009 in peanut oil and 
0.057 in sesame oil. BHT was not detected in one sample of peanut oil, two samples of 
sesame oil, and one sample of cake, biscuit and milk candy. The LOD was 0.15 mg/L. The 





LOD: 0.1 mg/mL 
Recovery data: The recovery of BHT was 101–104 
Instrument/detector:  GC-FID 
Results 
Number of samples: 27  
Concentration: BHT concentration in µg/g. BHT in soybean oil was 120.3 and 136.4; 
in olive oil 172.0 and not detected; in vegetable oil 43.5 and 146.4; in blended oil 
135.4 and 38.8; in sunflower oil 277.4 and 168.5; in butter 319.9 and 251.4; in 
cheese 56.7 and 87.1; in margarine 164.2 and 251.6; in mayonnaise 108.0 and 
124.7; in salad dressing 17.0 and 31.5. BHT was not detected in peanut oil. BHT in 
fish oil ranged from 51.9 to 304.4 
Other 
comments   
Study ID 
Reference: Maziero et al. (2001) 
Year the study was conducted/published: - 
Source category: Food 
Funding Funding source: Financial support from FAPESP (Oric. 1998/13818-0) Public/private: 








Sample extraction: ACN 
Calibration: 
LOD: 2.7 mg/kg 
Recovery data: Mean recovery of BHT in vegetable fat, margarine, vegetable cream 
and halvarina ranged from 78±4 to 98±2 
Instrument/detector:  HPLC-UV 
Results 
Number of samples: 54 
Concentration: In mg/kg, BHT in soybean oil ranged from 14.1 to 143; in corn oil 
from not detected to 62; inn hydrogenated vegetable fat from not detected to 125; 
in margarine from not detected to 69.4; in vegetable cream from from not detected 
to 109; in halvarina from 71 to 197 
Other 
comments   
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BHT in chewing gum samples was analysed by HPLC with amperometric detection (Ruiz et 
al., 1999). The concentration of BHT was 51 µg/g. The LOD was 30 ng (for a 50 µl volume 




Reference: Ni et al. (2000) 
Year the study was conducted/published: - 
Source category: Food 
Funding 
Funding source: the National Science Foundation of China (NSFC, No. 29765001) and 
the Natural Science Foundation of Jiangxi Province (NSFJX) 
Public/private: Public 








Sample extraction: MeOH 
Calibration:  Linear calibration graphs were also obtained in the concentration range 
of 0.5–8.0 
LOD: 0.15 mg/L 
Recovery data: The recovery values were in the range of 80–120% 
Instrument/detector:  Voltammetry 
Results 
Number of samples: 8 
Concentration: Concentrations given in mg/g. BHT in peanut oil were 0.009; in 
sesame oil 0.057. BHT was not detected in one sample of peanut oil, two samples of 
sesame oil, and one sample of cake, biscuit and milk candy. 
Other 
comments  MeOH too polar for suitable extraction 
Study ID 
Reference: Ruiz et al. (1999) 
Year the study was conducted/published: 
Source category: Food 
Funding 
Funding source: Fundación Universitaria San Pablo C.E.U. (project 12=97) and 
Subdirección General de formación y promoción del conocimiento (project PB96-
0640) 
Public/private: - 








Sample extraction: EtAc 
Calibration: BHT was linear in the range 2.0 to 10.0 µg/mL 
LOD: 30 ng 
Recovery data: 
Instrument/detector:  HPLC-ED 
Results Number of samples: 1 Concentration: 51±3 µg/g 
Other 
comments   
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A GC method to determine BHT in products containing capsaicinoids was developed by 
DeWitt and Finne (1996). BHT in pepperoni pizza toppings (14 samples) ranged from <1 to 
36.1. The LOD was 1000 µg/kg FW. The LOQ was not reported. 
  
 
Boussenadji et al. (1993) used microbore LC columns coupled to electrochemical detection to 
analyse BHT in bactericidal cream (1 sample) and chewing gum (2 samples). The reported 




Reference: DeWitt and Finne (1996) 
Year the study was conducted/published: - 
Source category: Food 
Funding Funding source: - Public/private: - 








Sample extraction: ACN:Hx 
Calibration: Standard curves were linear in the range 0.02 to 0.20 mg/mL  
LOD: 1000 µg/kg FW 
LOQ: - 
Recovery data: Average recovery was 104.3±4.8% 
Instrument/detector:  HPLC + GC/FID 
Results Number of samples: 14 
Concentration: BHT concentrations in ppm ranged from <1 to 36.1 
Other 
comments   
Study ID 
Reference: Boussenadji et al. (1993) 
Year the study was conducted/published: - 
Source category:  Food 
Funding Funding source: - Public/private: - 








Sample extraction: MeOH 
Calibration: 
LOD: - 
LOQ: -  
Recovery data: 
Instrument/detector:  HPLC UV+ECD 
Results Number of samples: 3 
Concentration: Ranged from 121 to 184 mg/kg for the chewing gums 
Other 
comments  MeOH too polar for suitable extraction 
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 BHT in foods 
This appendix provides a comprehensive description of all BHT concentration data available 
in food and beverages. Data are described for «realistic» and «high» datasets making use of 
KBS food categories. Table 11.3-1 is identical with Table 4.2.1-1. 
Table 11.3-1 BHT content in different foods and food groups, µg/kg wet weight (identical with table 
4.2.1-1). 
Food group n Lower bound Middle bound Upper bound 
Cereals, bread and cakes1 11 2.1 15.8 29.4 
Bread and cereals2 4 2.6a 
Cakes, biscuits2 5 2.6 2.9 3.2 
Instant noodles1,2 1 0.7 a 
Potatoes1,2 4 0.5 0.6 0.8 
Vegetables1,2 5 0.1 0.3 0.5 
Fruit1,2 4 1.5 1.5 1.6 
Meat, meat products1,2 6 0.1 0.3 0.5 
Pepperoni1,2 14 23586 a 
Fish and seafood, wild1 76 1.5 1.6 1.6 
Fish, wild2 15 1.6 1.6 1.7 
Fish, freshwater2 24 0.9 0.9 0.9 
Shrimp and mussles2 19 0.5 0.5 0.6 
Fish liver2 18 3.4 3.5 3.5 
Fish, farmed1,2 60 2644 2645 2646 
Egg1,2 4 0.3 0.5 0.6 
Dairy1,2 26 249 a 
Milk, goat1,2 8 147 a 
Coffee creamer1,2 1 0.7 a 
Vegetable cream1 9 45500 a 
Cheese1 2 71900 a 
Margarine and butter1 49 92039 a 
Various oils1 53 43138 43153 43168 
Various oils2 14 6.2 6.2 6.2 
Mayonnaise1 6 48117 a 
Fish oil1 5 144140 a 
Sweets, chocolate1,2 4 3.9 a 
Chewing gum1 35 218232 a 
Chewing gum2 10 135132 a 
Starchy snacks1 7 46200 a 
1 Used in «high» exposure scenario: all concentration data that fulfilled the quality criteria, regardless 
of country of origin. 
2 Used in realistic exposure scenario: concentration data from Europe/USA that fulfilled the quality 
criteria. 
a All analysed values were above LOQ. 
* The number is equal as the middle bound since all analysed values were above LOQ.  
 
 
VKM Report 2019:14  120 
Data from all countries were included in the «high» exposure dataset, and the overall 
number of samples was 359. For the realistic dataset, with samples from Europe and USA, 
the overall number of samples was 240.  
 
Cereals, bread and cake 
Concentration data for «cereals, bread and cake» were available from Livsmedelsverket et al. 
(2014), Ni et al. (2000) and Yuan et al. (2010), with a total of 11 samples in the «high» 
exposure scenario. Seven of the samples were of cake and biscuits, and four were of bread 
and cereals. 
The BHT concentrations ranged from non-detected with less than 150 µg/kg (Ni et al. 2000 
with a LOD of 150 µg/kg) to 6.75 µg/kg (Livsmedelsverket et al. 2014). When all 
concentrations were pooled together, the mean concentration (MB) was 15.8 µg/kg. 
 
Two samples (Ni et al. 2000, with a LOD of 150 µg/kg) from China were excluded from the 
realistic dataset, resulting in nine samples in the realistic dataset. 
 
To be more specific in the coding prosess, cereals and bread were given the pooled 
concentrations of four samples 2.6 µg/kg (MB), and cakes and biscuits were given the 
pooled concentration of five samples, 2.9 µg/kg (MB).  
 
Instant noodles 
One sample of instant noodles was aviable from Yuan et al. (2010) with a concentration of 
0.7 µg/kg.  
 
This concentration from North America was used for instant noodles in both the «realistic» 
and «high» scenario. 
 
Potatoes 
Concentration data for «potatoes» were available from Livsmedelsverket et al. (2014), with a 
total of four samples. The BHT concentrations ranged from less than 0.5 µg/kg to 1.12 
µg/kg. Since the LOD value (1 µg/kg) was higher than several reported sample 
concentrations, the lowest value of 0.5 µg/kg was used as basis to account for uncertainties 
of measurements. When the concentrations were pooled together, the mean concentration 
(MB) was 0.6 µg/kg. 
 




Concentration data for «vegetables» were available from Livsmedelsverket et al. (2014), with 
a total of five samples. The BHT concentrations ranged from less than 0.5 µg/kg (LOD of 1 
µg/kg) in four samples to 0.68 µg/kg. When the concentrations were pooled together, the 
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Concentration data for «fruits» were available from Livsmedelsverket et al. (2014), with a 
total of four samples. The BHT concentrations ranged from less than 0.5 µg/kg (LOD of 1 
µg/kg), to 4.72 µg/kg. When the concentrations were pooled together, the mean 
concentration (MB) was 1.5 µg/kg. 
 
These concentrations were from Sweden, and used both in the «realistic» and «high» 
scenario. 
 
Meat, and meat products 
Concentration data for «meat, and meat products» were available from Livsmedelsverket et 
al. (2014), and Yuan et al. (2010), with a total of six samples. The BHT concentrations 
ranged from less than 0.5 µg/kg (LOD of 1 µg/kg) in the five samples from Livsmedelsverket 
et al. (2014), to 0.59 µg/kg in sausages from Yuan et al. (2010). When the concentrations 
were pooled together, the mean concentration (MB) was 0.3 µg/kg. 
 




Concentration data for «pepperoni» were available from DeWitt et al. (1996), with a total of 
14 samples. The BHT concentrations ranged from 500 µg/kg, to 36100 µg/kg in pepperoni 
w/capasaicinoid-oleoresin. When the concentrations were pooled together, the mean 
concentration (MB) was 23586 µg/kg. 
 
These concentrations were from the USA, and used both in the «realistic» and «high» 
scenario. 
 
Fish, and seafood 
Concentration data for «fish and seafood» were available from Livsmedelsverket et al. 
(2014), Lundeby et al. (2013), Miljødirektoratet (2014), and Overvåkning (2005), with a total 
of 76 samples. Fifteen of the samples were of «wild fish», 24 of the samples were of 
«freshwater fish», 19 of the samples were of «shrimp and mussles», and 18 samples were of 
«fish liver». 
 
The BHT concentrations ranged from less than 0.1 µg/kg (in perch and mussels) to 11.86 
µg/kg (in cod liver). When all concentrations were pooled together, the mean concentration 
(MB) was 1.6 µg/kg. 
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To be more specific in the coding process for the realistic dataset, «wild fish» were given the 
pooled concentrations of 1.6 µg/kg (MB), «fish, freshwater» were given the pooled 
concentration of 0.9 µg/kg (MB), «shrimp, and mussles» were given the pooled 




Concentration data for «farmed fish» were available from Lundby et al. (2010), with a total 
of 60 samples. The BHT concentrations ranged from 30 µg/kg, to 7560 µg/kg in «farmed 
fish». When the concentrations were pooled together, the mean concentration (MB) was 
2645 µg/kg. 
 




Concentration data for «egg» were available from Livsmedelsverket et al. (2014), with a 
total of four samples. The BHT concentrations ranged from less than 0.5 µg/kg (LOD of 1 
µg/kg) to 1.05 µg/kg. When the concentrations were pooled together, the mean 
concentration (MB) was 0.45 µg/kg. 
 




Concentration data for «dairy» were available from Livsmedelsverket et al. (2014), and 
Pattono et al. (2009), with a total of 26 samples. The BHT concentrations ranged from less 
than 0.5 µg/kg (LOD of 1 µg/kg), to 1412 µg/kg from Pattono et al. (2009). When the 
concentrations were pooled together, the mean concentration (MB) was 249 µg/kg. 
 




Concentration data for «goat milk» were available from Pattono et al. (2009), with a total of 
eight samples. The BHT concentrations ranged from 5 µg/kg, to 290 µg/kg in «goat milk». 
When the concentrations were pooled together, the mean concentration (MB) was 147 
µg/kg. 
 
These concentrations were from Italy, and used both in the «realistic» and «high» scenario. 
 
Coffee creamer 
One sample of coffee creamer was available from Yuan et al. (2010) with a concentration of 
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Concentration data for «vegetable cream» were available from Maziero et al. (2001), with a 
total of nine samples. The BHT concentrations ranged from less than 2700 µg/kg (LOD), to 
109000 µg/kg in «vegetable cream». When the concentrations were pooled together, the 
mean concentration was 45500 µg/kg. 
 
The concentrations were from Brazil and were excluded from the realistic dataset. 
 
Cheese 
Concentration data for «cheese» were available from Yang et al. (2002), with a total of two 
samples. The BHT concentrations ranged from 56700 µg/kg, to 87100 µg/kg in «cheese». 
When the concentrations were pooled together, the mean concentration was 71900 µg/kg. 
 
The concentrations were from Taiwan and were excluded from the realistic dataset. 
 
Margarine and butter 
Concentration data for «margarine and butter» were available from Yang et al. (2002), 
Maziero et al. (2001), Saad et al. (2007), and Sasha et al. (2014) with a total of 49 samples. 
The BHT concentrations ranged from 7800 µg/kg, to 310000 µg/kg in «margarine and 
butter». When the concentrations were pooled together, the mean concentration was 92039 
µg/kg. 
 
The concentrations were from Zimbabwe, Malaysia, Taiwan and Brazil, and were excluded 
from the realistic dataset. 
 
Various oils 
Concentration data for «various oils» were available from Yang et al. (2002), Maziero et al. 
(2001), Saad et al. (2007), Ni et al. (2000), Cacho et al. (2016), Lin et al. (2013), and Sasha 
et al. (2014) with a total of 53 samples. The BHT concentrations ranged from less than 0.04 
µg/kg (LOD), to 336400 µg/kg in «various oils». When the concentrations were pooled 
together, the mean concentration was 43153 µg/kg. 
 
Forthy samples from Taiwan, China, Brazil, Zimbabwe, and Malaysia were excluded from the 
realistic dataset. Fourteen concentrations from Sweden and Spain were included in the 
realistic dataset. The samples included concentrations form the Swedish foodbasket, and 
Spanish samples of peanut oil, olive oil, sunflower oil, and sesame oil. When the European 
concentrations were pooled toghether, the mean concentration was 6.2 µg/kg (MB).  
 
Mayonnaise 
Concentration data for «mayonnaise» were available from Medeiros et al. (2010), and Yang 
et al. (2002), with a total of six samples. The BHT concentrations ranged from 11000 µg/kg, 
 
 
VKM Report 2019:14  124 
to 124700 µg/kg in from Yang et al. (2002). When the concentrations were pooled together, 
the mean concentration (MB) was 48117 µg/kg. 
 




Concentration data for «fish oil» were available from Yang et al. (2002) with a total of five 
samples. The BHT concentrations ranged from less than 51900µg/kg, to 304400 µg/. When 
the concentrations were pooled together, the mean concentration (MB) was 144140 µg/kg. 
 
The concentrations were from Taiwan, and were excluded from the realistic dataset. 
 
Sweets and chocolate 
Concentration data for «sweets and chocolate» were available from Livsmedelsverket et al. 
(2014), with a total of 4 samples. The BHT concentrations ranged from 1.53 µg/kg, to 8.32 
µg/kg. When the concentrations were pooled together, the mean concentration (MB) was 3.9 
µg/kg. 
 




Concentration data for «chewing gum» were available from Ruiz et al. (1999), Boussenadji 
et al. (1993), Edin et al. (2010), Garcia-Jimenez et al. (2009), and Lin et al. (2003) with a 
total of 35 samples. The BHT concentrations ranged from 25800 µg/kg, to 295600 µg/kg. 
When the concentrations were pooled together, the mean concentration was 135132 µg/kg. 
 
These concentrations were from Spain, France, and the USA, and were used both in the 
»realistic» and «high» scenario. 
 
Starchy snacks 
Concentration data for «starchy snacks» were available from Sasha et al. (2014), with a total 
of seven samples. The BHT concentrations ranged from 1800 µg/kg, to 151300. When the 
concentrations were pooled together, the mean concentration (MB) was 46200 µg/kg. 
 
The concentrations were from Zimbabwe, and were excluded from the realistic dataset. 
  BHT in PCPs 
Table 11.4-1. BHT concentration data (µg/g) in personal care products (PCP) taken from literature 
and allocated according to a «realistic» and a «high» exposure scenario.  
Product BHT concentration µg/g 
«Realistic» exposure approach 
BHT concentration µg/g 
«High» exposure approach 
After shave   30.60 30.60 
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Product BHT concentration µg/g 
«Realistic» exposure approach 
BHT concentration µg/g 
«High» exposure approach 
After-sun cream 3.16 3.16 
Antiwrinkle cream 13.41 26.81 
Deodorant 269.79 700.00 
Eye make-up remover 43.90 43.90 
Facial cleansing milk 85.20 85.20 
Foundation 50.00 100.00 
Lip gloss & lipstick 1201.88 2996.00 
Hair conditioner 71.10 71.10 
Hair gel 183.33 220.00 
Hair oil 863.33 1540.00 
Hand cream 187.76 354.24 
Hand sanitizer 200.00 200.00 
Hand soaps 31.30 93.30 
Liquid soap 2.10 10.00 
Make-up 34.50 34.50 
Make-up remover 1760.00 1760.00 
Moisturizing cream 285.73 2201.00 
Shampoo 0.00 4.10 
Shower gel 0.16 0.16 
Sunscreen 7.42 14.50 
Toothpaste 200.00 200.00 
 
 
Table 11.4-2. Amount of personal care products (PCPs) used (g) per application taken from 
literature and allocated according to a «realistic» and a «high» exposure approach. 
















Shower gel 8.00 23.20 8.50 26.20 
Shampoo 8.10 25.30 5.10 13.90 
Conditioner 7.50 27.00 5.20 7.20 
Deodorant 0.86 2.55 0.88 2.54 
Facial cleanser 2.73 8.04 2.79 6.75 
Facial moisturizer 0.68 2.63 1.24 3.63 
Body lotion 7.55 23.55 5.10 19.60 
Anti-wrinkle cream 0.51 1.90 0.73 0.77 
Sunscreen 1.45 7.90 2.35 4.80 
Mouth wash 15.10 28.20 15.60 30.40 
Toothpaste 1.09 3.00 1.42 2.81 
Perfume 0.22 0.59 0.23 0.62 
Lip-gloss, lipstick, lip balm 0.01 0.04 0.02 0.05 
Foundation 0.09 0.37 0.60 1.20 
Intimate soap 2.00 6.50 na na 
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Hand cream 0.88 2.73 1.39 3.06 
Foot cream 2.73 8.37 3.31 8.49 
Hair styling products 2.87 8.50 1.93 6.57 
Hair styling hair spray 1.35 3.94 na na 
Hair treatment products stay on 0.94 3.15 na na 
Hair treatment products rinse off 10.80 37.70 na na 
Eye-makeup products 0.01 0.02 na na 
Rouge and powder 0.01 0.03 na na 
Make up remover 2.01 5.32 0.30 0.80 
Shaving products 7.53 25.37 2.82 10.04 
Antibac 0.88 2.73 1.39 3.06 
Oils 1.80 4.00 2.10 9.01 
Hand soap 1.99 4.90 2.90 7.26 
 
 
Table 11.4-3. Dermal and oral retention factors (RFs) applied for the estimation of BHT exposure 
from personal care products (PCPs) in the EuroMix study population.  
PCP categories in EuroMix Application scenario RF dermal   RF oral 
Shower gel Rinse off skin  0.01 
 
Shampoo Rinse off skin  0.01 
 
Conditioner Rinse off skin  0.01   
Deodorant Stay on skin 1   
Facial cleanser Rinse off skin  0.01 
 
Facial moisturiser Stay on skin 1 
 
Body lotion Stay on skin 1 
 
Anti-wrinkle cream Stay on skin  1 
 
Sunscreen Stay on skin 1 
 
Mouthwash Brush teeth 0 0.2 
Toothpaste Brush teeth 0 0.2 
Perfume Spray on skin (perfume) 1 
 
Lip-gloss, lipstick, lip balm Leave-on skin 0.1 0.9 
Foundation Leave-on skin 1 
 
Intimate soap Rinse-off skin  0.01 
 
Hand cream Leave-on skin 1 
 
Foot cream Stay on skin 1 
 
Hair styling products Stay on hair 
  
Hair treatment products rinse off Rinse off skin  0.01 
 
Eye-makeup products Stay on skin 1 
 
Rouge and powder Stay on skin 1 
 
Make up remover Stay on skin 0.01 
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PCP categories in EuroMix Application scenario RF dermal   RF oral 
Antibac Stay on skin 1 
 
Oils Stay on skin 1 
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12 Appendix - Deviations from the 
protocol 
According to the protocol the assessment should include all age groups. It turned out that 
calculating external and total internal exposure from multiple exposure pathways became 
tedious, and it was therefore limited to including adults only. It was considered most 
important to make the exposure calculations thorough for one age group, in order to gain 
experience with the methodology. In this way, focus could be kept on the differences in 
methodology used for the exposure assessment 
Exposure from indoor air was not estimated as stated in the protocoldue to lack of 
concentration data on BHT in indoor air.  
The total exposure to potential harmful metabolites was not estimated. The BHT metabolism 
is complex and more than 40 metabolites have been identified. Due to lack of knowledge on 
the metabolites, the Panel was not able to perform this estimation. 
The exposure were calculated both deterministically and probabilistically. The deterministic 
approach was called OIM in this assessment.  
 
